University of Tennessee, Knoxville

TRACE: Tennessee Research and Creative
Exchange
Doctoral Dissertations

Graduate School

5-2012

An integrative functional genomics approach towards quantitative
trait gene nomination in existing and emerging mouse genetic
reference populations
Vivek Philip
vphilip@utk.edu

Follow this and additional works at: https://trace.tennessee.edu/utk_graddiss
Part of the Genetics Commons, and the Genomics Commons

Recommended Citation
Philip, Vivek, "An integrative functional genomics approach towards quantitative trait gene nomination in
existing and emerging mouse genetic reference populations. " PhD diss., University of Tennessee, 2012.
https://trace.tennessee.edu/utk_graddiss/1336

This Dissertation is brought to you for free and open access by the Graduate School at TRACE: Tennessee
Research and Creative Exchange. It has been accepted for inclusion in Doctoral Dissertations by an authorized
administrator of TRACE: Tennessee Research and Creative Exchange. For more information, please contact
trace@utk.edu.

To the Graduate Council:
I am submitting herewith a dissertation written by Vivek Philip entitled "An integrative functional
genomics approach towards quantitative trait gene nomination in existing and emerging mouse
genetic reference populations." I have examined the final electronic copy of this dissertation for
form and content and recommend that it be accepted in partial fulfillment of the requirements
for the degree of Doctor of Philosophy, with a major in Life Sciences.
Elissa J. Chesler, Major Professor
We have read this dissertation and recommend its acceptance:
Brynn H. Voy, Arnold M. Saxton, Matthew A. Cooper
Accepted for the Council:
Carolyn R. Hodges
Vice Provost and Dean of the Graduate School
(Original signatures are on file with official student records.)

An integrative functional genomics approach towards
quantitative trait gene nomination in existing and emerging
mouse genetic reference populations

A Dissertation
Presented for the
Doctor of Philosophy
Degree
The University of Tennessee, Knoxville

Vivek M. Philip
May 2012

Copyright © 2012 by Vivek M. Philip
All rights reserved.
ii

DEDICATION

To my loving wife, Lucy Reynolds Philip, who has been with me and
unconditionally supported me through both the joyful and difficult times.
To our son Nicholas Vivek Philip, a constant source of joyful entertainment and a
reminder of what matters most in life.

iii

ACKNOWLEDGEMENTS
I would like to thank my parents, Commander (Retd.) Mohan and Annamma
Philip, my brother, Vinod M. Philip, my sister-in-law Ira S. Philip, and my fatherin-law and mother-in-law, Michael and Charlene Reynolds for their support and
encouragement during my years in graduate school. The unwavering support of
my family and their confidence in my abilities was immeasurably beneficial in
keeping me focused and motivated throughout the duration of my graduate
studies.

I would like to express my gratitude towards my advisor, Dr. Elissa J. Chesler for
providing me with the opportunity of pursuing my graduate studies under her
tutelage. I also thank her for giving me the opportunity to attend multiple scientific
conferences, on a yearly basis. These conferences helped in improving upon and
in learning new concepts directly related to my field of research. Furthermore, it
provided me with the opportunity to meet and network with other graduate
students and faculty.

I also thank Drs. Brynn H. Voy, Arnold M. Saxton, Matthew A, Cooper, Wayne
Frankel and Mary Ann Handel for their support, advice and feedback on my
research. It has truly been an extremely enjoyable experience. Last but not the
least, I thank the Genome Science and Technology program for giving me the
opportunity to pursue my graduate studies.
iv

ABSTRACT
An approach that has been widely applied for the genetic dissection of
complex traits is Quantitative Trait Locus (QTL) mapping. QTL mapping identifies
genomic regions that harbor polymorphisms, responsible for the observed
variation in a complex trait. If these polymorphisms are located within a gene,
then these genes are called Quantitative Trait Genes (QTG). Prior to
advancements in QTL mapping populations, QTL mapping resolution was often
poor, resulting in large QTL intervals. Therefore, after mapping a QTL, fine
mapping was initiated to further reduce the QTL interval and to identify the QTG.
While successful, fine mapping using genetic approaches have been extremely
time and resource intensive, making it the rate-limiting step in QTG discovery.
Thus far, only a few QTGs have been successfully identified and validated. The
disproportionate ratio of QTLs mapped to QTGs identified has been a cause of
concern.
Successful QTG discovery relies on the power and resolution with which
QTLs are mapped and the genetic architecture of the underlying QTL mapping
population. Here, QTL mapping performance in two recently developed QTL
mapping populations, namely the expanded BXD Recombinant Inbred (RI) strain
panel and the collaborative cross (CC) are assessed. Results indicate that while
both the expanded BXD RI strain panel and the CC improve QTL mapping
resolution, the CC is able to achieve greater precision and resolution in QTL
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mapping. However, neither the BXD RI nor the CC facilitates gene level
resolution in QTL mapping.
Recent studies have used the integration and convergence of evidence
among functional genomics studies as a successful strategy towards the efficient
and rapid nomination of QTG. Here, the complementary in silico approach of
integrative functional genomics, using GeneWeaver (www.geneweaver.org), is
applied towards the reduction of two cocaine-induced locomotor activation QTLs,
mapped in the expanded BXD RI strain panel. Integrative functional genomic
analyses of these QTLs led to the nomination of Rab3b as a putative QTG.
Functional assessment of Rab3b using Rab3bcd knockout mice reveals its role in
acute habituation mediated cocaine response, serving as evidence of the
efficiency and utility of integrative functional genomics for the identification of
highly relevant QTG.
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CHAPTER I: INTRODUCTION
This dissertation illustrates the progress that has been made to address
the challenge of identifying quantitative trait genes (QTG) underlying complex
traits. Identification of QTG has relied heavily on the technique of quantitative
trait locus (QTL) mapping. However, the power and resolution of detecting QTL
and thereby QTG, depends on the nature of the experimental crosses or genetic
reference populations (GRPs) used. To improve upon the prospects of identifying
QTGs using QTL mapping, advances in GRPs have been made. The studies
presented here help assess the performance of QTL mapping and prospects of
QTG discovery in two GRPs, namely the expanded BXD Recombinant Inbred
(RI) strain panel (Chapter II) and the collaborative cross (CC) GRP (Chapter III).
While advances in GRPs have improved the performance of QTL mapping, gene
level resolution is still not attainable. Hence, after a QTL has been mapped
additional fine mapping is required to identify the QTG. Even though, fine
mapping has been successful in identifying QTG, it is an extremely time and
resource intensive process. To expedite the discovery of QTGs, complementary
bioinformatic and computational approaches have been proposed, with limited
success. In Chapter IV, the in silico approach of integrative functional genomics
is proposed as a complementary approach to fine mapping and existing
bioinformatic approaches and is applied towards the behavior of cocaine-induced
activation for the nomination and validation of a putative QTG.

1

Background
Tremendous success has been achieved in understanding the genetic
basis of a variety of complex human diseases and disorders. Part of this success
is attributable to the field of behavioral quantitative trait genetics. Utilizing
induced organismal models of complex human disorders, behavioral genetics
aims to understand the genetic basis of quantitative traits and mechanisms that
facilitate interactions between organisms and their environments. Among the
variety of model organisms available, Mus musculus has been widely used to
study both simple, Mendelian diseases (e.g. cystic fibrosis (174), HermanskyPudlak syndrome (69) and Waardenburg syndrome (141)) and complex
multigenic disorders (e.g. alcohol preference (75, 177, 225), diabetes (207) and
bipolar disorders (65, 128)). The high degree of homology between human and
mouse genomes, availability of basic and advanced genomic tools, resources
and decades of research findings are some of the reasons for the widespread
use of Mus musculus as a model organism.
Studies involving mice as models for human disorders dates back to the
HDUO\¶V$URXQGWKLVWLPHPRXVHJHQHWLFLVWVVWDUWHGWRGHYHORSLQEUHG
strains of mice and document spontaneously arising mutations. Since then inbred
strains of mice have been the mainstay of mouse genetics. They have been used
as founders for the derivation of quantitative trait mapping populations (e.g. F2,
BC and genetic reference populations), which have been utilized in complex trait
analysis. Despite the availability of inbred strains, mapping populations and
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JHQRPLFUHVRXUFHVLWZDVQRWXQWLOWKHHDUO\¶VWKDWFRPSOH[WUDLWVZHUHILUVW
mapped using mice. This occurred as a consequence of the development of
statistical methodologies along with the availability of large collections of
molecular tools and/or genetic markers facilitating the association of trait
variation to genetic variation. Furthermore, these methodologies permitted, albeit
crudely, the estimation of genomic regions responsible for complex traits. This
led to the development of the field of quantitative trait locus (QTL) mapping.
Advances in genomic resources and statistical methodologies, even
though extremely beneficial, have resulted in the current situation that plagues
the field of QTL mapping, i.e., far more QTLs than QTG. The low turnover ratio of
QTL to QTG has raised doubts about the utility of QTL mapping with proposals of
alternate approaches such as ENU mutagenesis (148) in identifying genes
underlying complex traits. While such concerns are reasonable, the rate-limiting
step in the identification of QTG is not the QTL mapping process, but rather the
lack of an efficient and rapid methodology that facilitates reduction of a QTL
interval to nominate a QTG. While expansions (e.g. recent expansion of the BXD
RI strain panel (162)) and advances (e.g. collaborative cross (42)) in genetic
reference populations will improve precision and resolution in QTL mapping,
complementary computationally efficient approaches that facilitate QTG
discovery must be developed. One such approach is integrative functional
genomics, which provides a robust, efficient and scalable framework within which
the reduction of a QTL interval to highly relevant QTG can be achieved.
Furthermore, integrative functional genomics allows analyses to be performed
3

across multiple species and experimental data types, thereby implicitly facilitating
translation research.
Quantitative trait locus mapping
Behavioral quantitative trait genetics aims to achieve a better
understanding of the genetic basis of behavior. To do so one must associate
phenotypic variation in behavior to genetic or sequence variation. Genetic
variation comes in the form of segregating polymorphisms. A widely used
statistical method that facilitates detection of genomic regions that are
significantly associated with phenotypic variation is QTL mapping. The concept of
QTL mapping was first defined by K. Sax in 1923 (181). QTL mapping belongs to
the class of genome-wide scanning approaches rather than a candidate gene
approach. Unlike the candidate gene approach, genome-wide scanning
approaches make no presumptions regarding the importance of any particular
gene or genes for the phenotype being investigated. As a result, QTL mapping is
a truly unbiased approach that helps facilitate the discovery of polymorphisms
associated with a given phenotype.
Methods for mapping QTL
QTL mapping is often carried out in populations that originate from
crosses of inbred lines that differ phenotypically for the trait of interest. As these
lines are inbred, they are homozygous at all loci (markers and QTL) of their
respective genomes. The first filial (F1) generation involving these inbred lines
will be heterozygous and genetically identical across all loci. F1 progeny can then
4

be either backcrossed to one of the two parents generating a backcross (BC)
population or sib mated to generate a second filial (F2) population. Both the BC
and the F2 populations consist of genetically diverse individuals, who also exhibit
phenotypic variation and are consequently extremely useful in QTL mapping.
Another valuable and widely used population for QTL mapping is the panel of
recombinant inbred lines (RILs). RILs are derived from twenty or more
generations of inbreeding via full sibling matings or selfing in plants, starting with
an F2 population. During the process of inbreeding, the genomes of the F2
progeny undergo recombination, resulting in the creation of RILs that are
genomic mosaics of their founders. Historically, RILs have proven to be
extremely useful in mapping QTL in multiple model organisms, including, M.
musculus, C. elegans and D. melanogaster. Once a QTL mapping population
has been derived, the next steps involves phenotyping and genotyping all
individuals within the population. This is followed by application of one of two
statistical methods for mapping QTL, namely, single marker analysis or interval
mapping.
Single-marker analysis
Single-marker analysis is the simplest approach to QTL mapping
(15, 223). This approach utilizes an analysis of variance (ANOVA) methodology,
also referred to as marker regression. In this method, the genotypes at a QTL
marker are separated into their respective groups. If one were to consider a BC
mapping population, individuals within this mapping population can be divided

5

into one of two groups, namely, homozygotes or heterozygotes. Statistical tests
for strength of evidence of a QTL are then carried out either using a t-test or an
F-test depending upon the type of cross. The primary advantage of single marker
analysis is its simplicity. However, this approach has multiple limitations. First,
this approach fails to account for recombination between a marker and a QTL.
Second, incorrect estimates of QTL location can be obtained, especially when a
marker is far way from the true QTL. Third, individuals with missing genotypes
have to be omitted from the analysis.
Interval mapping
Interval mapping was developed in order to over come the
simplistic nature of single marker analysis (114). Interval mapping incorporates
the genetic map of the markers and interrogates the genome at regular intervals
for the evidence of a QTL. By calculating a LOD (logarithm of odds favoring the
presence of a QTL) score across the genome, interval mapping generates a LOD
curve (Figure 1-1). In Figure 1-1, the LOD curve at its maximum point indicates
the most likely location of a QTL. Using either 1-, 1.5- or 2-LOD drops from the
peak marker, an estimated location or confidence interval (CI) of a QTL is
obtained. The 1.5-LOD drop is the most widely used, as it corresponds to an
approximately 95% QTL CI (61), However, careful attention should be paid
towards the selection of LOD drop based CI as it depends largely on the QTL
effect size and marker density. The main advantage of interval mapping over
single marker analysis is that in the light of incomplete or missing genotypic data,
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Figure 1-1. A typical QTL LOD curve.
Data plotted here are a significant Chr 5 QTL from the experiment of Boyartchuk
and colleagues on the susceptibility to Listeria monocytogenes infection in the
mouse using R/QTL (22, 27). The solid, dotted and dashed lines represent
permutation based significance and suggestive thresholds. Vertical ticks on the
x-axis represents genotyped marker on Chr 5 in this study.
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interval mapping imputes the missing genotype using the flanking markers rather
than discard the individual. The observed LOD score (obtained using the actual
mapping dataset) is then compared to the distribution of peak LOD scores
obtained following interval mapping on each permuted dataset. QTL significance
is then determined based on the proportion of permuted LOD scores exceeding
the observed LOD score, giving an estimated p value. It should be noted that the
distribution of a LOD scores obtained during a permutation analysis is influenced
by the type of cross, number of markers, the inter-marker interval, missing
genotypic data patterns and the original or observed phenotypic distribution (26).
This was shown by Lander and Botstein (114), who performed a variety of
simulation estimating the LOD threshold as a function of cross type, genome
sizes and marker density. Depending on the cross type, a map expansion factor
of 1 (BC), 2 (F2) or 4 (RIL) needs to be incorporated into the calculation of LOD
scores (114). The permutation approach put forth by Churchill and Doerge can
be applied to any mapping dataset, regardless of the distribution of the
underlying data. However, this approach must be used appropriately, taking into
account the underlying population or family structure of the mapping population.
Failing to do so will result in incorrect estimates of significance thresholds leading
to inflated type I error rates in QTL mapping. Specifically, simple permutations
described above cannot be applied without modifications to mapping populations
such as advanced intercross lines (AIL) and heterogeneous stock (HS). In such
mapping populations, due to their inherent population structure, approaches such
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as mixed model association (103) or model averaging approaches (214) are
employed to map QTL after taking into account the population structure.
From QTL to quantitative trait genes
Advances in genotyping and phenotyping technologies have resulted in an
exponential increase in the number of published QTLs. However, very little
progress has been made in the positional cloning or identification of the relevant
gene(s) affecting complex traits. As of today over 4,600 QTLs exists. Of these
QTLs only 20 genes have been nominated and validated as QTG (74, 138). The
current miniscule ratio of QTG to QTL has raised concerns about the utility of
QTL mapping for dissecting complex traits (148). The reasons why little progress
has been made in the identification of QTG include:
•

The majority of the cloned QTLs to date have been QTL with unusually
large effect sizes (74). However, QTLs typically have small effect
sizes, thereby making them harder to dissect and clone. It is not
reasonable to expect that experimental procedures used to clone large
effect QTL will also be both applicable and successful for small effect
QTL. Unlike large effect QTL, small effect QTL are driven by multiple
linked loci, thereby requiring many more recombinants to successfully
isolate a single gene. For example, a genetic strategy employing
congenic strain pairs will not successfully clone small effect QTLs.
Interval specific congenics could probably facilitate cloning of small
effect QTLs, but would require large numbers of recombinant progeny.
9

•

It has been reported that the underlying molecular basis of QTL are
often due to non-coding regulatory variants compared to coding
regulatory variants (107, 129). Unlike coding regulatory variants that
would result in a missense, nonsense or some other form of easily
detectable polymorphism, non-coding regulatory variations are harder
to detect and validate.

•

Lastly, a typical QTL interval width can span tens of cM. A typical QTL
interval in mice spans 10 – 30 cM or approximately 20 to 60 Mb (78).
Multiple factors affect the QTL interval, including, marker density,
phenotypic variance accounted for by the QTL, and the type of cross.
Large QTL intervals will invariably contain hundreds of genes (also
called candidate genes), making it tedious and painstaking to identify
the causative gene or genes.

Methodologies that currently exist for the nomination of QTGs can be
classified into two main categories, namely, genetic and bioinformatic
approaches.
Genetic approaches
Genetic approaches facilitate QTG nomination by making use of the
concept of homologous recombination. Using homologous recombination, the
original QTL region is reduced to a narrower region consisting of a handful of
potential QTG. Classical approaches include congenic strain pairs, chromosome
substitution strains, advanced intercross lines and heterogeneous stock. In
10

addition to classical approaches, newer genetic approaches have been
developed that include collaborative cross and Diversity outbred.
Existing mouse genetic resources
Congenic strain pairs and interval specific congenics
Congenic strain pairs or congenics have been the most
widely used resource for fine-mapping QTL. Congenics are derived from two
inbred strains, a donor and recipient strain, which differ on the trait of interest.
The progenitors strains are crossed to produce the F1 generation progeny. F1
progeny carrying the donor region of interest are selected for and backcrossed to
the recipient strain. At least ten generations of backcrossing to the recipient
strain is performed to reduce the amounts of donor strain genome, such that
99.9% of the genome in the progeny is recipient derived. At this generation, the
residual amount of unlinked donor strain genome is < 0.01%. This is done in
RUGHUWRUHGXFHWKHDPRXQWRI³EDFNJURXQG´RUKLWFKKLNLQJJHQHVWKDWDUHFORVHO\
linked to the donor strain region of interest. The presence of hitchhiking genes in
the recipient genome would very easily lead us to the wrong conclusion and in
the failure to capture the true QTL. At the end of backcrossing, heterozygous
congenics are intercrossed to obtain homozygous congenics. The primary
drawback of classical congenics is that the donor strain interval tends to be too
large, often around 50 Mb, and is often dissected into several linked QTLs (169,
170). If these linked QTLs exert opposite effects on the phenotype, then the
identification of the causative gene(s) involved becomes even more difficult (60,
11

237). Furthermore, isolating a QTL onto a recipient strain can result in a
reduction in the effect size compared to the originally mapped QTL. This would
further complicate the identification of the causative gene(s). In order to
overcome these limitations, interval specific congenics (ISC) were developed.
Backcrossing the congenics or consomics to the background strain of interest
serves as the first step in the derivation of ISC. Some among the first generation
(N1) offspring will be recombinant within the original interval of interest, i.e. the
QTL interval. These offspring are identified using markers that reside within or
flank the QTL interval. Once these individuals are identified, further refinement of
the interval of interest is achieved by backcrossing to the background strain.
Once the maximum amount of interval refinement has been achieved,
backcrossing generates a panel of ISC lines. At this stage the ISCLs are
heterozygous at the region of interest. In order to obtain ISCLs that are
homozygous for the donor regions, the heterozygous mice are intercrossed.
Phenotyping the ISCL facilitates detection of narrow genomic regions positively
associated with or manifesting the QTL of interest.
The use of ISCLs often achieves fine mapping of the original QTL to 1-2
Mb. This results in only a handful of potentially causative genes to follow-up,
thereby facilitating QTG discovery. Mpdz (189), II-2 (55) and Kcnj10 (71) are
QTGs that have been identified using the ISC approach in mice, while Cyp11b1
(44) is an example of application of the ISC approach in rats. Despite its
theoretical simplicity and feasibility, this approach has multiple challenges and
drawbacks. First, there is a good chance that the QTL of interest might not be
12

captured due to loss of an epistatic interaction or closely linked QTL that exists
with the original QTL. Secondly, it takes a considerable amount of time and
resources to generate sufficient numbers of ISCs to successfully identify a single
candidate gene or gene variant that defines the QTL.
Chromosome substitution strains
Chromosome substitution strains (CSSs) or consomics
strains have been proposed as a means to achieve the genetic dissection of a
QTL. Transferring an entire chromosome from a donor strain onto a background
strain by repeated backcrossing generates CSS strains (134, 149). The first
complete set of CSS created was from the two inbred strains A/J (donor) and
C57BL/6J (background) (192, 193). While CSS have been used to dissect QTL,
they have also been utilized to map QTLs. This is because a CSS panel has the
advantage of mapping QTLs that explain a greater proportion of the total
phenotypic variance or QTL effect size and the ability to employ lower
significance thresholds towards the detection of significant QTLs. Their utility in
high-resolution mapping is made possible in two ways, through rapid creation of
interval specific congenic lines and recombinant progeny testing (RPT) (50). By
backcrossing the CSS that harbors the QTL followed by intercrossing the F1
progeny, a congenic (smaller introgressed intervals in comparison to the original
CSS) F2 population is created. A new set of ISC is created from the congenic F2
population followed by high-resolution mapping. In RPT, animals that are
recombinant in the QTL region of interest are backcrossed to a background strain
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that helps in the identification of the QTL location relative to the site of
recombination (19, 68).
Despite the ease with which one can map and generate a CSS panel, they
suffer from a major limitation, i.e. their inability to facilitate the dissection of large
effect QTLs into many loci smaller of effects. This hinders the ability with which
smaller effects QTLs can be fine-mapped using this resource.
Advanced intercross lines
Advanced intercross lines (AIL) facilitate refinement in QTL
mapping by introducing new recombinations via intercrossing (51). Starting with a
F2 population, intercrossing is typically performed for eight or more generations
(to arrive at F10), by randomly intercrossing progeny in each generation to
produce the next. Careful attention is paid towards the selection of mice that
produce the next generation by avoiding sib-pairs and cousins. This is done in an
attempt to maintain a randomly mating population and avoid fixation (due to
inbreeding) of alleles so as to maintain maximum genotypic diversity. Increased
numbers of recombinant progeny within an AIL facilitates high-resolution
mapping of QTLs. It has been shown that for a QTL with large effect mapped in a
large population (N = 1500), an AIL (greater than F10) achieves a QTL CI of
approximately 5 cM compared to 14.8 cM in an F2 population (51). Furthermore,
AILs can help resolve closely linked QTLs. For example, if two QTLs are closely
linked (approximately 5 cM apart), an F2 population will fail to dissect them.
However, in an AIL at F10 these loci are predicted to be 26 cM apart facilitating
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detection of both loci and thereby resolving linked QTLs (51). Numerous studies
have made use of AILs for fine-mapping QTLs (67, 94, 180, 199, 220, 221, 234,
238). Despite the advantages offered by an AIL, the primary disadvantage is the
inherent presence of family structure that exists at the final generation of AILs.
Family structure or non-independence among individuals due to the complex
breeding history of AILs, when unaccounted for, results in detection of spurious
QTLs (160). Statistical methods have been devised to account for family
structure and must be utilized when an AIL is used for fine-mapping a QTL (104,
153, 214).
Heterogeneous stock
A series of repeated intercrosses involving inbred strains of
mice results in the derivation of the heterogeneous stock (HS). Existing HS have
been derived from an initial cross involving eight progenitor strains. Currently,
two HS panels exist: the Boulder IBG heterogeneous stock (136) has been in
existence for over 60 generations and is derived from the C57BL/6, BALB/c, RIII,
AKR, DBA/2, I, A/J and C3/HeJ strains and the Northport heterogeneous stock
(53) that has been in existence for over 40 generations and is derived from the
A/J, AKR/J, BALB/cJ, C3H/HeJ, CBA/J, DBA/2J and LP/J strains. New
recombinations are introduced by using a pseudo-random breeding protocol of
circle mating. The increase in numbers of recombinations results in higherresolution mapping. In order to map traits using the HS, specialized statistical
methodologies are utilized that incorporate the probability that an allele descends
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from one of the eight progenitor strains followed by association of these alleles to
the phenotype of interest (145). The fine-grained mosaic of the HS along with
specialized statistical methods has facilitated high-resolution QTL to within 1 cM
for several behavioral measures (90, 131, 145, 204, 205, 230). The primary
disadvantages of the HS lie in the complexity of the mapping analysis,
requirement of high-density genotyping and large mapping sample sizes required
to fine-map QTLs (144).
Emerging mouse genetic resources
Collaborative cross
The collaborative cross (CC) is an emerging mouse genetic
recombinant inbred (RI) panel that is derived combining the genomes of eight
genetically diverse founder strains, namely, A/J, C57BL/6J, 129S1/SvImJ,
NOD/LtJ, NZO/HlLtJ, CAST/EiJ, PWK/PhJ, and WSB/EiJ (42). When completed
the CC will be the largest RI panel, vastly exceeding the genotypic and
phenotypic variation captured in currently existing RI panel such as the BXD RI.
Like the HS, the CC is a fine-grained mosaic of genomes of eight inbred strains
with increased recombinations facilitating high-resolution QTL mapping. Studies
involving the interim CC lines have validated increased precision and resolution
in QTL mapping and vastly increased phenotypic variation across multiple
phenotypes compared to existing RI panels (8, 62, 165). The limitations of this
strategy are primarily due to the complexity of mapping and interpretation of
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mapping results. Furthermore, despite improvements in resolution of QTLs,
single gene identification is yet to be achieved.
Diversity outbred
Originating from a set of 160 breeding lines that founded the
CC population, the DO is produced by an outbreeding rather than an inbreeding
strategy (41). The DO breeding design ensures a balanced contribution of the
founder genomes and at the same time is shielded from the consequences of
inbreeding, such as allele purging. As the DO is outbred, the mice within this
population will be heterozygous, thereby incorporating high levels of allelic
variation and genetic diversity. The high levels of genetic diversity in the DO are
comparable to that in humans, making the DO an extremely useful resource for
the study of complex human disorders.
Bioinformatic approaches
Challenges in transitioning from QTL to QTG have led to the development
of complementary bioinformatic approaches that facilitate QTG nomination.
Bioinformatic approaches incorporate publicly available genomic resources that
include sequence and gene expression databases to refine and narrow a QTL
interval (57).
Comparative genomics
Comparative genomics takes advantage of the structural
conservation of genomes across mammals, specifically those that have been
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used in QTL mapping. Human and mouse genomes have similar genomic
contents and linear arrangement of genes (222). Furthermore, over 300 genomic
segments with conserved synteny have been identified in whole-genome
comparison of humans and mouse (163). Comparison of human and rat
genomes have revealed similar results (155). By searching for overlapping QTL
regions for the same phenotype across multiple species, comparative genomics
has been used successfully to narrow large QTL intervals. Identification of Rf-1
(renal failure-1) is an example of the successful application of this approach for
the reduction in the QTL interval. Using synteny between the rat and human
genome, this QTL was reduced to a set of 66 highly likely candidate diseases
genes. This strategy has also been used for the identification of candidate gene
loci for male fertility (156) and reduction of QTL interval for HDL cholesterol
levels (30, 47). The biggest challenge with this strategy is when a rodent QTL
maps to multiple syntenic blocks along the human genome instead of one
contiguous block, making it harder to detect the true homologous gene.
Combined cross analysis
Combined cross analysis works on the assumption that when the
same causal polymorphism and gene underlies a QTL that has been mapped in
multiple crosses, by combining these crosses one increases the number of
recombination events in the combined cross panel thereby achieving increased
resolution or reduction in the QTL interval. Furthermore, combining multiple
crosses results in an increase in the mapping sample size, facilitating increased
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power in the detection and resolution of QTLs with small effect sizes (121). This
strategy has been successfully applied in achieving better QTL mapping
resolution across diverse traits, such as HDL cholesterol (47, 201, 224) and ear
hole punch healing (39) in mice and experimental autoimmune encephalomyelitis
in rats (96). Limitations of this strategy stem primarily from the fact that not all
QTL have been mapped in multiple crosses. Most of the multiple cross studies
involve the analysis of cholesterol levels, making it the most feasible trait to be
employed in a combined cross analysis. Care should also be taken to ensure that
the phenotype or trait mapped across the multiple crosses is the same.
Combining diverse phenotypic data across multiple crosses will produce spurious
results.
Haplotype association mapping
Haplotype association mapping (HAM) stems from the concept of
genomic segments sharing polymorphisms that in turn are associated with
common ancestral origins. These genomic segments are often referred to as
haplotype blocks. Two methods of HAM exist, namely, interval-specific haplotype
analysis and genome-wide haplotype analysis.
Interval-specific haplotype analysis
Here, an underlying QTL detected in a two strain mapping
study is mapped back to their respective ancestral subspecies of origin. If the
QTL region is identical by descent (IBD) i.e., originating from a common
ancestral subspecies, then it is unlikely to contain the causal genetic
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polymorphism. This strategy has been applied towards the genetic dissection of
rodent QTLs. A metastasis QTL on Chr 19 was reduced from over 400 genes to
around 23 genes (158). Another example is of a blood pressure QTL on Chr 1
that was originally around 42 cM but was refined to an interval of 2.3 cM (56). A
more recent example of a behavioral trait that was refined is of open field
behavior, wherein, by employing multiple crosses and interval specific haplotype
analysis, an approximately 50 Mb region was refined to a 7.8 Mb region on Chr 9
(66).
Genome-wide haplotype analysis
Contrary to interval-specific haplotype analysis, genome
wide haplotype analysis is performed in the absence of the a priori knowledge
that is obtained from a QTL mapping study. Also known as in silico QTL
mapping, genome-wide haplotype analysis seeks to associate phenotype
variation across a panel of inbred strains to their genotypes rather than to a
mapping population derived from inbred strains. Grupe and colleagues (83) were
the first to develop the methodology behind in silico QTL mapping. Using this
methodology Smith and colleagues (195) were the first to perform in silico QTL
mapping of atherosclerosis susceptibility across six inbred strains.
The concept and use of HAM in QTL mapping has been rather
controversial. Questions have been raised regarding the actual sample sizes or
number of strains and the basis of the statistical approach (35, 49). Even in the
light of these controversies, HAM has been utilized for narrowing QTL intervals of
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HDL-C concentration on Chr 8 (167) and Chr 5 (221). Pletcher and colleagues
used HAM to identify a single candidate gene containing a non-synonymous
polymorphism, starting from a QTL that spanned 5 Mb (167). Wang and
colleagues used a combination of AIL first refine the QTL interval from 8.6 Mb to
2.6 Mb. Using HAM, the authors were able to further refine this QTL to a 0.4 Mb
region (221). HAM has also been used for the identification of candidate lung
tumor susceptibility genes by refine the original QTL interval to < 0.5 Mb (123)
and in the detection of Cer1 as a potential candidate for bone mineral density
(BMD) regulation across a panel of inbred strains. By studying CER1 in Chinese
populations with high and low BMD, the authors were able to detect a nonsynonymous polymorphism within CER1 that conferred an increased risk of low
BMD in premenopausal women and an increased risk of vertebral fractures in
postmenopausal women (206).
Sequence and gene expression comparison
Variation present within a QTL interval could either be due to
differences in the gene sequence or expression. As a result, sequence
comparison and gene expression analyses have been performed in order to
detect the most plausible QTG. The recently completed next-generation
sequencing (NGS) by the Sanger Center Mouse Genomes Project has made
available the genomes of 17 inbred mouse strains commonly used in QTL
mapping at very high resolutions (105, 231). This will result in the detection of
large insertion/deletions, copy number variations (CNVs) and other types of
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sequence variants that will help facilitate QTG discovery (105, 217, 231). The
advantage of sequence analysis is in its ability to identify sequence differences
that may not lie within the coding region of the gene (229).
In addition to sequence comparisons, gene expression analyses serves as
a complementary strategy for the identification of QTGs. The idea behind gene
expression analyses is that a QTL will contain genes that harbor sequence
polymorphisms that effect gene function, expression or both. The availability of
public gene expression databases, such as The Gene Expression Omnibus (64),
Array Express (23), The Alan Brain Atlas (1, 118), BioGPS (200), ExQuest (28)
and The Institute for Genome Research (2), facilitate tissue specific gene
expression and differential expression analyses. However, due to the large
numbers of gene expression differences exhibited by murine strains, finemapping will be necessary (138).
Characteristics of genes affecting quantitative traits
Glazier and colleagues (78) and The Complex Trait Consortium (CTC) (5),
have proposed a sets of guidelines or standards to characterize a gene as the
QTG. Listed below is a summarization of the characteristics of a QTG:
•

The QTL that contains the potential QTG should meet statistically
significant genome-wide thresholds (58, 113). In the absence of clear
genome-wide significance from a single study, the QTL should meet
consistent suggestive genome-wide thresholds across multiple
independent studies.
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•

Polymorphisms within a QTG, either in the coding or non-coding region,
should translate into changes in either the structure or expression of the
gene product. Coding sequence non-synonymous polymorphisms are the
easiest class of polymorphisms to detect and validate. Synonymous
coding region polymorphisms have been linked to differential mRNA
stability. Intronic (non-coding) or promoter region polymorphisms could be
detected as changes in mRNA splicing and transcription factor binding
(130). Even though salient, these changes could potentially affect the
amount, timing and tissue specific pattern of gene expression

•

In vivo confirmation of a QTG via alteration of its function should be
obtained. This can be performed using one of many strategies, namely,
targeted gene mutations such as knockouts or deficiencycomplementation tests, transgenesis, viral-mediated RNA interference
(RNAi) and knock-ins.

For a gene to be proven to be the QTG it must possess more than one of the
above stated QTG characteristics. In the absence of a clear and significant
empirical result that proves a gene as the QTG, preponderance of circumstantial
evidence will cumulatively work towards the nomination of a QTG.
Integrative functional genomics
To truly expedite the process of QTG discovery, the vast repertoire
of genomic resources and datasets currently available, need to be harnessed
and utilized efficiently. Currently two popular approaches exist that help integrate
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diverse genomic data sets, namely, meta-analysis and convergent functional
genomics. Meta-analysis is a statistical approach that analyzes large collections
of experimental data with the goal of integrating experimental results and findings
(77). Meta-analysis has been applied to a wide array of genomic data sets, such
as, microarrays (112, 143, 146, 147, 172, 173) and QTL mapping studies (17,
185, 228). Convergent functional genomics (CFG) is a Bayesian strategy that
facilitates integration of gene expression data across human linkage analysis and
relevant animal models (150). CFG has been successfully applied towards the
identification of candidate genes and blood biomarkers for bipolar disorder (111,
116, 159). Despite the successes of meta-analysis and CFG, both approaches
lack computationally efficient infrastructures in the form of databases, algorithms
and user interfaces that facilitates genome scale integrative analyses in a
seamless and scalable manner. Furthermore, while CFG integrates human and
rodent data sets, meta-analysis fails to attain cross-species analysis. Given that
many model organisms have their genomes sequenced, it would be beneficial for
integrative approaches to encompass more than just two species. Additionally,
CFG is tailored towards the needs of a specific laboratory and/or specific
research area.
To truly expedite the process of QTG discovery, computationally efficient
algorithms, databases and user-interfaces need to developed and utilized. One
such approach is integrative functional genomics. Integrative functional genomics
facilitates convergent analyses across multiple genomic experiments, platforms
and species (11), thereby readily lending itself towards the discovery of QTGs.
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Candidate genes within a QTL interval can be integrated with other relevant
empirically derived genomic data sets or gene sets. The gene sets to be used in
the analysis are selected based on the trait in which the QTL was detected. For
example, an integrative functional genomic analysis for a cocaine-induced
locomotor response QTL will include gene sets spanning multiple species for
basal expression across brain reward regions, differential gene expression
across brain reward regions for stimulants that influence brain reward regions
(such as methamphetamines and nicotine), previously mapped QTL studies
involving cocaine-induced locomotion and polymorphism information for the
genes across the founder strains. A ranked list (based on occurrence count
across genomic data sources) of candidate genes can be obtained to prioritize
genes for future validation studies. Such an analysis approach will yield highly
relevant polymorphic genes that can be functionally validated and eventually
nominated as a QTG.

25

CHAPTER II: QTL MAPPING AND QTG DISCOVERY IN EXISTING
GENETIC REFERENCE POPULATIONS
This chapter is adapted from the following publication:
Philip VM, Duvvuru S, Gomero B, Ansah TA, Blaha CD, Cook MN, Hamre KM,
Lariviere WR, Matthews DB, Mittleman G, Goldowitz D, Chesler EJ.
Genes, Brain and Behavior (2010) 9: 129-59.
My contributions to this paper were heritability analysis, QTL mapping, gene coexpression analysis, gene-phenotype combinatorial analysis, KEGG and GO
pathway analysis, interpretation of results, and part of the writing.

Abstract
Genetic reference populations, particularly the BXD recombinant inbred
(BXD RI) strains derived from C57BL/6J and DBA/2J mice, are a valuable
resource for the discovery of the bio-molecular substrates and genetic drivers
that mirror complex human disorders such as drug addiction and alcoholism. The
initial set of BXD RI strain panel consisted of only a limited number of strains
(approximately 30). The combination of a limited number of strains and sparse
marker maps resulted in low QTL mapping precision and resolution. In 2004, the
BXD RI strain panel underwent a large expansion resulting in the addition of 46
new BXD RI strains, making it the largest genetic reference population.
Furthermore, the expanded BXD RI strain panel has increased numbers of
recombination events resulting in improved precision and resolution in QTL
mapping. Additionally, the presence of approximately 1.8 million SNPs between
C57BL/6J and DBA/2J strains greatly improves the prospects of QTG nomination
and validation.
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Using the recently expanded BXD RI strain panel, members of the
Tennessee Mouse Genome Consortium (TMGC) have obtained phenotype data
from over 250 measures related to multiple behavioral assays across several
batteries: response to, and withdrawal from cocaine, MDMA, morphine and
alcohol; novelty seeking; behavioral despair and related neurological
phenomena; pain sensitivity; stress sensitivity; anxiety; hyperactivity; and
sleep/wake cycles. All traits have been measured in both sexes in approximately
70 strains of the recently expanded panel of BXD recombinant inbred strains.
Sex differences and heritability estimates were obtained for each trait, and a
comparison of early (n = 32) and recent (n = 37) BXD RI lines was performed.
Primary data is publicly available for heritability, sex difference and genetic
analyses using the MouseTrack database, and is also available in
GeneNetwork.org for QTL detection and genetic analysis of gene expression.
Together with the results of related studies, these data form a public resource for
integrative systems genetic analysis of neurobehavioral traits.

Introduction
,QWKHODWH¶V'RQDOG%DLOH\ZDVWKHILUVWWRUHDOL]HWKHSRWHQWLDORI
genetic reference populations (GRP) for linkage analysis (191). Once
established, a GRP can be used repeatedly over time and across laboratory
environments primarily due to their genetic stability. Recombinant inbred (RI)
strains are an example of a GRP. RI strains were initially used to map single loci
associated with Mendelian traits. However, over the last few decades, RI strains
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have also become an invaluable tool for the genetic dissection of complex traits
(168). The construction of an RI strain panel is initiated by selecting two highly
inbred progenitor strains that typically vary for a trait of interest. These
progenitors are intercrossed to form the F1 progeny. At the F1 generation, all
offspring are heterozygous and genetically identical. F1 progeny are crossed to
produce the F2 generation in which, due to meiotic recombination, random
rearrangement of the progenitor genomes occur. At the F2 generation, randomly
chosen pairs of animals are used as founders for subsequent derivation of RI
strains of mice. Performing brother-sister mating for at least 20 generations
eventually produces RI strains. After 20 sequential rounds of brother-sister
mating, the genomes of these RI strains are essentially fixed (approximately 99%
homozygosity) (162). This creates panels of RI strains wherein individuals within
any given strain are genetically identical to each other. Figure 2-1 illustrates the
process of creation of the BXD RI strain panel, the largest and most widely used
RI panel.
Properties of a RI strain panel
Due to the process of inbreeding, RI strains are fixed and homozygous at
DOPRVWDOOORFL7KLVPDNHVWKHPDQ³LPPRUWDO´UHVRXUFHDVWKH\FDQEH
maintained at the inbred homozygous state by continuation of brother-sister
mating as long as required. RI strains have three primary advantages over an F2
or BC. First, as they are genetically stable, experimental results obtained across
these panels can be compared across time and laboratories (82). Second,
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Figure 2-1. Construction of a RI strain panel.
Derivation of the BXD RI strain panel starts with intercrossing C57BL/6J (B) and
DBA/2J (D) inbred strains of mice. Three pairs of F2 siblings are randomly
chosen as founders for three resultant BXD RI strains called BXD 1, BXD 2 and
BXD 100.
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multiple experimental observations can be obtained per strain therefore
facilitating replication and increased statistical power (16). Thirdly, due to their
fixed genomes, genotyping is required only once, thereby greatly reducing
genotyping costs.
Initial BXD RI strains and behavior genetics
Given the above-mentioned advantages of RI strains, it is not surprising
that they been often used in studying quantitative traits. Among the panels of
RIstrains currently available, BXD RI strains are the largest (Table 2-1). The BXD
RI strain panel was first established by B. A. Taylor in 1977 (208) and expanded
to 35 strains in 1999 (209). The earliest reports of RI strains, specifically the BXD
RI strain panel, in the genetic dissection of behavioral traits dates back to the
HDUO\¶V(48, 135, 186). Even though early studies were limited in their power
to detect QTLs, due to the limited numbers of strains utilized (approximately 20
or fewer strains), the advantages and utility of a relatively small RI strain panel
called for the generation of larger RI strain panels (168).
Expanded BXD RI strain set
In 2004, Pierce and colleagues expanded the existing BXD RI strain set to
a total of 79 strains (162). These strains were derived from an advanced
intercross (AI) between C57BL/6J (B) and DBA/2J (D) progenitor strains. As
these new BXD strains were derived from AI lines (also termed BXD ARI), they
have increased numbers of recombinations, facilitating improved mapping
resolution (162, 187). Pierce and colleagues have estimated that the number of
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Table 2-1. Existing genetic reference populations.
Name
AKXD
AXB/BXA
BXD

BXH

CXB

LXS

Progenitor
Strains
AKR/J
(AK) x
DBA/2J (D)
A/J (A) x
C57BL/6J
(B)
C57BL/6J
(B) x
DBA/2J (D)

Strains
24

Known
recombinations
1027

Recombinations
/ strain
42.8

34

1600

54.4

89

1848 (36 older
BXD)
4366 (53 newer
BXD)
755 (16 core
BXH strains)

48.1

C57BL/6J
(B) x
C3H/HeJ
(H)
BALB/cBy
(C) x
C57BL/6J
(B)
Inbred
LongSleep (L) x
Inbred
ShortSleep (S)

20

13

694

53.4

77

3598

46.7

31

82.4
48.5

recombinations detectable in the 46 BXD ARI lines is equivalent to at least 90
BXD RI strains generated from an F2 population. Furthermore, the BXD ARI lines
are able to detect QTLs accounting for half the amount of genetic variance
compared to the BXD RI lines (24% compared to 47%) (162). Using this
expanded strain set will facilitate detection of QTLs explaining small effects (at
least 10% genetic variation) to 1 ± 2 Mb intervals (162). Another advantageous
property of the BXD RI strain panel is that the B6 and D2 progenitor strains
havebeen deeply sequenced facilitating the discovery of 1.8 million SNPs. These
progenitor strain differences used in concert with BXD RI genotypes permits the
discovery of coding sequence variants, such as SNPs and insertion-deletions.
Despite the utility of RI strains in studying complex traits, their use has
been limited to only a few areas, such as basal behaviors and ethanol related
traits. Furthermore, in most cases, only one sex was studied. To truly harness
the power of the largest RI strain population currently available, it is vital to
employ high-throughput behavioral phenotyping techniques that facilitate quick
and accurate measurements of behavior. This is particularly of great importance,
given the derivation of RI strain panels, such as the CC, that are expected to be
4 ± 5 times larger than the BXD RI strain panel.

Methods
High-throughput behavioral phenotyping
In order to rapidly develop a broad base of behavioral phenotyping data,
phenotyping was performed in several multivariate test batteries. Each battery
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consists of a set of tests administered serially to individual mice. This approach
also allows for the examination of partial-correlation within strain (non-genetic
correlation) but may upwardly bias estimates of genetic correlation obtained
using strain means of the measures. A given mouse was assigned to one and
only one battery and received all tests in that battery. The order of repeated
testing was either fixed where logical and necessary or, in the case of the
nociception battery, varied systematically using randomly generated Latin-square
designs each applied to a different strain and sex. In general, for fixed-order
batteries, the least stressful measures were obtained first, and all baseline
measures were necessarily obtained before conditioning or drug exposures. The
testing protocols were largely derivative of those developed in consultation with
the external advisory board of the Tennessee Mouse Genome Consortium
(TMGC) ENU-Neuromutagenesis Program (79). Detailed methods of the
phenotyping protocols are presented elsewhere (164).
Statistical genetics in the expanded BXD RI strain panel
Strain effects and sex differences
Sex, strain and strain ! sex interaction effects were tested using
non-sequential sums of squares estimation in a general linear model. The model
used for testing these effects was
yij ȝ6WUDLQi + Sexj + Straini ! Sexj İij,

(1)

Where, yij is the phenotype being measured for Straini and Sexj. In
addition to testing these effects, we estimated the magnitude of strain, sex and
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strain ! sex effects by estimating the intra-FODVVFRUUHODWLRQDSDUWLDOȦ2, for each
HIIHFWSHUWUDLW3DUWLDOȦ2 was estimated as the proportion of variance accounted
for by the main or interaction effects relative to the total phenotypic variance. All
variance components were estimated using the REML option of SAS PROC
VARCOMP. This method can be biased due to departures from normality, a
common phenomenon for behavioral traits. The percent variance accounted for
by strain is considered by some to be an estimate of broad-sense heritability (89,
127) for clones, and is formulated as the strain intra-class correlation:
h2 ı2 Between Strain  ı2 Between Strain ı2 Within Strain). (2)
Standard errors were obtained using an adjustment for unbalanced data
(202). This calculation was performed for the two sexes separately, and for the
data combining both sexes. It should be noted that this measure provides an
estimate of the resemblance among relatives in a population in which
segregation had occurred and does not reflect the transmission of genetic
material in a randomly mating population. It is nonetheless an indication of
suitability and plausibility of genetic analysis for a given phenotype.
Sub-populations effects
A limited number of systematic differences exist in the genotypes of the
old and new BXD RI strains such that loci have been identified that segregate in
only one of the two sub-populations (187). To test for global phenotypic effects of
these differences, we use the nested model,
yij ȝ6WUDLQi (Sub-Populationj) + Sub-Populationj İij
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An alternate F±test is applied. The F ratio is MSSub-Population / MSStrain(SubPopulation).

This test is used because the individual mice in the study are not

independent, but rather are replicates within a strain. Therefore, we use the
appropriate error term and degrees of freedom for the random effect of strain
nested within the sub-populations. To account for multiple testing, the false
discovery rate (FDR) was controlled using q-value estimation for the sex and
strain main effects and sex ! strain interaction effects. The R/qvalue software
developed by Storey (198) was used for the analyses. A q-value threshold of
0.05 was used to identify significant results. Quantitative trait locus mapping was
also performed separately for sub-populations.
Comparison of data across time and phenotypes
To determine if behavioral measures collected across time and
laboratories can be integrated we correlated saline induced locomotor activity
and thermal nociception. Saline induced locomotor activity was measured in two
laboratories in the current study (n = 62), Memphis (locomotion in 15 mins) and
UTHSC (locomotion in 20 mins). These data were compared to saline-induced
locomotion measured by Demarest and colleagues in 1999 (n = 25). Thermal
nociception measured in two laboratories in the current study (n = 62), Memphis
and ORNL, were compared to Mogil and colleagues (140) and Brigman and
colleagues (24).
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QTL mapping and genetic correlations
GeneNetwork (GeneNetwork.org) serves as a database and analysis
engine for QTL mapping and genetic correlations among strain phenotypic
means obtained in the BXD RI reference population. Strain means were
computed in MouseTrack by sex and other cofactors. For pooled sexes, the
mean values were the least-squares means with strain, sex and strain ! sex in
the model. Male and female strain means for each phenotyping battery were
exported from MouseTrack for submission to GeneNetwork. This enables gene
expression correlation and interval mapping, candidate gene searches and multitrait analyses.
Each exported dataset was subject to an interval mapping analysis, which uses
GeneNetwork’s embedded MapManager software, WebQTL, (132) to perform
Haley–Knott regression. Empirical p values were derived using 1000
permutations using the incorporated permutation feature of WebQTL. The peak
of each statistically significant (p < 0.05) or suggestive (p < 0.63) (113) QTL was
determined based on empirical p values (58). A one-LOD drop-off was used to
determine the QTL confidence interval about each peak. Positional candidates
residing within a one-LOD drop from the peak of each statistically significant and
suggestive QTL were identified.
Trait data were correlated against the following GeneNetwork gene
expression tissue databases: whole brain [INIA Brain mRNA 430 (June 2006)
RMA (161), neocortex [HQF BXD NeoCortex ILM6v1.1 (February 2008) RankInv
(76)], striatum [HBP Rosen Striatum M430V2 (April 2005) RMA (178)],
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cerebellum [SJUT Cerebellum mRNA M430 (March 2005) RMA (32)] and
hippocampus [Hippocampus Consortium M430V2 (June 2006) RMA (106)]. Lists
of genes were generated based on their correlation to each phenotype using a
correlation p value < 0.001.
Multi-trait QTL mapping
Multi-trait QTL analysis can be performed by extracting common
underlying factors from multiple behavioral phenotypes and generating strainspecific factor scores. The underlying hypothesis of this type of analysis is that
behavioral measures for stress, anxiety, pain and addiction to drugs of abuse are
under common genetic control and should share some degree of correlation.
Brigman and colleagues performed a similar decomposition of anxiety and fear
behavior in BXD RI mice (24). This approach to multi-trait QTL mapping has also
been performed by Trullas and Skolnick (212), wherein factor analysis was used
to report that elevated plus maze behavior predicts anxiety-like behavior, and
more recently by Henderson and colleagues, who performed QTL mapping on
multiple phenotypic assays of anxiety-like behavior (87). The value of performing
such studies in the BXD RI population is that the data can be expanded
indefinitely with additional independent phenotypic profiling which adds depth
and detail to the multi-dimensional analysis.
As the phenotypic data contained missing observations, any strain with
more than 25% of trait data missing was removed from this analysis. This
resulted in the elimination of 32 of the 95 BXD strains, giving us an effective
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sample size of 63 BXD strains. The resultant data set was subjected to column
mean imputation in order to fill in the missing trait values, given that the data
were missing at random, i.e. not missing over all measures within a battery.
Another issue that was encountered during this analysis was that of
dimensionality. The dataset used in the factor analysis had more variables/traits
(p) than observations/strains (n) (i.e. n < p). This results in incorrect estimation of
the covariance matrix and thereby leads to singularity of the estimated
covariance matrix. This issue was addressed by using the James–Stein-type
shrinkage estimator (182) of the covariance matrix. R packages e1071 (for
missing data imputation), corpcor (for covariance shrinkage), nFACTOR and
factanal were used for the purposes of factor analysis. Factor loadings were
analyzed to obtain factor interpretations. Factor scores were obtained for all
interpreted latent factors. Quantitative trait locus mapping was performed on
these latent factors to identify common genetic drivers of variability in factor
scores.
Combinatorial analysis of gene to phenotype associations
Each set of gene expression correlates with p value < 0.001 for gene–
phenotype association was subject to combinatorial analysis to identify those
genes that were directly correlated to multiple phenotypes. Positional candidates
defined as those that reside within a one-LOD support interval of significant (p <
0.05) or suggestive (p < 0.63) QTL. The top 5 and 10 percent of the highly
connected genes were analyzed for over-representation of genes in the Kyoto
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Encyclopedia of Genes and Genomes (KEGG) pathways (101) using the
analysis tool, WebGestalt (235), which performs a hyper-geometric test for the
similarity of the list of highly connected genes and the members of curated
pathways in the KEGG database. The resulting list of enriched categories of
genes represents those processes, functions and molecular classes that are
most involved in genetic variation in behavior.

Results
Strain effects and sex differences
Generalized linear models were used to test for sex and strain main
effects, and sex ! strain interaction effects. False discovery rate analysis was
used to control the family-wise error rate at 0.05 and showed significant sex
effects for 97 of the 257 measures with five expected false positives, significant
strain effects for all 257 measures, and significant sex ! strain interactions for
144 of the 257 measures with seven expected false positives. In the event that
there was no trend toward a significant sex difference or interaction, male and
female data were combined for subsequent QTL mapping and genetic
correlations. Effect sizes were estimated as partial Ȧ2 for the main effects of
strain and sex, and for the sex ! strain interaction. Consistent with statistically
significant strain effects, 146 measures under consideration had large effect
sizes (Ȧ2 !"0#30), 93 had intermediate effect sizes (0#30 !"Ȧ2 !"0#10) and 19 had
small effect sizes (Ȧ2 $"0#10) (Figure 2-2). Locomotor activity in a variety of
apparatus and under different drug exposure conditions typically had large strain
39

Figure 2-2. Strain intraclass correlation for all measures.
A histogram of strain intra-class correlations for all behavioral measures (sexes
combined). A majority of the behavioral measures (146 of 257) have !2 > 0.30,
making them amenable to QTL mapping (from (164)).
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effect sizes, consistent with the previous reports (216). Other traits with large
effect sizes include acoustic startle response, pre-pulse inhibition, morphine
withdrawal and alcohol withdrawal. Intermediate effect sizes were observed for
nociception-related traits, morphine side- effects, ethanol-induced ataxia,
baseline HIC, blood ethanol concentration, cocaine-conditioned place preference
and anxiety. Only a small number of measures had effect sizes below 0.1. These
were most often measures derived from linear combinations of two measures, for
which the expected variance of the derived scores is at least four times the
variance of either measure alone (98). The 30% effect size is a conventional
guide for traits amenable to genetic analysis. The proportion of variance
accounted for by strain varies between the sexes for many traits. For some traits,
females have a higher proportion of non-genetic variation and for others males
exhibit more non-genetic variation. Across test batteries, except for adrenal
weights, the main effect of strain consistently accounts for most of the variation.
7KHSDUWLDOȦ2 for the main effects of sex were considerably lower than the strain
main effects, except for left and right adrenal weight measures. However, sex !
strain interaction effects were of greater magnitude than the main effects of sex,
though not as large as strain effects.
Sub-populations effects
In our comparison of historical strains with the newly expanded BXD lines
(BXD Sub-population effects), we evaluated differences among the three groups
of BXD RI lines tested simultaneously for all 257 measures. These were BXD 1±
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32 (208), BXD 33±42 (209) and BXD 43±100 (162). Only the adrenal weight
measures show any significant differences among the three sub-populations for
the left (p = 3.23E±04) and right (p = 1.99 E±04) adrenal weights, when subpopulation means are considered. Below we address the issue of mapping in the
combined sub-populations.
Comparison of phenotypes across time and environments
Saline-induced locomotor response
Locomotor activity in an open field has been commonly used as a
measure for exploration, novelty seeking, anxiety and predisposition to addiction
to drugs of abuse. In our study, two laboratories, Memphis (cocaine) and UTHSC
(ethanol), collected data on open field locomotion following saline in 15 and 20
min on 64 BXD RI strains, respectively. We compared these data with data
collected on saline-induced locomotor response by Demarest and colleagues on
25 BXD RI strains (54). Results indicate that there is good correlation among
data on saline-induced locomotor response across the three sets (Figure 2-3).
Correlations among the rMemphis,UTHSC = 0.556, rMemphis,Demarest = 0.781 and
rDemarest,UTHSC = 0.695. These results confirm previous reports that locomotor
activity is a highly stable trait and that saline-induced locomotor response is not
only robust across laboratories but also across previously published studies.
Thermal nociception
Sensitivity to thermal stimuli is a complex trait that has been used as a
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Figure 2-3. Correlation of behavioral measures across environments and
time.
(a) Saline-induced locomotor activity is well correlated across test sites
and time periods. (b) Another measure for which positive correlations existed
across test sites and time periods is of thermal nociception (from (164)).
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predictor of sensitivity to analgesic drugs. Thermal nociception (hot plate latency)
was performed in two laboratories, namely, ORNL and Memphis in this study.
Data collected in this study were compared with a previously published study of
thermal nociception by Mogil and colleagues (140) and Brigman and colleagues
(24) (GeneNetwork RecordID: 10897). Correlations ranged from 0.274 and 0.799
(Figure 2-3). There is poor correlation among the data collected at the
Memphisand ORNL laboratories and can likely be attributed to the two different
hot plate temperatures used. The hot plate test was performed at 52°C at
Memphis, whereas at ORNL the hot plate temperature was 54°C. Specifically,
ORNL hot plate data have a slightly higher correlation to the Mogil study
compared with the Memphis hot plate data. This is likely due to the 54°C that
was employed in both the ORNL hot plate study and the Mogil study. The range
of values obtained at ORNL and Memphis was lower than those of the other
testing laboratories, which produced some range restriction in the observed
correlation coefficients. This may be due to more consistent laboratory
environmental conditions in these assays or to experimenter effects on stressinduced analgesia, both of which have been previously reported to influence
thermal nociception (37, 38). These correlations are lower than the interlaboratory correlations than those reported by Wahlsten and colleagues (216).
This may be due to the limited genetic variability in the BXD RI panel relative to a
survey of the common inbred strains, but could also be due to the lower
heritability of hot plate measures relative to other measures for which this type of
analysis has been performed.
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QTL mapping and genetic correlations
As an example of a single-trait analysis in the newly expanded strain set, we
performed an analysis of mechanical nociception, the latency to respond to a
plastic-coated smooth alligator clip placed on the tail (Figure 2-4). Previous
studies of this trait in inbred mouse strains show high heritability of 0.69 (115).
Analysis in MouseTrack using the RI analysis tool showed that this measure has
statistically significant main effects of sex and strain (Sex: !2 = 0.0029, p < 0.04;
Strain: !2 = 0.26, p < 0.001), and interaction effects (Sex " Strain: !2 = 0.021, p
< 0.03,). The variances accounted for by strain are 0.32 and 0.27 in females and
males, respectively. BXD sub-population effects on females (p < 0.68) and males
(p < 0.93) were non-significant. Because the main effect of sex was significant,
male and female data were exported separately for analysis in GeneNetwork,
which uses a single vector of strain means as input. Permutation thresholds for
significant and suggestive LOD scores were 3.78 and 2.21, respectively, in males
and 3.6 and 2.27, respectively, in females. Interval mapping of tail clip latency for
males of the full BXD RI panel shows suggestive QTL on Chr 2 (LOD = 2.8) and
9 (LOD = 3.5), whereas suggestive QTL for females of the full panel are located
on Chr 1 (LOD = 3.5), 11 (LOD = 3.0) and 17 (LOD = 2.5). Genes within the oneLOD confidence interval from QTL peaks for males (Chr 2: 77–97 Mb; Chr 9: 44–
48 Mb) and females (Chr 1: 90–95 Mb and 97–107 Mb; Chr 11: 53–55 Mb; Chr
17: 78–84 Mb) were exported as positional candidate gene lists. These results,
generated in the full RI panel (BXD 1–100) were compared with interval mapping
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Figure 2-4. QTL mapping of tail clip latency in old and recent BXD RI strain
panels.
QTL analysis of a single-trait, tail clip latency was performed across three BXD
panels, namely, Taylor I (BXD 1±32), Recent BXD RI (BXD 33±100) and Full
BXD RI (BXD 1±100). In females, suggestive QTL were detected on Chr 1 and 9
for Taylor I (a), Chr 8 for the Recent BXD RI (BXD 33±100) (b) and Chr 1, 11 and
17 for the Full RI Lines (c). Mapping of tail clip latency in males showed no
suggestive QTL for Taylor I (d), suggestive QTL on Chr 2, 9 and 18 for Recent
BXD RI (BXD 33±100) (e), and two suggestive QTL on Chr 2 and 9 for the Full RI
panel (f) (from (164)).
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results generated from previously available BXD RI lines including just the
original set (Taylor I, BXD 1–32), and with exclusive use of the recent RI lines by
Taylor (Taylor II, BXD 33–42) and by Peirce and colleagues (BXD 43–100).
Quantitative trait locus mapping for each of the four sets (two male and two
female sets) was performed. In females, suggestive QTL were detected on Chr 1
and 9 for Taylor I (Figure 2-4a), and Chr 8 for the recent RI set (Figure 2-4b).
Mapping of tail clip latency in males showed no suggestive QTL for Taylor I
(Figure 2-4d) and three suggestive QTL on Chr 2, 9 and 18 for the recent RI set
(Figure 2-4e). The marker present at the peak of the suggestive QTL for females
is gnf01.018.340 (Chr 1 at 21.43 Mb). This single nucleotide polymorphism
(SNP) lies within the Kcnq5 potassium channel gene (KCNQ5) (UCSC genome
browser, http://genome.ucsc.edu/index.html, July 7, 2009). KCNQ channel
(K(V)7.2-5) genes have been implicated in neuropathic pain (81). The effect at
this marker across the Taylor I and recent BXD RI set indicates that while mice
with the D allele have consistent phenotypic means across both sets, mice with
the B allele have higher means in the Taylor I lines and lower means in the
recent lines relative to the D2 allele. However, in the expanded RI set, the D2
allele is the allele with the higher effect and consequently results in a nonsignificant QTL (Figure 2-5). Genetic correlation of tail clip latency to genomewide gene expression was performed for each of five brain tissues for which
expression profiles across the BXD RI lines are in GeneNetwork, namely, whole
brain, neocortex, striatum, cerebellum and hippocampus. Correlation results from
each of the five brain regions were filtered using a p value threshold of 0.001 to
47

Figure 2-5. Effect plot by BXD RI Strain panel.
Effect plot of marker gnf01.018.340 (Chr 1at 21.43 MB) in the old (BXD 1 32) and recent BXD RI strain panel (BXD 33 - 100) for tail clip latency in females.
The marker present at the suggestive QTL in Taylor 1 has a higher phenotypic
means for the B allele when compared with the D allele. This difference is
significant and therefore results in the presence of a QTL. The same marker in
the Recent BXD RI lines has a higher phenotypic mean for the D allele, but no
QTL is present within this strain set (from (164)).
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create coexpression candidate lists. All candidate gene lists obtained from
interval mapping and genetic correlations were then uploaded to
GeneWeaver.org for combinatorial analysis. Maximum gene to measure
(phenotype) connectivity was observed for Slfn5 or schlafen 5 (associated with
positional candidates on Chr 11 for females, male cerebellum gene expression
correlates and male striatum gene expression correlates) and Ankrd12 or ankyrin
repeat domain 12 (associated with female cerebellum gene expression
correlates, male cerebellum gene expression correlates and male hippocampus
gene expression correlates). Other candidate genes in the interval were not
found on this list of correlates, but include genes belonging to voltage-gated
sodium (e.g. Scn2b and Scn4b, Tail Clip-male positional candidates on Chr 4) or
calcium channels class of genes (13), cholinergic receptors class of genes (e.g.
Chrm4, Tail Clip-male positional candidates on Chr 2, (63)) and calcitonin
receptor-like genes or calcitonin gene-related peptides (e.g. Calcrl, Tail Clip Male
Positional candidates on Chr 2, (120)), all of which have substantial literature
support for involvement in nociception.
Multi-trait QTL mapping
A total of 27 factors accounting for 73% of the total variance for the 234
variables were obtained using a maximum likelihood factor analysis of behavioral
traits spanning multiple test batteries. A parallel analysis and an optimal coordinates analysis from the R/nFACTOR package both show eight informative
factors. The top 15 factors together account for 63.5% of the total variance
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among the trait measures. Factors accounting for trivial amount of variances
(<1.3%) have been excluded, as they would contribute little to the overall
interpretation of the factors.
Factor interpretations were obtained by examining high and low factor loadings of
behavioral measures on factors. Significant correlations among factors exist and
are expected as no factor rotation procedure was applied, as factor rotation
procedures are often employed to identify distinct factors. Results indicate that
measures within test batteries load onto multiple factors, thereby supporting the
hypothesis that each latent factor is associated with multiple behavioral
measures and each behavioral phenotype measure is determined by variation
along multiple trait dimensions. Factor 1 has high factor loadings for measures
almost entirely from the Cocaine test battery and can be interpreted as injection
stress-induced locomotor activity. Factor 2 represents morphine withdrawal
measures such as jumps, defecation and urination. Factor 3 represents morphine
activity/response. Factor 4 represents reactivity measures such as startle
response and anxiety-like measures. Factor 5 predominantly consists of
measures pertaining to locomotor activity in a novel environment. Factor 6
contains measures pertaining to conflict avoidance. Factor 7, like Factor 3,
consists of measures with high factor loadings pertaining to morphine activity, but
instead of response these measures are related to duration of activity. Factor 8
consists of measures related to cocaine sensitization. Factor 9 consists of
measures related to stress and anxiety such as mechanical sensitivity (von Frey
threshold) and zero-maze measures and adrenal weights. Factor 10 consists of
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measures related to vertical activity spanning general behavior and cocaine test
batteries. Factor 11 represents measures related to startle response. Factor 12
consists of measures pertaining to drug environment conditioning. Factors 13
and 14 both consist of responsivity measures, with Factor 13 describing
response to sensitivity, whereas Factor 14 describes response to novelty. Lastly,
Factor 15 represents anxiety related to acute stress.
Quantitative trait locus mapping of these 15 latent factors showed the
presence of suggestive QTL on Chr 1, 4, 5, 6, 8 9, 10, 11, 13 and significant QTL
on Chr 9 (Factor 3), Chr 10 (Factor 2) and Chr 13 (Factors 1 and 13) (Table 2-2).
Results indicate that multiple factors map onto a single chromosome, for
example, distal Chr 13, has suggestive QTL for Factors 1 (76±86 Mbp), 5 (78±84
Mbp, 94±98 Mbp), 6 (75±98 Mbp) and 10 (91±98 Mbp) and significant QTL for
Factors 2 (78±80, 88±92 and 94±98 Mbp) and 13 (75±84 Mbp). Factor 15 also
maps to Chr 13 but maps to the proximal region rather than the distal region. The
Chr 13 genomic region that encompasses the above-mentioned QTL spans 23
Mbp (75±98 Mbp) with a total of 124 genes in the interval. Of these genes ninetysix are polymorphic, among the compelling candidates is Mctp1 (multiple C2
domains, transmembrane 1). Interestingly, Mctp1 has previously been reported
to be strongly associated with bipolar disorder in individuals of European
ancestry (Scott et al. 2009). The large number of polymorphic genes within Chr
13 QTL intervals could be one possible explanation for the fact that multiple
factors map onto the same genomic region. To determine the relationship of
these factors to a substance use-related phenotype, we correlated the factor
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Table 2-2. Multi-trait QTL mapping.

Factor
1
2
3
4
5
52

6
7
8
9
10
11
12
13
14
15

Chromosome
8
9
10
11

Interpretation
1
4
5
6
13
15
18
19
Locomotor (Injection
stress-induced
3.4*
activation)
Morphine Withdrawal
3.2*
4.2**
2.8*
Morphine Activity
3.0*
4.9** 3.2*
(Initial/Peak response)
Anxiety/Reactivity
2.9*
4.5**
3.0*
Locomotor response to a
2.5*
2.7*
novel environment
Activity (Conflict2.3*
3.0*
Avoidance)
Morphine
(Activity:Duration)
Cocaine Sensitization
2.8*
3.4*
Stress-Anxiety
Vertical Activity
Performance
2.6*
2.7*
2.7*
3.5*
(Exploration)
Startle
2.6*
Drug-Environment
Conditioning
Responsivity-Sensitivity
5.0**
Response to Novelty
3.0* 2.9*
Anxiety-Acute Stress
2.8*

scores to phenotypic values from a previous study of ethanol self-administration
(166). This analysis illustrates an approach to determine which dimensions of
heritable behavioral variation are most related to a specific behavioral phenotype.
Correlations of alcohol preference to factor scores ranged from |r| = 0.076 to |r| =
0.674, for Factor 4 for which the correlation was negative such that mice with
increased startle response and anxiety-like phenotypes had higher alcohol
preference values and vice-versa. This factor is regulated by a QTL on
chromosome 9 that contains Scn4b, which is an expression correlate of both
ethanol withdrawal and Factor 4.
Combinatorial analysis of gene to phenotype associations
GeneNetwork analysis of each trait resulted in the generation of over
3,500 sets of genes that are associated with trait values either via genetic
correlation of gene expression in one of the five target tissues or through
positional candidacy in significant or suggestive QTL. These gene±phenotype
associations were integrated via a combinatorial analysis, which represents the
data as a bi-partite graph consisting of gene vertices and phenotype vertices.
+HUHDµSKHQRW\SH¶YHUWH[UHSUHVHQWVHDFKOLVWRIFRUUHODWHVRUFDQGLGDWHVDQG
the gene vertices represent each list member. Edges connecting these vertices
represent significant gene ± phenotype associations. The union of all lists
contained occurrences of approximately 33,000 genes and ESTs. However,
many of these genes are represented only once, and through convergent
analysis can be eliminated. By analyzing the number of phenotypes to which
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each gene was associated, we were able to identify those genes that most
broadly and reliably related to the behavioral functions assessed. A ranked
RUGHULQJRIJHQHVZDVJHQHUDWHGEDVHGRQHDFKJHQH¶VFRQQHFWLYLW\WR
phenotypes. These rankings were made a part of the NeuroSNP database for
supplementing addiction arrays (179). The most highly connected gene was
Mef2c; interestingly this gene also resides in the Chromosome 13 QTL interval
for several behavioral factors. It should be noted that the composition of the
behavioral phenotypes in this analysis influences the results obtained. For
example, some aspects of behavior such as locomotor behavior and anxiety-like
behaviors have many measures in this study. As such, they are over-weighted
relative to other aspects of behavior. Despite the overweighting of certain
measures, we conclude that the most highly connected genes are still broadly
connected with approximately 150 unique traits. These traits include traits
measuring anxiety, stress and pain sensitivity and span multiple test batteries
namely cocaine, general behavior, morphine, ethanol and pain.
Genes that were highly connected to many of the trait measures were entered
into gene set over-representation analysis using WebGestalt system, which
performs a hyper- geometric test for the enrichment of Gene Ontology and
KEGG pathway annotations among sets of genes. Among the top most highly
connected 5% of genes, significant over-representation (p < 1E ± 05) was
observed in 30 pathways of relevance to brain and behavior. The top most highly
connected 10% of genes showed significant over- representation (p < 1E ± 05) of
32 pathways related to brain and behavior (Table 2-3). These results indicate the
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Table 2-3. Top 5 and 10 percent genes of the resultant gene sets and their
KEGG pathway.

Hypergeometric
Test for Enrichment
(p values)

KEGG Pathways

Adherens junction
Adipocytokine signaling pathway
Axon guidance
B cell receptor signaling pathway
Calcium signaling pathway
Cell adhesion molecules (CAMs)
Cell cycle
Chronic myeloid leukemia
Colorectal cancer
Cytokine-cytokine receptor interaction
Focal adhesion
Gap junction
Huntington's disease
Insulin signaling pathway
Jak-STAT signaling pathway
Leukocyte transendothelial migration
Long-term depression
Long-term potentiation
MAPK signaling pathway
Natural killer cell mediated cytotoxicity
Neuroactive ligand-receptor
interaction
Phosphatidylinositol signaling system
Regulation of actin cytoskeleton
T cell receptor signaling pathway
Tight junction
Toll-like receptor signaling pathway
Wnt signaling pathway

Top 5%
of Genes
(1684)
5.42E-08
4.43E-03
2.74E-11
3.21E-06
1.02E-09
9.12E-09
1.67E-09
1.53E-05
6.16E-09
NE
4.42E-09
6.08E-08
2.09E-07
8.06E-08
7.35E-03
1.38E-05
6.56E-08
9.80E-11
8.66E-15
1.07E-07

Top 10%
of Genes
(3368)
8.18E-07
3.38E-09
7.72E-08
1.47E-08
1.03E-11
5.02E-05
2.26E-04
4.53E-06
6.31E-08
1.05E-07
4.96E-08
4.57E-07
8.18E-08
7.15E-08
1.91E-06
8.57E-08
7.13E-05
1.04E-05
1.43E-13
3.60E-14

NE
7.27E-06
1.13E-12
4.48E-08
6.36E-07
7.98E-05
1.07E-15

1.31E-07
1.31E-03
5.51E-10
9.56E-12
1.45E-04
1.73E-09
2.50E-09
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pathways that are either candidate causes or are under regulation of genetic
polymorphisms that are commonly observed in the BXD population. The principle
behind this approach is that genetic variation affects many genes associated with
QTL candidates, and that the convergent evidence gained from multidimensional analyses of the same traits can highlight the most frequently
associated pathways. Because these data have all been deposited in the
GeneWeaver.org tool, users of these data can perform analyses of specific and
roughly balanced subsets of the traits.

Discussion
BXD RI panels are currently the largest RI strain panel available. In
addition to being the largest, the BXD RI panel have a rich history of use in
behavioral genetics, increased numbers of recombinations and improved
precision in QTL mapping (compared to a F2 or BC mapping population).
However, effective utilization of this resource warrants improvements in
behavioral phenotyping protocols that facilitate rapid, efficient and accurate
phenotypic measurements across large numbers of strains. By taking advantage
of the high-throughput behavioral cores established by the NIMG ENUNeuromutagenesis program of the TMGC, we were able to measure over 250
behavioral phenotypes across four sites in the expanded BXD RI strain panel.
These measures were obtained, on average, across 58 BXD RI strains with at
least 10 males and 10 females per strain. 64.61% of these phenotypes have
genetic effect sizes of at least 30% making them amenable to QTL mapping. A
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genetic effect size of 30% with a within-strain sample size of 20, allows us to
detect QTLs where the correlations between the molecular marker and the
behavioral phenotype is approximately 0.97. It should be noted that these
calculations were performed using two assumptions: First, the molecular marker
is directly linked to the QTL and second, only additive QTLs are considered.
Violations of these assumptions will result in lower correlations between the
molecular marker and phenotype, possibly leading to increases in false positives.
Additionally, the sample sizes employed in our study enable us to detect
significant QTLs (p < 0.05) with an effect size of 16% with 90% power. Increasing
the number of strains will help in detecting QTLs with smaller effect sizes. For
example, if one were to utilize the entire BXD RI strain panel (n = 89), one can
map QTLs with an effect size of 11%. Furthermore, if one were to utilize a F2
population to map traits with heritability of 0.30, then the effective sample size
would be approximately 295. This number increases to 760, when the heritability
of the train being mapped is low, around 0.10 (Figure 2-6). It would be extremely
resource and cost intensive (genotyping) to perform QTL mapping population in a
F2 populations with the above mentioned sample sizes. Even if methods such as
selective genotyping are used to abate genotyping costs, this comes with a
decrease in statistical power to detect QTLs.
The majority of the behavioral traits measured had significant main effects
of sex and strain ! sex interactions. This observation is consistent with previous
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Figure 2-6. Equivalent F2 sample sizes for 58 RI strains for varying n and
h2.
Estimated F2 sample sizes for 58 RI strains as a function of within strain sample
size (n) and heritability (h2). As h2 decreases the equivalent F2 sample size
required increases compared to an RI strain panel, resulting in increased cost
(due to genotyping).
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studies (38, 215). It is important to account for significant strain ! sex interactions
while mapping such traits. In GeneNetwork, this can be achieved by mapping the
two sexes separately (as was done in our study). Another approach is to regress
male data with female data and vice versa followed by single marker correlations
using the resultant regression residuals (70). Both the above-mentioned
approaches decrease the overall statistical power as they involve grouping the
data by sex prior to running the analysis. By employing a nested model that
appropriately accounts for sex across and within strain, better statistical power in
mapping traits can be achieved. However, permuting such a model is complex
due to the resulting non-independence within strains. Permutations
methodologies have been proposed to address such issues (160). In our study,
we found sex differences in trait heritability such that for certain traits female
were higher than males and vice versa. This suggests increased within strain
variance relative to between strain variance. Increased within stain variation is
indicative of additional factors that influence the proportion of phenotypic
variation that is genetic. In males such factors include, social dominance. In
females, studies have revealed the influence of estrous cycle variation in
behavior (14). Housing density and social isolation due to testing protocols also
introduce additional variation that influences trait heritability (139).
Since the BXD RI strain panel has gone through two expansions after its
initiation in 1979, we assessed sub-population effects across all traits measured.
Only male adrenal weights had significant sub-population main effects. Since all
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but one trait showed significant sub-populations effects, phenotypically it is safe
to consider all three BXD RI sub-populations as one large BXD RI strain panel.
However, genotype distribution patterns reveal a completely different picture.
Shifman and colleagues (187) detected 52 of 13,367 SNPs wherein the first BXD
RI sub-population showed no variation in their genotype distribution patterns. In
the second BXD RI sub-population, only five of the 52 SNPs show no variation.
All SNPs with fixed SDPs in the first two BXD RI sets show variation in the
expanded BXD RI sub-population. The lack of variation in the SDPs of typed loci
in the first and second sub-population will affect QTL mapping, as these loci will
be non-detectable. Similarly using the entire BXD RI panel without accounting for
sub-population structure could result in varying mapping results.
Despite the advantages offered by the BXD RI strain panel, it suffers from
certain limitations. First, as it is derived from two progenitor strains, the breeding
design is only able to capture a limited amount of genetic variation
(approximately 16%). Second, centimorgan or sub-centimorgan precision in QTL
mapping is not yet attainable. And lastly, the presence of linkage disequilibrium
could lead to detection of false positive QTLs. Even in the light of these
limitations, the ability to undertake integrative data analysis within the BXD RI
strain panel makes them an ideal resource for the genetic analysis of quantitative
traits. This is primarily due to its role as a genetic reference population. With the
advent of advanced mapping populations, such as the CC, the limitations of RI
panels such as the BXD RI will be alleviated. The CC is an emerging RI panel
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that is being derived from eight phenotypically and genetically diverse founder
strains (34, 42, 95, 142). The initial founder strain diversity facilitates increases in
the total amount of genetic variation captured, numbers of recombination, and
precision and resolution of QTLs. Application of high-throughput behavioral
phenotyping techniques to the CC may help in validating QTL detected in two
progenitor RI strain panels. Furthermore, the increased mapping resolution
supported by the CC will facilitate and improve prospects of QTG discovery.
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CHAPTER III: PROMISE OF EMERGING GENETIC REFERENCE
POPULATIONS
This chapter is adapted from the following publication:
Philip VM, Sokoloff G, Ackert-Bicknell CL, Striz M, Branstetter L, Beckmann MA,
Spence JS, Jackson BL, Galloway LD, Barker P, Wymore AM, Hunsicker PR,
Durtschi DC, Shaw GS, Shinpock S, Manly KF, Miller DR, Donohue KD, Culiat
CT, Churchill GA, Lariviere WR, Palmer AA, O'Hara BF, Voy BH, Chesler EJ.
Genome Res. 2011 Aug;21(8):1223-38.
My contributions to this paper were QTL mapping, analysis of inbreeding
depression, SNP selection for the custom CC genotyping array, interpretation of
results and part of the writing.

Abstract
Over the last few decades, panels of genetic reference populations (GRP)
have been utilized for the genetic dissection of complex traits. A lot has been
learnt from existing GRP, however they are yet to be utilized to their full potential.
Furthermore, current GRP fail to model complex human diseases due to limited
heterogeneity as a consequence of derivation from two founder strains. The
collaborative cross (CC) is a mouse reference population with high allelic
diversity that is being constructed using a randomized breeding design that
systematically out-crosses eight founder strains, followed by inbreeding to
establish new highly recombinant inbred (RI) strains. Five of the eight founders
are common laboratory strains and three are wild-derived. Since its inception, the
partially inbred CC has been characterized for physiological, morphological and
behavioral traits. The construction of this population provided a unique
opportunity to observe phenotypic variation as new allelic combinations arose
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through inter-crossing and inbreeding to create new stable genetic combinations.
Processes including inbreeding depression and its impact on allelic and
phenotypic diversity were assessed. Phenotypic variation in the CC breeding
population exceeds that of any existing mouse genetic reference populations due
to both high founder genetic diversity and novel epistatic combinations. However,
some focal evidence of allele purging was detected including a suggestive QTL
for litter size in a location of changing allele frequency. Despite these natural
consequences of inbreeding, high diversity and precision for genetic mapping
remains. These results demonstrate the potential of the CC population, once
completed.

Introduction
Genetic reference populations (GRP) are an invaluable resource for the
study of complex traits. An extremely valuable characteristic of these populations
is their ability to facilitate data integration across multiple phenotypic domains
and biological scales (210). However, currently existing reference populations
are yet to be utilized to their full potential. This is primarily due to the derivation of
existing panels from two founder genomes and limited number of RI strains
available in an analysis. The presence of only two founder strains limits the
amount of genetic variation that can be captured. Additionally, the founder strains
(the classical inbred strains currently used) share large fractions of their
genomes due to identity by descent (IBD), further limiting allelic diversity and
variation. This results in non-GHWHFWDEOHJHQHWLFYDULDWLRQFDXVLQJ³EOLQG-VSRWV´LQ
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QTL mapping (175). These limitations have necessitated the development of new
and advanced GRP. The collaborative cross (CC) is one such emerging
advanced GRP. The CC is derived from eight genetically and phenotypically
diverse inbred founder strains. The eight strains that were selected are ± A/J,
C57BL/6J, 129S1/SvImJ, NOD/LtJ, NZO/HlLtJ, CAST/EiJ, PWK/PhJ and
WSB/EiJ. Three of the eight founder strains, namely, CAST/EiJ, PWK/PhJ and
WSB/EiJ are wild-derived strains representing, M. m. castaneus, M. m. musculus
and M. m. domesticus mouse sub-species, respectively. The inclusion of three
wild-derived strains introduces additional genetic diversity and in addition to the
five inbred strains, helps capture approximately 90% of available genetic
variation. In addition to increased genetic variation, the CC is expected to have
higher numbers of recombinations and larger numbers of independent genetically
diverse RI strains than any existing GRP. These features will make the CC a
widely used resource for the genetic analysis of complex human disorders and
diseases.
Breeding design
The breeding scheme employed in the derivation of the CC involves three
generations of out-crossing followed by over 20 generations of inbreeding (Figure
3-1). The first generation of out-crossing (G0) results in 56 G1 (two-way) hybrids.
Pairs of non-overlapping G1 hybrids are then out-crossed to generated four-way
G2 progeny. Out-crossing pairs of four-way G2 yields an eight-way G2 progeny
(G2:F1). The G2:F1 generation serves as the starting point for inbreeding, by
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Figure 3-1. Collaborative cross breeding design (34).
Breeding design for one eight-way CC RI strain is shown. Letters A-H represent
the eight CC founder strains. Positions of the eight founder strains determine
contributors of mitochondrial DNA and Y chromosome. In above schematic,
strain A contributes the mitochondrial DNA, while strain H contributes the Y
chromosome (from (34)).
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sibling mating for over 20 generations. The overall goal of breeding design
described above is to generate hundreds of independent CC RI strains, each a
fine-grained mosaic of the eight founder strains.

Methods
Subjects
A total of 650 lines were initiated according to the Complex Trait
Consortium protocol (42). Of these, 414 lines with at least one male or one
female survived to the G2:F5 generation, while the remaining lines were lost
during the inbreeding process. Litters were weaned at approximately three weeks
of age, into breeding pairs determined by the CCWORKS software assisted
mating system developed by Kenneth F. Manly (34). Litter size, parental age at
birth of first litter, and length of the interval from mating to the first litter were
recorded as measures of fecundity. Mice were maintained in breeding pairs until
they entered the phenotyping protocol. Retired breeders from the cross
population were phenotyped on a variety of behavioral, physiological and
morphological measures. Phenotyping was performed across generations to
evaluate trait heritability. Phenotyping and genotyping were performed in at least
one breeding pair per line from generation G2:F5-G2:F8 for QTL analysis. Most
of the genotyped mice came from the G2:F5 generation. From this generation,
235 lines were tested. At this generation the population is estimated to be
approximately 75% inbred at the genotyped loci (34), based on allelic identity by
descent calculations performed using the R/ricalc package (25). Because assays
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were added to the phenotyping pipeline throughout the course of the breeding
project not all mice were evaluated on all measures. Approximately 7,500 mice of
both sexes (except for gonadal fat pad mass and testes weight) from up to 626
lines were phenotyped for body weight, tail length, fasting plasma glucose level,
and weights of kidney and heart, behavioral and physiological traits; of these,
approximately 3,000 have been phenotyped for adiposity based on perigonadal
fat pad weight.
Mice did not enter the phenotyping queue until the birth of their grandprogeny to ensure that lines could be propagated. Average age of testing was
38.5 weeks. Over 95% of the mice were phenotyped between the ages of 20 to
100 weeks. Of the total number of mice phenotyped, 52% were females and 48%
were males.
General phenotyping methods
The phenotyping strategy was designed to capture a panel of complex
traits amenable to high throughput analyses while broadly reflecting behavior,
morphology and physiology. Upon birth of grand-progeny mice were separated
into individual pens for phenotyping. The individuals were then moved to a
holding room where they were housed for three weeks prior to testing where
females were checked to ensure that they were not pregnant at the time of
testing. Mice were housed in this room throughout testing. At the start of the
week prior to the first test an elbow shaped PVC pipe was added to each cage as
a standardized enrichment device. At this point in the queue, mice intended to
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begin testing the following week remained in place on one side of one rack.
Detailed phenotyping and dissection methods are described in detail elsewhere
(165)
Genotyping and SNP selection
A custom array using the Illumina iSelect platform for the Infinium system
was developed for SNP genotyping. A subset of 11,969 SNPs were chosen from
the NIEHS-Perlegen combined SNP panel (232). A sliding window was utilized in
order to search for the minimum sets of SNPs that could discern all eight founder
strains. The search was terminated either when a set of SNPs were identified
that together could discriminate all eight founder haplotypes or the window length
reached 1.86 Mbp. Upon termination a new search window was initiated. The
resulting array enabled genotyping at over 1200 such windows. This algorithm
ensured that for a given number of SNPs on the array, the maximum density of
informative markers could be used, while still ensuring that at any locus, ancestry
can be traced back to one of eight founders.
Data analysis
Statistical analyses were performed within the MouseTrack database
environment (mouse.ornl.gov; (10)), which includes SAS v. 9.1.3 tools for
univariate statistics, univariate and multivariate outlier detection, modeling of litter
size, and calculation of parent-offspring regression coefficients (34). For
modeling of cross type and other effects on litter size and inbreeding depression,
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we employed mixed models with random effects of specific crosses within cross
types. Heritability for the progenitor generation was estimated using strain
intraclass correlations, and for subsequent generations, it was estimated using
parent-offspring regression by calculating the slope of the regression between
the mid-parent (mean of the two parents) and offspring trait values. We note that
these estimates cannot be extrapolated to heritability defined as transmission of
phenotypic values in wild randomly mating populations. In wild randomly mating
populations it is customary to adjust regression coefficients by relatedness of the
two samples, nor is that our objective. We use unadjusted parent-offspring
relations for the monitoring of resemblance among relatives throughout the
inbreeding process. For the majority of traits, untransformed data were used to
estimate resemblance of relatives. To more closely reflect genetic contribution to
tissue function rather than allometric relationship to body weight, organ weights
were first adjusted to body weight using a regression model in which individual
trait values were regressed to the population mean. Only data from extant lines in
the terminal generation studied were used to calculate parent-offspring similarity
estimates.
QTL mapping
QTL mapping was undertaken using the R/Happy package developed
based on multipoint HAPPY dynamic-programming algorithm and regression
models (145). Trait data from G2:F5 generations and greater were utilized in the
mapping analysis. Sample sizes ranged from 160 to 293 lines with at most one
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male and/or one female per line. Each trait was assessed for normality prior to its
mapping. Appropriate data transformations were applied to trait data that
deviated significantly from normality. For each trait an additive model genome
scan was preformed. For each marker, R/Happy (145) returns a ±logP value.
Additionally, for each marker using the residual sums of square under the null
hypothesis of no segregating QTL (RSS0) and alternative hypothesis (RSS1,
additive or full model) LOD scores were calculated using the following equation:
LOD Score = (n/2) * log10(RSS0/RSS1).
This statistic can be utilized to determine significant and/or suggestive
QTLs. Genome-wide significance thresholds were obtained using a modified
permutation algorithm rather than the one available in the R/Happy package. The
R/Happy package treats each observation as an independent observation and
permutes the phenotype between subjects while keeping the genotypes fixed. In
the mapping data utilized in the collaborative cross, we use two subjects per line
(one male and one female). This introduces a dependent relationship among
subjects (sib-pairs). Therefore lines are permuted rather than subjects and sex is
randomized within lines, while keeping the genotypes fixed. One thousand
permutations were performed and permutation based genome-wide thresholds
were used to identify significant (5%, 10%) and suggestive (63%) QTLs.
Confidence intervals around significant and/or suggestive QTL peak was defined
using a 1.5 LOD support interval. Genes within this interval are considered
candidate genes.
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Results
Phenotypic variation
Phenotypic variance for many traits increased in the G1 generation (Table
3-1) relative to progenitor lines. However, phenotypic variation decreased slightly
in the G2 and beyond. For all morphometric measures, the distribution of
individual scores showed greater dispersion in the CC lines relative to the
progenitors (Kolmogorov-Smirnov p < .05). As expected from the wide range of
body sizes among the progenitor strains, indicators of overall growth, vary widely
among the CC lines. For example, among progenitors, body weight ranged from
25.56 ± 0.85 g (WSB/EiJ) to 29.66 ± 2.16 g (NZO/HlLtJ), whereas in the
inbreeding generations (G2:F5 ± G2:F8) this measure ranged from 23.65 g to
32.00 g. Tail length, an index of linear growth, ranged from 67.92 ± 7.98 mm
(PWK/PhJ) to 94 ± 7.94 mm (NOD/LtJ) among the progenitors, whereas it
ranged from 59.04 mm to 112.00 mm among the inbreeding generations Heart
weight and adiposity index also showed considerable variation among the
progenitors and in the CC offspring, but the CC range was within the progenitors.
While it is interesting to note the spread of phenotypic variation relative to
progenitor lines, increased phenotypic variation among offspring is expected due
to transgressive segregation, the random assortment of increasor and decreasor
alleles that were once in a fixed assortment in the progenitor lines. Therefore,
we assessed phenotypic variation in the CC in contrast to a relatively large and
widely used genetic reference population, the BXD recombinant inbred lines, for
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Table 3-1. Trait heritability and variation in the emerging CC.
Table 3-1 continued.
Gen.
G0

G1

G2

G2
F1

G2
F2

G2
F3

G2
F4

G2
F5

G2
F6

G2
F7

G2
F8

Trait
611
27.64
5.89
34.59
13.7 53.3
0.21
0.46
0.04

Tail
length
[cm]

63
85.43
10.73
115.08
45 Range
100
C.V.
0.13
h2
0
S.E.
NA

566
91.17
7.94
62.9
60 112
0.09
0.72
0.04
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Body
weight
[g]

70
240
557
731
1002
950
754
26.25
33.95
30.8
30.91
31.23
30.49
29.13
12.21
10.94
5.79
5.65
6.21
6.41
6.05
148.84 119.54 33.41
31.84
38.52
41.08
36.56
15 19.36 - 20.14 - 18.92 - 15.75 - 16.25 - 14.67 Range
63.4
93.36
51.68
50.32
56.06
56.53
54.12
C.V.
0.47
0.32
0.19
0.18
0.2
0.21
0.21
h2
0.5
NA
0.3
0.36
0.42
0.64
0.56
S.E.
NA
NA
0.04
0.06
0.05
0.04
0.05
nmice
ȝ
S.D.
ı

nmice
ȝ
S.D.
ı

185
96.95
4.62
21.31
78 110
0.05
0.55
0.08

313
97.33
5.42
29.3
65 113
0.06
0.28
0.1

471
98.55
5.56
30.86
86 115
0.06
0.44
0.08

702
97.34
6.18
38.09
80 118
0.06
0.58
0.07

717
95.85
6.92
47.83
75 115
0.07
0.66
0.04

607
93.36
8.41
70.66
20 112
0.09
0.7
0.05

403
333
27.92
24.78
6.26
6.91
39.19
47.65
17.22 - 12.29 45.57
50.47
0.22
0.28
0.61
0.59
0.05
0.07
367
90.99
8.49
71.94
32 110
0.09
0.69
0.05

277
85.57
9.81
96.15
40 105
0.11
0.67
0.07

181
24.33
6.54
42.65
11.8 47.6
0.27
0.59
0.09
141
85.65
12.15
147.42
0105
0.14
0.72
0.18

Table 3-1 continued.
Gen.
G0

G1

G2

G2
F1

G2
F2

G2
F3

G2
F4

G2
F5

G2
F6

G2
F7

G2
F8

58
0.17
0.05
0
0.11 0.33
0.29
NA
NA

179
0.19
0.05
0
0.12 0.32
0.26
0.59
0.12

274
0.19
0.06
0
0.11 0.7
0.32
0.07
0.09

371
0.19
0.05
0
0.12 0.39
0.26
0.2
0.06

536
0.21
0.07
0
0.1 0.9
0.33
0.34
0.09

670
0.22
0.06
0
0.09 0.5
0.27
0.21
0.05

605
0.2
0.07
0
0.1 0.59
0.35
0.34
0.05

566
0.19
0.06
0
0.1 0.8
0.32
0.47
0.06

367
0.19
0.06
0
0.1 0.44
0.32
0.49
0.06

277
0.17
0.06
0
0.07 0.64
0.35
0.29
0.09

141
0.16
0.06
0
0.08 0.31
0.38
0.66
0.14

C.V.
h2
S.E.

23
1.74
0.43
0.18
0.96 2.79
0.25
NA
NA

271
1.57
0.28
0.08
0.97 2.54
0.18
0.26
0.07

221
1.67
0.33
0.1
0.97 2.63
0.2
0.02
0.1

202
1.6
0.32
0.1
0.63 2.41
0.2
0.29
0.1

120
1.62
0.35
0.12
0.83 2.62
0.22
0.53
0.15

156
1.65
0.43
0.18
0.62 3.1
0.26
NA
NA

273
1.71
0.41
0.17
0.53 3.2
0.24
0.38
0.12

437
1.7
0.42
0.17
0.79 3.31
0.25
0.44
0.1

317
1.65
0.41
0.17
0.86 3.21
0.25
0.45
0.06

185
1.67
0.38
0.14
0.79 2.62
0.23
0.45
0.08

70
1.62
0.34
0.11
0.91 2.52
0.21
0.37
0.1

nmice

221

804

964

1069

933

776

618

566

366

201

87

Trait

Heart
weight
[g]

nmice
ȝ
S.D.
ı
Range
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C.V.
h2
S.E.

Hot
plate
latenc
y [log
s]

Captur

nmice
ȝ
S.D.
ı
Range

Table 3-1 continued.
Gen.
G0
Trait
e and
hold
combi
ned
wildne
ss
score

74
Distan
ce
from
center
of
open
field
[cm]

Distan
ce
travele

G1

G2

G2
F1

G2
F2

G2
F3

G2
F4

G2
F5

G2
F6

G2
F7

G2
F8

ȝ
S.D.
ı
Range
C.V.
h2
S.E.

0.52
1.18
1.38
0-7
2.27
0.96
0.17

0.48
1.05
1.1
0-8
2.19
0.47
0.07

0.52
1
0.99
0 - 10
1.92
0.04
0.07

0.62
0.88
0.76
0-9
1.42
0.15
0.05

0.59
0.93
0.86
0 - 10
1.58
0.24
0.06

0.52
0.79
0.61
0-6
1.52
0.32
0.04

0.52
0.8
0.63
0-6
1.54
0.28
0.05

0.47
0.79
0.61
0-8
1.68
0.14
0.07

0.44
0.77
0.59
0-5
1.75
0.4
0.1

0.46
0.68
0.46
0-3
1.48
0.36
0.18

0.41
0.66
0.43
0-4
1.61
NA
NA

nmice
ȝ
S.D.
ı

NA
NA
NA
NA

Range

NA

C.V.
h2
S.E.

NA
NA
NA

173
5.31
2.85
8.1
1.02 14.46
0.54
0.15
0.09

59
4.8
1.94
3.73
1.83 9.9
0.4
NA
NA

103
5.27
3.3
10.86
1.29 17.26
0.63
0.07
0.34

83
4.29
2.65
6.99
1.26 14.24
0.62
0.07
0.2

83
5.24
2.82
7.94
1.1 11.72
0.54
0.49
0.34

60
5.67
3.59
12.83
1.54 13.87
0.63
0.01
0.32

134
5.25
3.17
10.05
1.32 16.44
0.6
0.36
0.21

166
5.53
3.65
13.25
0.85 16.98
0.66
0.22
0.24

117
5.76
3.68
13.48
0.81 16.05
0.64
0.32
0.16

56
5.28
4.25
18.04
1.17 16.43
0.8
0.7
0.41

nmice

NA

ȝ

NA

173
60
107
86
1298.5 1469.1 1410.5 1439.9
6
1
6
8

92

65
136
168
120
56
1324.8 1215.5 1283.3 1242.5 1399.1
1566.3
9
1
4
6
2

Table 3-1 continued.
Gen.
G0

75

Trait
d in an
S.D.
open
ı
field
during
the
first 3 Range
min
[cm]
C.V.
h2
S.E.

NA
NA
NA
NA
NA
NA

G1

G2

G2
F1

G2
F2

G2
F3

G2
F4

G2
F5

G2
F6

G2
F7

G2
F8

480.13 353.66 412.91 469.71 634.68 510.09 489.89 590.29 622.01 801.14
23052 12507 17048 22062 40280 26018 23998 34844 38688 64181
0.7
2.1
9
4.7
7
4.1
2.6
0.4
4.3
2
450.13 806.37
269.28 551.92 180.85 111.09
147.03 147.71
505.23
118.71
2751.2 2433.7
2665.2 4380.5 2189.8 3016.9
2609.8 4385.2
2420.2
3003.9
7
9
2
3
1
1
8
1
0.37
0.24
0.29
0.33
0.41
0.39
0.4
0.46
0.5
0.57
0.08
NA
0.48
0.49
0.4
NA
0.58
0.22
0.58
0.89
0.06
NA
0.26
0.24
0.46
NA
0.29
0.2
0.15
0.32

which we have previously reported phenotypic values for diverse behavioral
measures (164) obtained under the same conditions as our collaborative cross
phenotypic data. Phenotypic values observed in generations G2:F5 and beyond
for thermal nociception, distance travelled in the open field and body length
spanned a far greater range than those obtained in the BXD RI strain panel
(Figure 3-2).
Analysis of inbreeding depression
During the generation of the CC, we were able to assess the impact of
inbreeding in the emerging CC population using the measure of litter size in
these mice, as previous studies have shown that litter size reflects the impact of
inbreeding depression in mouse populations (88, 91). Among the G1 crosses,
mean litter size was lower for crosses involving one or two wild-derived lines
(Fcross type (2, 51) = 6.07; p < 0.0043). The pattern of mean differences reveals outcrossing depression in litter size for some crosses. As previously reported,
NZO/HlLtJ x PWK/PhJ and NZO/HlLtJ x CAST/EiJ matings were avoided due to
exceedingly poor mating performance, and PWK/PhJ x 129/SvImJ gave rise to
infertile males (34). The mean litter size in the crosses was lower than both
parental means for the 129/SvImJ x NZO/HlLtJ, but not for the reciprocal
NZO/HlLtJ x 129/SvImJ cross. The mean litter size was between the two
progenitors for C57BL6/J x WSB/EiJ and its reciprocal, 129/SvImJ x PWK/PhJ
and its reciprocal, CAST/EiJ x NOD/HlLtJ, WSB/EiJ x A/J and WSB/EiJ
129/SvImJ. For all other crosses, the majority of which were crosses between
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Figure 3-2. Trait variation in the CC compared to the BXD.
Shaded bars represent the phenotypic distribution of the BXD population (A)
Distribution of thermal nociception across the CC and BXD populations. (B)
Distribution of distance travelled in the open field across the CC (during the first 3
minutes) and BXD populations (during the first 5 minutes). (C) Distribution of
body lengths across the CC and BXD populations (from (165)).
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common laboratory strains, an increase in litter size was observed.
Among the G2 crosses, patterns of both depression and heterosis were
again observed. G2 mean litter sizes were compared to G1 litter sizes for each of
576 four-way crosses (G1 x G1). Among these, 19 exhibited decreased litter size
indicative of depression, 330 exhibited heterosis, and the remainder fell between
their G1 parental means. All four-way crosses in the G2 generation were
classified into 15 configurations based on whether the parents were offspring of
common x common, common x wild-derived, or wild-derived x wild-derived
strains. Analysis of change in litter sizes (!LS) from G1 to G2 reveal significant
effects of configuration (F (15,561) = 3.00; p < 0.0002) and number of wildderived lines in the four-way cross (F (3,572) = 7.39; p < 0.0001). With increasing
numbers of wild-derived lines among the four grandparents, !LS is increasingly
positive (!0LS < !1LS < !2LS < !3LS).
Effects of genetic composition are dependent on the direction of the cross.
When the common x common derived parent is female, the change in litter size
from the previous generation is lower than for all other configurations (F (1,561) =
6.29; p < 0.012), and the litter size itself is higher. As a further test of the
directionality of mating effects, we directly compared each comparable cross of
common x common derived males or females to other configurations (e.g.,
[(common x common) x (wild x common)] vs. [(common x wild) x (common x
common)] which revealed significant effects only for the difference between CC x
WW and WW x CC crosses such that wild derived males resulted in an increase
78

in litter size when crossed to a common background than do wild-derived
females (F (1,561) = 6.29; p < 0.012). This was tested again by comparing the
effect of crossing wild-derived males to that of common-derived males into
common derived females, which again reveals a greater increase in litter size
when the male is wild-derived (F (1,561) = 5.04 p < 0.025).
Fecundity and reproductive fitness among the advanced inbreeding lines
typically varied outside the range of progenitors. Dispersion of CC fertility related
phenotypes, obtained from G2:F5 and subsequent generations, exceeds the
inbred progenitors for measures including mean litter size, parental age at first
litter, and interval from mating to first litter (Kolmogorov-Smirnov p < .05).
However, litter sizes in these lines cover a smaller range than the G2:F1
population (Figure 3-3). The shrinking range was unilateral such that the
maximum litter size obtained among the lines in inbreeding generations was
successively lower than that observed in the G2:F1, a phenomenon considered
consistent with over-dominance related inbreeding depression.
Intercrossing, inbreeding and their effect on allele frequencies
Lines from G2:F1 and G2:F7 were genotyped to track changes in allele
frequencies across generations. Progenitor alleles entered the population at a
minimum minor allele frequency (MAF) of 0.125 for all autosomal locations and it
is expected that allele frequencies remain stable throughout each generation and
genome location. Efforts were made to balance alleles on the sex chromosomes
during initial breeding (34). Expected X chromosome allele frequencies are
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Figure 3-3. Litter size and inbreeding depression.
As a consequence of inbreeding, litter size diminishes at each successive
generation of inbreeding. This reflects the phenomena of over-dominance as a
mechanism of inbreeding (from (165)).
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dependent on the position of the progenitor strains in each line’s mating scheme
and were adjusted accordingly. Distribution of strain specific alleles (MAF =
0.125) grouped by progenitor strain of origin indicates that there is no statistically
significant deviation from expectation for the MAF at the majority of these loci
using a !2 test for goodness of fit with a family-wise false discovery rate of 0.05.
Only 95 strain-specific genotyped SNPs showed significant deviations when
comparing progenitor allele frequencies to those of G2:F1 allele frequencies.
Sixty-two were from PWK/PhJ, 15 of these were located on Chr 16 and 22 of
which were on Chr X. Another 21 of these 95 loci were from CAST/EiJ, 18 were
on Chr X. The remaining loci originated from WSB/EiJ (8 loci), A/J (1 locus), and
C57BL/6J (3 loci). Genotyped loci from the three other progenitor strains,
namely, 129S1/SvImJ, NZO/HlLtJ and NOD/LtJ showed no significant deviation
from expected segregation patterns. Comparison of G2:F1 strain specific alleles
relative to those of G2:F7 resulted in only 13 loci with significant deviations from
expected frequencies. Nine of these loci were from PWK/PhJ while the remaining
four loci were from CAST/EiJ. Twelve loci show declining allele frequencies
throughout both out-crossing and inbreeding. Of these, eight loci were from to
PWK/PhJ and four were from CAST/EiJ. The strain specific allele distributions
spread from G2:F1 to G2:F7 indicating that overall alleles at some loci increase
in frequency while other alleles decrease in frequency through the process of
inbreeding (Figure 3-4). A comparison of observed local allele frequencies
relative to expected frequencies in the G0 to G2:F1 and G2:F1 to G2:F7
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Figure 3-4. Changes in minor allele frequencies (MAF) due to inbreeding.
Strain specific MAF in the G2:F1 (A) generation depicts less variation than the
G2:F7 (B) generation, with some spread of allele frequencies evident in the
G2:F7 generation. Allele frequency distributions become asymmetrical for some
strains. The distribution becomes right skewed PWK/PhJ indicating more loss
than gain has occurred, and left skewed for WSB/EiJ (from (165)).
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generations reveals that this increase in variance occurs on a genome wide level
(Figure 3-5). In general, observed changes in allele frequencies relative to
expected frequencies were less pronounced following out-crossing (Figure 3-5A)
than during inbreeding (Figure 3-5B).
QTL mapping in the CC
A total of 102 reproductive, behavioral, physiological and morphological
traits were subject to QTL mapping, though several of the measures were highly
correlated, including 50 sleep related parameters and several similar blood
measures. Approximately 72 unique, though not statistically independent
phenotypes were considered. Among these, eight statistically significant (p <
0.05, Table 3-2) main effect QTLs were detected, including red cell distribution
width, hotplate latency, average percent of sleep time in the dark, distance
traveled in open field during the first three minutes, periosteal circumference of
the femur, and peak activity onset after sleep deprivation, body length and
cumulative distance from the center of the open field (Figure 3-6). An additional
nine suggestive QTL were detected (p < 0.10, Table 3-2). Confidence intervals
around the significant QTL peaks, estimated using 1.5-LOD drop-off, had an
average width of 3.98 Mb and contained an average of 50 genes each, with
fewer than 10 candidate coding genes for three of the traits. The narrowest 1.5
LOD drop interval detected is 530 Kbp for Peak activity time in hours from activity
onset after sleep deprivation (Chr 9: 29.70 - 30.03 Mbp Build 36 between
RefSNPs rs33767143 and rs6264816), which harbors coding sequence for a
83

Figure 3-5. Allele loss and inbreeding.
Comparison of the percent allele loss between (A) progenitors (G0) and final out-cross
generation (G2:F1). (B) G2:F1 and the seventh inbreeding generation (G2:F7). Positive
values indicate SNPs with an increase in minor allele frequency, while negative values
indicate a decrease (allele loss) in minor allele frequency. The y-axis indicates % change
from G0 allele frequency (from (165)).
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Figure 3-6. QTL mapping in the CC.
(A) Red blood cell width distribution. (B) Periosteal circumference. (C) Peak activity time
in hours from dark onset after sleep deprivation. (D) Average percentage of sleep time
over dark cycles for all baseline days. (E) Average minimum distance of the center of the
mouse from the absolute center of the open field (cm). (F) Thermal nociception. (G)
Open field locomotion in the first three minutes. (H) Body length. Horizontal lines indicate
genome-wide significance thresholds based on 1,000 permutations. Dotted lines are
genome-wide significant thresholds at p dashed lines indicate genome-wide
suggestive thresholds at p  (from (165))
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Table 3-2. Genome-wide significant and suggestive QTLs, effect sizes and allele effects.
Table 3-2 continued.
Phenotype

Chr

Peak
Marker

1.5 LOD
CI (Mbp)

# Pos.
Cand.

Effect
Size

Mean

Strain

Mean
±
S.E.M

Dev.
from
Mean

129S1/SvI
mJ

104.61
± 0.96

-1.63

A/J

106.61
± 1.07

0.37

C57BL6/J

104.20
± 0.97

-2.04

CAST/EiJ

106.53
± 1.02

0.29

NOD/LtJ

106.22
± 0.98

-0.02

WSB/EiJ

112.20
± 1.25

5.96

NZO/HlLtJ

106.80
± 1.13

0.56

PWK/PhJ

105.30
± 1.01

-0.95

129S1/SvI
mJ

29.55
± 1.39

5.15

SIGNIFICANT QTLS

86
Body length

Average
percent

2

7

rs2733802
4

rs6381934

152.9158.5

90.996.9

70

39

6.93

7.3

106.24

24.4

Table 3-2 continued.
Phenotype

Chr

Peak
Marker

1.5 LOD
CI (Mbp)

# Pos.
Cand.

Effect
Size

Mean

sleep at
night

87
Hot plate
latency

5

rs1347823
8

45.561.0

6

6.7

1.64

Strain

Mean
±
S.E.M

Dev.
from
Mean

A/J

20.98
± 1.45

-3.42

C57BL6/J

25.24
± 1.18

0.84

CAST/EiJ

24.55
± 1.13

0.15

NOD/LtJ

22.06
± 1.23

-2.34

WSB/EiJ

27.27
± 1.61

2.87

NZO/HlLtJ

27.12
± 1.76

2.72

PWK/PhJ

20.84
± 1.27

-3.56

129S1/SvI
mJ

1.57 ±
0.05

-0.07

A/J

1.63 ±
0.05

-0.01

C57BL6/J

1.69 ±
0.05

0.05

Table 3-2 continued.
Phenotype

Chr

Peak
Marker

1.5 LOD
CI (Mbp)

# Pos.
Cand.

Effect
Size

Mean

88
Red cell
distribution
width

7

rs3175210
8

105.5 112.5

221

25.99

14.07

Strain

Mean
±
S.E.M

Dev.
from
Mean

CAST/EiJ

1.64 ±
0.05

0

NOD/LtJ

1.54 ±
0.05

-0.1

WSB/EiJ

1.60 ±
0.05

-0.04

NZO/HlLtJ

1.59 ±
0.04

-0.05

PWK/PhJ

1.88 ±
0.05

0.24

129S1/SvI
mJ

13.73
± 0.20

-0.34

A/J

13.69
± 0.24

-0.38

C57BL6/J

14.85
± 0.18

0.78

CAST/EiJ

13.64
± 0.17

-0.43

NOD/LtJ

14.64
± 0.16

0.57

Table 3-2 continued.
Phenotype

Chr

Peak
Marker

1.5 LOD
CI (Mbp)

# Pos.
Cand.

Effect
Size

Mean

89
Peak activity
after sleep
deprivation

9

rs3376714
3

29.7 30.2

2

7.77

1.96

Strain

Mean
±
S.E.M

Dev.
from
Mean

WSB/EiJ

13.20
± 0.26

-0.87

NZO/HlLtJ

15.00
± 0.25

0.93

PWK/PhJ

13.39
± 0.20

-0.68

129S1/SvI
mJ

3.38 ±
0.56

1.42

A/J

0.46 ±
0.69

-1.5

C57BL6/J

1.15 ±
0.70

-0.81

CAST/EiJ

-2.04 ±
1.01

-4.00

NOD/LtJ

1.49 ±
0.82

-0.47

WSB/EiJ

2.19 ±
0.72

0.23

NZO/HlLtJ

1.95 ±
0.85

-0.01

Table 3-2 continued.
Phenotype

Chr

Peak
Marker

1.5 LOD
CI (Mbp)

# Pos.
Cand.

Effect
Size

Mean

Strain

Mean
±
S.E.M

Dev.
from
Mean

PWK/PhJ

3.68 ±
0.62

1.72

129S1/SvI
mJ
A/J
90

C57BL6/J
Open field
locomotion
in the first 3
minutes

4

rs2772361
8

21.1 30.4

16

8.23

1232.67

CAST/EiJ
NOD/LtJ
WSB/EiJ
NZO/HlLtJ

1276.0
4±
122.84
1210.1
8±
92.01
989.28
±
94.34
1621.7
5±
90.90
1159.4
3±
90.90
1118.8
3±
76.70
1374.0
5±
101.04

43.37
-22.48
-243.39
389.08
-73.23
-113.84
141.38

Table 3-2 continued.
Phenotype

Chr

Peak
Marker

1.5 LOD
CI (Mbp)

# Pos.
Cand.

Effect
Size

Mean

Strain

PWK/PhJ

91
Integrated
distance
from center

Periosteal
circumferen

6

19

rs4949582
9

rs6287522

89.6 93.2

21.522.5

45

5

9.54

11.6

Dev.
from
Mean
-30.31

129S1/SvI
mJ

5.68 ±
0.47

0.08

A/J

7.50 ±
0.64

1.9

C57BL6/J

4.86 ±
0.50

-0.74

CAST/EiJ

5.21 ±
0.57

-0.39

NOD/LtJ

8.52 ±
0.75

2.92

WSB/EiJ

5.01 ±
0.43

-0.59

NZO/HlLtJ

5.98 ±
0.68

0.38

PWK/PhJ

4.31 ±
0.59

-1.29

129S1/SvI
mJ

4.78 ±
0.07

-0.09

5.6

4.87

Mean
±
S.E.M
1202.3
6±
73.64

Table 3-2 continued.
Phenotype

Chr

Peak
Marker

1.5 LOD
CI (Mbp)

# Pos.
Cand.

Effect
Size

Mean

ce

92

Strain

Mean
±
S.E.M

Dev.
from
Mean

A/J

4.85 ±
0.07

-0.02

C57BL6/J

4.95 ±
0.06

0.07

CAST/EiJ

4.78 ±
0.08

-0.09

NOD/LtJ

4.66 ±
0.07

-0.21

WSB/EiJ

5.16 ±
0.08

0.29

NZO/HlLtJ

5.14 ±
0.09

0.27

PWK/PhJ

4.78 ±
0.09

-0.1

129S1/SvI
mJ

4.12 ±
0.37

-0.33

A/J

5.01 ±
0.39

0.56

C57BL6/J

3.97 ±
0.32

-0.48

SUGGESTIVE QTLS

Litter size

6

rs6258737

93.9 128.3

291

7.24

4.45

Table 3-2 continued.
Phenotype

Chr

Peak
Marker

1.5 LOD
CI (Mbp)

# Pos.
Cand.

Effect
Size

Mean

93
Gonadal fat
pad weight

8

rs3195476
6

64.580.8

28

6.06

0.67

Strain

Mean
±
S.E.M

Dev.
from
Mean

CAST/EiJ

3.80 ±
0.32

-0.64

NOD/LtJ

3.93 ±
0.34

-0.52

WSB/EiJ

3.61 ±
0.26

-0.83

NZO/HlLtJ

2.79 ±
0.34

-1.65

PWK/PhJ

4.66 ±
0.31

0.21

129S1/SvI
mJ

0.74 ±
0.10

-0.07

A/J

0.58 ±
0.08

0.09

C57BL6/J

0.60 ±
0.07

0.07

CAST/EiJ

0.82 ±
0.10

-0.15

NOD/LtJ

0.53 ±
0.07

0.13

Table 3-2 continued.
Phenotype

Chr

Peak
Marker

1.5 LOD
CI (Mbp)

# Pos.
Cand.

Effect
Size

Mean

94
Body weight

2

rs2733802
4

154.0159.5

55

5.55

27.27

Strain

Mean
±
S.E.M

Dev.
from
Mean

WSB/EiJ

0.47 ±
0.09

0.2

NZO/HlLtJ

0.62 ±
0.06

0.04

PWK/PhJ

0.98 ±
0.07

-0.32

129S1/SvI
mJ

27.94
± 0.57

-0.67

A/J

27.39
± 0.72

-0.13

C57BL6/J

25.72
± 0.62

1.55

CAST/EiJ

33.22
± 2.97

-5.96

NOD/LtJ

26.30
± 0.86

0.97

WSB/EiJ

24.99
± 0.74

2.28

NZO/HlLtJ

27.83
± 0.64

-0.56

Table 3-2 continued.
Phenotype

Chr

Peak
Marker

1.5 LOD
CI (Mbp)

# Pos.
Cand.

Effect
Size

Mean

95
Brain weight

Tail clip
latency

7

2

rs6263981

rs2708518
4

36.3 52.7

11.6212.58

121

5

12.1

5.33

Strain

Mean
±
S.E.M

Dev.
from
Mean

PWK/PhJ

28.97
± 0.58

-1.7

129S1/SvI
mJ

0.43 ±
0.01

0

A/J

0.42 ±
0.01

-0.01

C57BL6/J

0.44 ±
0.01

0.01

CAST/EiJ

0.42 ±
0.01

-0.01

NOD/LtJ

0.44 ±
0.01

0.01

WSB/EiJ

0.45 ±
0.01

0.02

NZO/HlLtJ

0.39 ±
0.01

-0.04

PWK/PhJ

0.43 ±
0.01

0.01

129S1/SvI
mJ

41.76
± 2.02

9.19

0.43

32.57

Table 3-2 continued.
Phenotype

Chr

Peak
Marker

1.5 LOD
CI (Mbp)

# Pos.
Cand.

Effect
Size

Mean

96
Percentage
of
monocytes

17

rs6311776

27.6 42.5

41

9.92

10.23

Strain

Mean
±
S.E.M

Dev.
from
Mean

A/J

26.42
± 2.77

-6.15

C57BL6/J

31.07
± 2.77

-1.5

CAST/EiJ

27.61
± 2.27

-4.97

NOD/LtJ

37.13
± 2.46

4.56

WSB/EiJ

35.52
± 2.36

2.95

NZO/HlLtJ

25.24
± 3.18

-7.33

PWK/PhJ

26.16
± 2.77

-6.41

129S1/SvI
mJ

10.07
± 0.19

-0.16

A/J

11.14
± 0.22

0.9

C57BL6/J

10.01
± 0.30

-0.23

Table 3-2 continued.
Phenotype

Chr

Peak
Marker

1.5 LOD
CI (Mbp)

# Pos.
Cand.

Effect
Size

Mean

97
Percentage
of
eosonophils

17

rs3332584
5

12.7 22.5

147

9.08

11.23

Strain

Mean
±
S.E.M

Dev.
from
Mean

CAST/EiJ

10.21
± 0.23

-0.02

NOD/LtJ

9.60 ±
0.28

-0.63

WSB/EiJ

9.91 ±
0.21

-0.33

NZO/HlLtJ

10.61
± 0.26

0.38

PWK/PhJ

10.11
± 0.28

-0.12

129S1/SvI
mJ

10.96
± 1.13

10.96

A/J

10.27
± 1.16

10.27

C57BL6/J

12.10
± 0.85

12.1

CAST/EiJ

14.72
± 0.91

14.72

NOD/LtJ

11.33
± 1.43

11.33

Table 3-2 continued.
Phenotype

Chr

Peak
Marker

1.5 LOD
CI (Mbp)

# Pos.
Cand.

Effect
Size

Mean

98
Mean
corpuscular
volume

11

rs2822879
0

69.2 82.9

276

15.18

46.38

Strain

Mean
±
S.E.M

Dev.
from
Mean

WSB/EiJ

8.86 ±
0.91

8.86

NZO/HlLtJ

10.42
± 1.24

10.42

PWK/PhJ

9.95 ±
1.05

9.95

129S1/SvI
mJ

48.62
± 0.49

2.24

A/J

46.36
± 0.76

-0.02

C57BL6/J

47.05
± 0.64

0.67

CAST/EiJ

45.44
± 0.43

-0.93

NOD/LtJ

47.31
± 0.47

0.93

WSB/EiJ

46.45
± 0.46

0.07

NZO/HlLtJ

44.29
± 0.76

-2.09

Table 3-2 continued.
Phenotype

Chr

Peak
Marker

1.5 LOD
CI (Mbp)

# Pos.
Cand.

Effect
Size

Mean

99
Femur
length

14

rs5133656
0

95.898.9

3

8.5

Strain

Mean
±
S.E.M

Dev.
from
Mean

PWK/PhJ

44.50
± 0.52

-1.88

129S1/SvI
mJ

15.37
± 0.13

-0.08

A/J

15.48
± 0.12

0.03

C57BL6/J

15.73
± 0.14

0.28

CAST/EiJ

15.60
± 0.16

0.15

NOD/LtJ

15.69
± 0.13

0.24

WSB/EiJ

15.55
± 0.11

0.1

NZO/HlLtJ

14.96
± 0.19

-0.49

PWK/PhJ

14.92
± 0.14

-0.53

15.45

microRNA and two genes ² Ntm (neurotrimin) and Snx19. The largest interval
detected for a statistically significant locus was 6.96 Mbp for red blood cell
distribution width containing 232 positional candidate genes.
Periosteal circumference was mapped to a 1.5-LOD interval from 21.55 22.51 Mbp on Chr19 (Build 36), containing five candidate genes, including
Tmem2 and Trpm3. For thermal nociception, the 1.5-LOD drop interval (Chr5:
45.44 ± 60.99 Mbp) around the peak marker contains just six genes, Slit2,
Pacrgl, Gpr125, Dhx15, Sod3 and Kcnip4. The 1.5-LOD drop interval for average
minimum distance from the center of the open-field (Chr6, 89.59 ± 93.20 Mbp),
average percentage of sleep time over dark cycles for all baseline days (Chr7,
90.92 ± 96.94 Mbp) and red cell distribution width (Chr7: 105.55-112.52 Mbp)
respectively map onto gene-rich genomic regions with 45, 39 and 221 genes, the
latter containing a cluster of 130 Olfr family members in addition to three
compelling functional candidates, hemoglobins Hbb-b1, Hbb-bh1 and Hbb-y.
We also mapped litter size to identify potential loci that could influence
litter size thereby reflecting inbreeding depression. A suggestive QTL was found
on Chr 6 for the regulation of litter size. This locus harbors several genes for
which alleles have been annotated to embryonic lethality. At this locus, A/J
alleles are associated with higher litter sizes, and NZO with lower litter sizes.
Interestingly, these alleles have significant decrease in frequency (rs13478994, p
< .003; rs29829339, p < .02), suggesting that for any surviving line with an A/J
allele at this location, litter size is elevated.
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Significant QTLs for some traits are the effect of alleles from single strains,
while for other traits the effect is due to alleles present among multiple strains
(Table 3-2). For body length, individuals with alleles originating from WSB/EiJ at
the QTL were significantly different from individuals with alleles derived from
other strains. The QTL for hot plate thermal nociception was driven by significant
differences among individuals with alleles derived from PWK/PhJ and relative to
those with other alleles except for C57BL6/J. For gonadal fat pad mass, alleles
specific to PWK/PhJ were significantly different from others alleles except for
CAST/EiJ and 12S1/SvImJ. For peak activity onset after sleep deprivation, wildderived strains PWK/PhJ and CAST/EiJ differ significantly from WSB/EiJ,
CAST/EiJ is significantly different from 129S1/SvImJ, PWK/PhJ is significantly
different from A/J and A/J is significantly different from 129SvImJ. For other
measures, a more complex pattern of strain-specific effects emerges (Table 3-2).
A composite interval mapping approach enabled the detection of additional loci
for several phenotypes (Table 3-3). For example, a search for additional QTLs for
open field locomotor behavior, conditioned on the Chr 4 locus reveals an
additional locus on Chr 9 at rs33324954, from 108 ± 113 Mbp, consistent with
previously reported QTL for this phenotype (90).

Discussion
The need for advanced GRPs stems from the inherent drawbacks that
plague existing GRPs. These drawbacks include limited genetic variation and
limited numbers of strains, which ultimately makes the task of QTL detection and
101

Table 3-3. Additional loci detected using composite interval mapping.
Table 3-3 continued.
Trait

Original
QTL

Second
Locus

refSNP

Mbp

CI

Two
locus
model
LOD
Score

Body
length

Chr 2

Chr 13

rs6216118

99.3

75.23 101.45

7.15

Body
weight

Chr 2

Chr 8

rs31787744

66.88

60.82 87.93

7.28

Chr 7

Chr 17

rs33558716

56.63

Chr 1

rs6263216

177.76

Chr 13

rs29513935

31.59

Chr 4

rs27479104

118.79

Chr 19

rs30748908

57.83

Chr 8

Chr 9

rs6387702

46.82

Hot plate
latency

Chr 5

Chr 18

rs6203819

52.98

Monocytes
%

Chr 17

Chr 2

rs27184231

23.43

Brain
weight

Eosonophil
%

Chr 17

Gonadal
fat pad
weight
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55.67 64.91
173.30 182.73
30.66 34.12
103.41 155.32
57.34 61.14
38.47 41.22
43.20 50.56
106.92 107.62
50.29 55.21
22.07 25.32
32.12 34.11

9.3
8.94
9.23

7.24
6.68

6.83

8.69

9.51

Table 3-3 continued.
Trait
Open field
distance
from
center

Original
QTL

Second
Locus

refSNP

Mbp

Chr 6

Chr 3

rs30002306

47.28

Chr 16

rs37822351

21.37

Chr 4

Chr 9

rs33324954

111.42

Chr 7

Chr 1

rs51956473

146.34

Chr 8

rs6304230

119.88

Chr 7

Chr 2

rs6226117

178.88

Chr 2

Chr 5

rs32966653

56.15

Chr 15

rs33196993

37.34

Chr 13

rs46919382

19.04

!!
Open field
locomotion

% Sleep
night on
average

Red cell
width
distribution

Tail clip
latency

Periosteal
circ

Chr 19

103

CI
35.96 36.25
42.48 47.45
14.19 30.95
108.93 113.57
136.71 155.81
119.09 124.88

171.36 178.97
53.92 65.37
72.53 75.66
76.14 79.62
11.60 12.27
12.73 23.44
25.53 27.34
30.13 51.60
4.68 - 6.92
18.92 20.95

Two
locus
model
LOD
8.71
Score

8.11

7.77

7.14
6.44

12.38

8.42

7.55

9.68

candidate gene identification extremely labor intensive. The availability of
advanced, large and diverse panels of GRPs will help alleviate these drawbacks,
while at the same time serving as an invaluable resource to the biomedical
research community. The collaborative cross (CC) is one such advanced GRP
for mouse genetics. Similar panels have either been or are being developed
across multiple species, including D. melanogaster (9), A. thaliana (108), Z. Mays
(29) and C. elegans (99, 122, 176)
The completed CC RI strain panel is expected to have increased numbers
of recombination and smaller haplotype blocks resulting in a fine-grained mosaic
of the eight founder strains. Simulations performed by Karl Broman (25) have
supported this expectation by showing that on average, eight-way RILs have 134
recombinant haplotype blocks compared to 85 in two-way RILs. As expected, the
median lengths of these haplotype blocks are smaller in eight-way RILs (8.5 cM)
compared to two-way RILs (12.9 cM). Comparing the emerging CC populations
(pre-CC) to the above-simulated CC population has been revealed 6% more
detectable recombination breakpoints and smaller median block or segment
lengths (8). Additional simulations, performed by Valdar and colleagues (213),
have assessed the power and precision with which one can map QTL in the CC.
In an extensive series of simulations with several assumptions, Valdar and
colleagues has shown that a QTL with 5% effect size can be mapped with
moderate power (0.67) and high precision (mean location error of 1.14 cM) when
employing 500 RILs. QTL analysis in the emerging CC reveals that with sample
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size of approximately 250 lines with only one or two mice per line, it is possible to
map genetic loci with high precision and moderate to large effect sizes. Among
the significant loci detected, QTL effect sizes ranged from (6.7% to 26%), while
the average 1.5 LOD support interval ranged from (530 Kb to 6.96 Mb) (Table 33). In several instances, the emerging CC had sufficient mapping resolution to
identify one or a few candidate genes. Mapping of activity after sleep deprivation
revealed only three positional candidates, a microRNA and two genes, Ntm
(neurotrimin), which encodes a neural cell adhesion molecule that plays a role in
brain development (31) and Snx19. Allelic variation in neurotrimin could affect
sleep, wake and activity by influencing developmental patterns in central nervous
system structure or through dynamic effects on adult neuronal functions. Sleep
deprivation maximizes the magnitude of slow-wave activity (SWA), which is
directly proportional to the duration of prior periods of wakefulness (6). Increasing
evidence suggests a functional role for sleep and high SWA in synaptic plasticity
(86, 110). Periosteal circumference at the mid-shaft of the femur mapped to five
candidates, Gda, 1110059E24Rik, Tmem2, and Trpm3, a transient receptor
potential channel gene. Periosteal circumference is one of many measures for
skeletal size and is correlated with total body size and total skeletal size,
therefore the gene underlying this QTL could be responsible for global effects on
body size. Mechanistic analysis of the causative locus is the best method to
interpret the specificity of these effects. Neither 1110059E24Rik nor Fam108b
appear to be expressed in osteoblasts or osteoclasts. The Tmem2 gene is highly
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expressed in primary osteoblasts, but the function of this gene in bone biology is
unknown. The Gda gene appears to be moderately expressed in osteoclasts,
but like Tmem2, the function of this gene in bone biology has not been previously
determined. Expression of Trpm3 has been demonstrated in human osteoblastlike cell lines and other genes in this family have a known role in osteoblast
differentiation (4). In addition to increased recombinations, improved QTL
mapping power and resolution evident in the emerging CC, the out-crossing and
inbreeding process has had minimal effect on founder strain contribution.
Founder strains entered the populations at a minor allele frequency of 0.125 and
a genome-wide analysis in the emerging CC has revealed equal founder strain
contribution at all loci. This is important since this ensures that the breeding
scheme is truly randomized, balanced and that no single founder strain was
being selected for or against.
Genetic analysis in the emerging CC provides valuable insights in to what
is to be expected from the completed CC. The ability to have large numbers of
independent, phenotypically and genotypically diverse CC RILs will facilitate high
precision QTL mapping and subsequent QTG discovery. Furthermore, the high
amount of genetic variation captured in the CC will make it a better suited to
model complex human disorders thereby facilitating translation research.
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CHAPTER IV: INTEGRATIVE FUNCTIONAL GENOMICS AND QTG
IDENTIFICATION
Abstract
Despite the high heritability of addiction, relatively few underlying genes or
quantitative trait genes (QTG) have been identified. Recent studies have used
the integration and convergence of evidence among functional genomics studies
as a successful strategy towards the efficient and rapid nomination of QTGs.
GeneWeaver (www.geneweaver.org) is a web resource that facilitates integrative
functional genomic analyses by providing comprehensive data sources and
analytical tools. While GeneWeaver facilitates a multitude of genomic analysis,
one specific application of it is the identification and prioritization of QTGs. Here,
we apply this web resource towards the identification a highly likely QTG for
cocaine-induced locomotor activation. Cocaine-induced locomotor activation was
previously mapped in the recently expanded panel of BXD RI strains to a region
on Chr 4 and Chr 15, with over 100 and over 70 positional candidate genes in
their respective 1.5 LOD drop support intervals. Combinatorial analysis using
GeneWeaver resulted in the identification of Rab3b, based on the following its
co-occurrence with previously published QTL mapping studies of cocaine related
behaviors, methamphetamine related climbing and cocaine and amphetamine
regulated transcript (CART) abundance; convergent evidence from other
substances of abuse; polymorphisms albeit upstream and intronic; and
expression pattern in reward pathways. Preliminary functional evaluation of Rab3
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complex in cocaine response was performed using mixed background Rab3bcd
triple null mice (B6;129 Rab3bcd-/-). Rab3bcd-/- mice have increased cocaineinduced activation compared to Rab3bcd+/- and C57BL/6J mice, further
implicating Rab3b in acute cocaine response. In conclusion, integrative functional
genomics, performed here within the framework of GeneWeaver, facilitates
efficient in silico reduction of a QTL interval with numerous positional candidate
genes to a handful of testable candidate QTGs.

Introduction
Advances in genotyping and phenotyping technologies have led to
mapping of complex traits at an ever-increasing pace across multiple species. To
date, over 4,600 published mouse Quantitative Trait Loci (QTL) exist, of which
less than one percent have been successfully identified at the gene and/or
mutation level. Of these 4,600 QTL, approximately 250 are alcoholism and
addiction related. Among all the published QTLs, only 20 genes have been
accepted as QTG (138). The rate-limiting step in the identification of QTGs is not
in QTL mapping but rather in the identification of the causative variant and
validation of a gene(s) as the QTG. As shown in Chapters II and III , QTL
confidence intervals are influenced by a number of factors, including the mapping
population, sample sizes and trait heritability. This results in a large number of
positional candidate genes within the QTL confidence interval, making the task of
gene identification formidable. The emergence of advanced mapping panels,
such as the collaborative cross (CC) and the diversity outbred (DO), will help
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achieve greater precision in QTL mapping. However, even in these advanced
mapping populations, gene level resolution using QTL mapping is still not
attainable for most traits, requiring the utilization of multiple approaches for the
identification of causal loci and the nominations of QTGs.
The QTL to QTG approaches that have been proposed to date can be
categorized as genetic and bioinformatic approaches. Genetic approaches
facilitate QTG identification by fine-mapping of the original QTL by taking
advantage of meiotic recombination. Strategies falling in this category include
chromosome substitution strains, congenic strain pairs, interval specific
congenics and fine mapping using advanced intercross lines (AIL) or
heterogeneous stock (HS), recombinant inbred segregation test (RIST) and YinYang crosses (50, 74, 188). Genetic approaches often take years and large
numbers of resources to fine map and confirm QTLs. For example, in a BXD
recombinant inbred (RI) strain panel of 100 strains, mapping resolution or the
95% confidence interval (CI) of a QTL with a 5% effect size is approximately 7
cM (74, 213). A 7 cM interval corresponds to approximately a 14 Mb genomic
region. Given the average gene density of 10 genes per Mb in the mouse, one is
still left with approximately 140 positional or QTL candidate genes for further
validation. This problem is alleviated to a certain extent in the CC mapping
population. QTL mapping results in the emerging CC population have been
promising. The average 1.5 LOD support interval was 4.80 Mb with
approximately 50 positional candidate genes (165). While 50 is a considerable
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reduction from 140 positional candidate genes, the necessity of additional fine
mapping remains. Using only genetic approaches one could easily take six or
more years to fine-map and identify the QTG (74). In an attempt to accelerate
QTG identification, complementary bioinformatic approaches have been
proposed, including comparative genomics, combined cross analysis and
sequence and expression analysis (57). These approaches help facilitate the in
silico reduction of a QTL interval and the identification of highly likely QTGs via
the use of publicly available genotypes and expression databases.
Examples of successful identification of QTGs related to addiction using
genetic approaches include Mpdz (189) and Kcnj9 (109). In these and all QTGs
identified to date, a stepwise process was utilized in an effort to eliminate all
other possibilities. The process involved fine mapping, comparing sequence and
expression levels of genes across the progenitor strains, and in vivo
confirmation. Bioinformatic approaches on the other hand, although meant to
accelerate QTG identification, have yet to catch up with the large numbers of
unresolved QTL. Whether one uses purely genetic approaches or combines
genetic and bioinformatic approaches for the identification of QTGs, integration
among diverse genomic data sets is often performed. Furthermore, translating
findings from mouse to human populations is of utmost importance, so as to
achieve additional progress in understanding complex human disorders.
The strategy of integrative functional genomics, complementary to genetic
and bioinformatics approaches, has been successfully applied towards the
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nomination of highly likely candidate genes for alcoholism, bipolar disorder and
drug addiction (117). However, existing integrative functional genomics
methodologies are tailored towards the needs of a specific laboratory and lack
computationally efficient infrastructure in the form of databases, algorithms and
user interface that facilitates genome scale integrative analyses in a seamless
and scalable manner. Here, a web-based software system called GeneWeaver
(www.geneweaver.org) (11) is described that facilitates convergent analyses
across multiple genomic experiments, data sources, platforms and species (11).
Using this system, we demonstrate the integration of empirically derived QTL
mapping results with other relevant genomic data sets, with the aim of
nominating highly likely QTG.
The QTL mapping results described here are for cocaine-induced
locomotor activation in the recently expanded BXD RI genetic reference
population (164). Drug (here, cocaine) induced locomotor activation is an animal
model focused on a very specific and important characteristic of human drug
abuse, i.e., initial sensitivity to drugs. Furthermore, given the heritable and
complex nature of cocaine-induced locomotor activation, it is readily amenable to
the approach of QTL mapping and has been mapped previously in multiple
studies (20, 82, 100). To date, 13 chromosomes and multiple chromosomal
regions have been identified. However, a cocaine-induced activation QTG is yet
to be discovered. Here, using these previously published results in conjunction
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with relevant genomic data sets within the framework of GeneWeaver (12), a
putative QTG is nominated.
Once a QTG has been nominated, confirmation of the gene as the QTG
necessitates in vivo assessment of the gene. Multiple approaches exist for the in
vivo assessment of QTGs, including targeted gene knockouts, transgenic
overexpression and rescue and viral mediated RNA interference. Of these, the
targeted gene knockout approach is utilized here. The targeted gene knockout
approach assesses the role of the QTG by nullifying its function in an otherwise
normal animal. The detection of significant differences in the trait of interest in a
comparison of null to control animals enables further validation and serves as
evidence of the gene as the QTG.

Methods
QTL mapping in the BXD RI
QTL mapping for cocaine-induced locomotor activation after the second
intraperitoneal (ip) injection of 10 mg/kg of cocaine was performed in combined
male and female, male only and female only BXD RI strains using GeneNetwork
(http://www.GeneNetwork.org) and R/QTL (33, 219). R/QTL was utilized for
additional QTL model fitting and to ensure reproducibility of QTLs mapped in
GeneNetwork.org. One thousand permutations were performed to obtain
genome-wide suggestive and significant thresholds. Ninety-five percent
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confidence intervals (CI) were obtained by extracting 1.5-LOD support interval
around the peak marker for statistically suggestive and/or significant QTLs.
Integrative functional genomic analysis of the candidate genes
Positional candidate genes residing within the 1.5 LOD drop support
interval of the Chr 4 and Chr 15 QTLs were deposited to GeneWeaver
(www.geneweaver.org). These gene lists, called ³gene sets´ in GeneWeaver,
were integrated with a core collection of gene sets associated with cocaine,
methamphetamine and nicotine. This core collection consists of empirically
derived gene sets associated with mammalian phenotype (MP) and gene
ontology (GO) annotations, previously published QTLs, gene expression studies
obtained from either the Neuroscience Information Framework
(http://www.neuinfo.org) or previous publications, striatal and nucleus accumbens
basal gene expression obtained from Allen Brain Atlas (http://www.brainmap.org), polymorphic genes among the BXD RI strain panel and lastly, BXD
gene expression correlates for striatal and nucleus accumbens to locomotor
response after the second ip injection of 10 mg/kg of cocaine using GeneNetwork
(http://www.GeneNetwork.org). The complete list of gene sets used in this
analysis is provided in Appendix Table A1.
*HQH:HDYHU¶V3KHQRPH0DSWRROZDVXWLOL]HGfor the integrative analysis
of each of the two candidate gene sets with the above defined core collection of
gene sets (12). The result obtained using Phenome Map is a hierarchical
representation of gene-to-gene set interactions across the diverse collection of
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gene sets, such that gene(s) shared across a greater number gene sets are
placed at the top of this map. The Phenome Map tool also enables the
generation of a gene-to-gene set association matrix that can be used to calculate
gene membership counts. The gene membership counts can be used to rank
each list of positional candidates to obtain a ranked list (or prioritized list) of
positional candidates for functional validation.
Assessment of Rab3b polymorphisms
The Variant Brower interface in GeneNetwork (33, 36, 219) was queried
for the presence of SNPs among the C57BL/6J (B6) and DBA/2J (D2) strains for
Rab3b. Once locations for SNPs were retrieved, Integrative Genomics Viewer
2.0 was used for the extraction of genomic regions for transcription factor binding
VLWHDQGDVVHVVPHQWRIFU\SWLFVSOLFHVLWHV7KH-DFNVRQ/DERUDWRU\¶VFXVWRP
&%/- ³(YH´ DQG6DQJHU'%$-EDPILOHV(105) were imported in to IGV.
For the prediction of transcription factor binding sites, 1Kb upstream of Rab3b
was used. The B6 and D2 sequences were analyzed for putative TFBS using
AliBaba 2.1 (80). Putative TFBS were then scanned for the presence of the two
upstream polymorphisms. For the assessment of cryptic splice sites, nucleotides
19 bp upstream and downstream of the SNP location (for B6 and D2) were
extracted and compared against consensus splice donor, branch and acceptor
sites. Figure 4-1 depicts the consensus eukaryotic sequence logos, obtained
from enoLOGOS (227) used in this analysis.
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Figure 4-1. Donor, branch and acceptor consensus sequences (227).
Consensus sequences for the determination of cryptic splice sites. GT, A and AG
are the most frequently seen dinucleotides at donor, branch and acceptor
sequences, respectively.
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Animals
Generation of mice with targeted deletions in Rab3a; Rab3b; Rab3c
and/or Rab3d function has been previously described (184). Rab3a
heterozygous and Rab3bcd triple null mice were obtained from The Jackson
Laboratory (Strain Name: B6;129-Rab3btm1Sud Rab3atm1Sud Rab3dtm1Rja
Rab3ctm1Sud/J ; Stock Number: 006375) and bred to produce obligatory Rab3bcd
triple heterozygous (Rab3bcd+/-) and triple null (Rab3bcd-/-) offspring. Ninety-six
mice belonging to three genotype (C57BL/6J, Rab3bcd+/- and Rab3bcd-/-) and
both sexes were tested. Age and sex matched mice were randomly assigned to
the following groups: saline (SAL) and cocaine (COCA). Mice were between 56
and 132 days of age at the start of behavioral testing. All mice were maintained
at The Jackson Laboratory in climate- and 12 h light cycle-controlled rooms and
provided acidified water and 5K52 chow (LabDiet/PMI Nutrition, St. Louis, MO)
ad libitum. The Jackson Laboratory Animal Care and Use Committee approved
all protocols involving mice.
Breeding and genotyping
Mutant mice, B6;129-Rab3btm1SudRab3dtm1RjaRab3ctm1Sud/J carrying
targeted mutations in Rab3b, Rab3c and Rab3d genes were acquired from the
Jackson Laboratory Repository (JR#006375). Production of these mice has been
described by Schluter and colleagues (184). Briefly, all genes were targeted
using a neomycin resistance gene to replace exons encoding either amino acids
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1-76 of Rab3b or exons encoding amino acids 9-84 of Rab3c or Rab3d. The
constructs were independently electroporated into 129P2/OlaHsd ES cells.
Chimeric mice were mated to C57BL/6J mice and the compound mutants
created by intercrossing individual lines. The strain was backcrossed 2 or 3 times
to C57BL/6J before being deposited in the repository. Homozygous triple null
mice were received and maintained by sibling crosses. Heterozygous triple nulls
were produced by crossing to C57BL/6J.
In order to isolate the Rab3b null allele from the Rab3c and Rab3d
knockout alleles (and produce B6.129P2-Rab3btm1sud mice), the triple mutants
were additionally backcrossed to C57BL/6J for 3 or 4 times, selecting for the
Rab3b heterozygotes and Rab3c and Rab3d wild-type loci at each generation.
Experimental Rab3b-/-, Rab3b+/- and Rab3b+/+ mice were generated by
intercrossing Rab3b+/- mice. Progeny were produced in the expected 1:2:1 ratio.
All mice were genotyped for the presence of the wild-type or mutant Rab3b,
Rab3c or Rab3d locus by PCR (184) on genomic DNA isolated from peripheral
blood collected by retro-orbital plexus or submandibular bleeding.
Behavioral analysis
Assessment of acute and sensitized response to cocaine-induced
locomotor activity
Prior to testing, mice from all three genotypes (C57BL/6J, Rab3bcd+/- and
Rab3bcd-/-) were randomly assigned either to a saline (SAL) or cocaine (COCA)
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group. Mice were brought from their home room into the test room and allowed to
habituate for one hour. Mice were administered either saline or cocaine (10
mg/kg) by ip injection. Immediately post injection, mice were placed in an open
field box and locomotor activity was recorded for a duration of 20 minutes using
the EthoVision XT 8 video tracking and analysis system (Noldus Information
Technology, Wageningen, The Netherlands). On Days 1 and 2 of testing all mice
received saline. Day 1 measures locomotor activity in response to injection stress
and novel environment, while Day 2 measures locomotor activity within a familiar
environment and attenuated injection stress. On Days 3, 5, 7 and 9, mice
received their assigned saline or cocaine injection ip.
Assessment of habituation and its effect on cocaine induced
locomotor activity.
Prior to testing mice from all three genotypes (C57BL/6J, Rab3bcd+/- and
Rab3bcd-/-) were randomly assigned to one of three groups ± Group A, B or C.
Group A received saline on all three consecutive days of testing. Group B
received saline on Days 1 and 2 and cocaine (10 mg/kg by ip) on Day 3. Group C
received cocaine (10 mg/kg by ip) on Day 1 only. Group A serves as the baseline
group, while Group B facilitates the assessment of cocaine induced locomotor
activation following two days of habituation. Group C enables the assessment of
cocaine induced locomotor activation in a novel environment, as mice belonging
to this group have not been exposed to test apparatus. Immediately post
injection, mice were placed in an open field box and locomotor activity was
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recorded for a duration of 20 minutes using the EthoVision XT 8 video tracking
and analysis system (Noldus Information Technology, Wageningen, The
Netherlands).
Tissue retrieval
All mice across the three genotypes (C57BL/6J, Rab3bcd+/- and Rab3bcd/-

) subjected to behavioral testing were sacrificed via decapitation 24 ± 48 hrs

following the last behavioral trial. In addition to these three genotypes, a naïve
group of mice representing C57BL/6J (n = 8), DBA/2J (n = 8) and Rab3bcd-/- (n =
8) were also sacrificed via decapitation in an attempt to obtain baseline levels of
gene expression for Rab3b (C57BL/6J and DBA/2J) and Cartpt (C57BL/6J and
Rab3bcd-/-). Striatal regions were extracted and total striatal RNA was isolated.
Striatal RNA from naïve C57BL/6J (n = 8) was used in the analysis of Rab3b
transcript abundance and Cartpt expression. Striatal RNA from naïve DBA/2J (n
= 8) was used in the analysis of Rab3b transcript lengths. Striatal RNA from
naïve Rab3bcd-/- was used in the analysis Cartpt expression
Statistical analysis
Statistical analyses were performed in JMP 9.0 (SAS Institute Inc.,
Raleigh, NC). For the assessment of intra-session habituation, for days 1 and 2
data were binned into five-minute epochs and activity change scores were
calculated using the following formula: activity during the initial five minutes /
[activity during the initial five minutes + activity during the final five minutes]
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(119). Mean activity change scores across all three genotypes for each of the two
days were calculated. These scores were compared with an activity change
score of 0.5 (representing no habituation). Significantly different and lower mean
activity change scores from 0.5 are representative of normal intra-session
habituation. For acute response to cocaine, total distance travelled in 20 minutes
(TD20) on Day 2 was subtracted from TD20 on Day 3 was analyzed using a oneway analysis of variance (ANOVA), with genotype as the only factor. Similarly, for
assessment of sensitized response to cocaine, TD20 on Day 3 was subtracted
from TD20 on Day 9 and analyzed using a one-way ANOVA. Following each
ANOVA, planned contrast statements were utilized to test for significant
differences among the levels of genotype. To assess locomotor response
following repeated exposure to cocaine, a repeated measures ANOVA was
performed. For this analysis day was the within-subject variable and genotype as
the between-subjects variable.
qRT-PCR
Briefly, tissue samples were stored in RNAlater (Life Technologies,
Carlsbad, CA) per manufacturer's instructions and homogenized in TRIzol (Life
Technologies, Carlsbad, CA). Total RNA was isolated by standard TRIzol® Plus
PHWKRGVDFFRUGLQJWRPDQXIDFWXUHU¶VPHWKRGVLQFOXGLQJRQWKHFROXPQ'1DVH
digestion. The quality of the isolated RNA was assessed using an Agilent 2100
Bioanalyzer instrument and RNA 6000 Nano LabChip assay. 500ng of total RNA
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was then reverse transcribed with random decamers and M-MLV RT using the
Message Sensor RT Kit (Life Technologies, Carlsbad, CA).

Results
QTL mapping
Cocaine-induced locomotor activation (second ip injection of 10 mg/kg of
cocaine) was previously mapped separately in BXD RI males and females. No
QTL were detected in the males. In the females, on the other hand, suggestive
QTL were detected on Chr 4 and Chr 15 respectively (p < 0.63, Figure 4-2). The
two QTL additive model involving Chr 4 (rs13477919 @ 104.96 Mb) and Chr 15
(rs13482528 @ 38.82 Mb) accounted for 34.40 % of the trait variance. Taken
independently, the Chr 4 and Chr 15 QTLs accounted for 11.71 % and 15.65 %
of the trait variance respectively. No significant interaction among these loci was
detected. Furthermore, at each of these loci the DBA2/J (D2) allele is the
increasor allele (Figure 4-3A,B) A genome-wide pair scan was also performed,
resulting in the detection of a significant Chr 4 (rs13477881 @ 103.31) x Chr 5
(rs3723202 @ 91.57) interaction (Figure 4-3C, p < 0.001). Inclusion of this
interaction term increases the % variance accounted for by the model to 55.40%.
1.5 LOD support intervals were used to define the 95% CIs. The Chr 4 (COCIA
Chr4) CI spans 101.10 (rs13477873) ± 114.51 (gnf04.110.583) Mb, while the Chr
15 (COCIA Chr15) CI spans 33.43 (rs8267966) ± 45.11 (rs13482547) Mb (Figure
4-4). Positional candidate genes residing in each these regions were obtained by
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Figure 4-2. QTL Mapping of cocaine-induced locomotor activation in the
expanded BXD RI panel.
QTL mapping of locomotor response following the second injection of cocaine in
females resulted in the detection of suggestive QTLs on Chr 4 and Chr 15. Green
lines indicate that DBA/2J is the increaser allele, while red lines indicate that
C57BL/6J is the increasor allele.
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Figure 4-3. Main and interaction effect plots.
A) Effect plot for the peak marker on Chr 4 (rs13477919 @ 104.96 Mb) indicates
a significant effect of genotype (p < 0.0003). Furthermore at this locus the D2derived allele is the increasor allele. B) Effect plot for the peak marker on Chr 15
(rs13482528 @ 38.82 Mb) indicates a significant effect of genotype (p < 0.0001).
C) Interaction plot for the significant Chr 4 (rs13477881 @ 103.31 Mb) x Chr 5
(rs3723202 @ 91. 67 Mb) (p < 0.0001). There is a significant difference in the
phenotypic values when the genotypes at rs3723202 and rs13482528 are BB,
BB and BB, DD, respectively.
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A

B

Figure 4-4. Chromosome 4 and Chromosome 15 QTL LOD support
intervals.
The black horizontal lines represent the 1.5 LOD support interval on Chr 4 (A)
and Chr 15 (B). The LOD support interval on Chr 4 spans 101.10 (rs13477873) ±
114.51 (gnf04.110.583) Mb, while on Chr 15 it spans 33.43 (rs8267966) ± 45.11
(rs13482547) Mb. 108 and 61 positional protein coding candidate genes reside in
the Chr 4 and Chr 15 intervals, respectively.
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searching for genes underlying the flanking marker coordinates in Mouse
Genome Informatics (MGI; http://informatics.jax.org). Each gene list was
uploaded to GeneWeaver.org (11) for integrative functional genomic analysis.
Integrative functional genomic analysis reveals Rab3b as a putative QTG
acute cocaine response
A term search involving keywords pertaining to cocaine,
methamphetamine and nicotine was performed in GeneWeaver (11) followed by
a closer inspection of the search results, gave a total of 122 gene sets with an
average of 72.41 genes per gene set spanning 21 publications. The Phenome
Map analysis tool in GeneWeaver was used to construct an empirically derived
hierarchical representation of the input gene sets for both the Chr 4 and Chr 15
candidate gene list. A ranked list of genes was obtained using the gene-to-gene
set connectivity metric. Rab3b was the most highly ranked gene (gene-to-gene
set connectivity = 7) across Chr 4 (Figure 4-5) and Chr 15. The most highly
connected gene on Chr 15 in this analysis has a gene-to-gene set connectivity of
four. Additional analysis of Rab3b reveals that Rab3b is polymorphic among the
BXD RI panel with 46 intronic polymorphisms, specifically within introns 1 and 2
(Table 4-1). Additionally, a search for polymorphisms less than 1Kb upstream
from Rab3b revealed the presence of two upstream polymorphisms. These
upstream polymorphisms were investigated further for the possibility of serving
as transcription factor binding sites (Table 4-1). Polymorphism at or near
transcription factor binding sites could potentially alter transcription regulation.
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Figure 4-5. Integrative functional analysis in GeneWeaver (11).
A) Phenome map tool depicting a hierarchical representation of gene sets used
in the integrative analysis. Nodes at the top are highly connected genes. Pink
colored nodes represent nodes containing one or more QTL candidate genes.
Rab3b is revealed as the most highly connected QTL candidate gene. B)
GeneSet graph representing the underlying interconnections among the genes
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Table 4-1 Consequence of upstream and intronic polymorphisms between
C57BL/6J and DBA/2J.
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Table 4-1 continued.
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Furthermore, Rab3b is expressed in the dorsal and ventral striatum, downregulated in C57BL/6J and up-regulated in C3H/HeJ after exposure to nicotine
(218), differentially expressed in D1 receptor mutants when compared to their
wild-type controls after saline treatment (236) and is differentially expressed in
the striatum in a recent RNA-Seq gene expression analysis across the C57BL/6J
and DBA/2J BXD RI founder strains (21). Additionally, Rab3b is a candidate
gene among three previously published QTLs, all of which were mapped in the
BXD RI reference population, namely climbing in response methamphetamine
(82), repeated movements following cocaine (100) and hypothalamic Cart
abundance (20). In each of the three QTLs, the D2 derived alleles underlie the
QTL, which is the case for our cocaine-induced locomotor activation QTL on Chr
4 (COCIA Chr4).
Remapping of previously published QTLs
Three previously published QTLs overlap COCIA Chr 4 QTL, namely,
CART transcript abundance (Crq2) (20), methamphetamine related climbing
response (82) and cocaine related behavior (Cocrb5, repeated movements at 5
mg/kg) (100). The advantages of utilizing previously published QTLs are: a) to
achieve reduction in the QTL interval by overlapping the previously published
QTLs on to the cocaine-induced activation QTL and b) to show that locomotor
behaviors after exposure to drugs that affect the dopaminergic system, such as
cocaine and methamphetamine, co-map to a common genomic region in multiple
independent studies. In an attempt to obtain accurate peak marker locations and
129

confidence intervals based on the updated BXD genotypes and mouse genome
builds, each of the three previously published QTLs were remapped. However,
the results of this undertaking were rather surprising. None of the peak markers
on Chr 4 that were originally reported were reproducible (Table 4-2). A closer
inspection of the BXD genotypes used reveals that the peak loci initially reported
are no longer represented in the most recent BXD genotypes, except for Crq2.
The peak marker on Chr 4 for Crq2 is D4Mit249. When marker regression is
performed using D4Mit249 alone, the marker remains significantly associated
with Cart abundance (F (1,23) = 6.96, p < 0.0147). Legacy marker data are
available for Adpf (currently, Plin2) and Mshm6 in MGI. Using these data, a point
biserial correlation analysis was performed (as done in the original publications).
Both markers remain significantly correlated with their corresponding trait data
(Adpf; r = 0.67, p = 0.0008; Mshm6: r = 0.51, p = 0.0107). This suggests due to
the inclusion of additional markers in current BXD genotypes, there exists newer
markers that have better associations with the underlying behavioral data and
hence mask the detection of the original peak loci resulting in a failure to
reproduce the original QTLs.
Assessment of Rab3b polymorphisms
Forty-six intronic and two upstream polymorphisms exist between B6 and D2
(Table 4-1). The upstream polymorphisms, if within potential promoter binding
sites, transcription start sites or transcription factor binding sites, could result in
alterations in gene regulation. The intronic polymorphisms, on the other hand,
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Table 4-2 Remapping of previously published QTLs.

Original
QTLs
(Chr:cM)

Start End
(Mbp)

Marker
(cM:Mbp)

Updated
markerIncreasor
Symbol Reproducible
trait
allele
association
(method)

Allele effects at
markers
C57BL/6J
DBA/2J
Mean ± SE Mean ± SE

61.29
Adfp
(40.69:82.11)
111.29
99.84
D4Mit249
D4Mit249
(4:58.2)
(48.18:124.84)
149.84
Adfp
(4:38.9)
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Ms6hm
(4:40.3)

60.41
110.41

Ms6hm
(40.3:85.41)

Cocrb5
[193]

No

r = 0.67, p =
0.0008 (pbr)

DBA/2J

22.24 ±
5.48

52.24 ±
5.22

Crq2
[192]

No

r = 0.51, p =
0.0107 (pbr)

DBA/2J

23.72 ±
0.39

24.93 ±
0.24

No

F (1,23) =
6.96, p <
0.0147
(sma)

DBA/2J

-0.16 ±
0.33

1.08 ± 0.3

Mrc16
[194]

pbr: point biserial correlations, sma: single marker analysis.

could result in the creation of cryptic splice sites due to the presence of new
splice acceptor, branch and donor sites. To assess the effect of the upstream
polymorphisms, 1 Kbp upstream of Rab3b (specific to B6 and D2) were extracted
for the determination of its promoter region, transcription start site and potential
transcription factor binding sites. Both strain sequences have the same predicted
promoter region, transcription start sites and transcription factor binding sites.
However, an upstream polymorphism (wt37-4-108551617, B6: A> D2: T) exists
at a predicted transcription factor binding sites for nuclear factor 1 or Nf-1.
Assessment of B6 and D2 sequences around the location of the
polymorphisms revealed the presence of putative splice branch sites, a splice
donor site and a splice acceptor site. The two potential splice branch sites are
located at 108.553715 Mb (wt37-4-108553715, B6: G> D2: A) and 108.554864
Mb (wt37-4-108554864, B6: G> D2: A), respectively. Both loci are within intron12 and contain the sequence TTGATT (D2), which closely resembles the
consensus splice branch site sequence (TCCT(A/G)A(C/T)). The splice donor
site is located at 108.557288 (wt37-4-108557288, B6: C> D2: T) within intron1-2
and contains the following sequence TTAGTGTAA (D2). The splice acceptor site
is located at 108.568303 (wt37-4-108568303, B6: G> D2: A) within intron2-3 and
consists of the following sequence CATTCAGG (D2). The donor and splice site
sequence present in D2, closely resembles their corresponding consensus
sequences (Figure 4-1).
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Assessment of cocaine response in Rab3bcd triple null mice
Preliminary in vivo assessment for the role of Rab3b in cocaine response
was performed using targeted gene disruption. Rab3b knockout mice were not
readily available but were available by proxy as a triple knockout in combination
with Rab3c and Rab3d. Rab3c and Rab3d are also members of the Rab3 family,
as are Rab3a and Rab3b. All Rab3 family members, except for Rab3d localize
on synaptic vesicles. As a whole, Rab3's are involved in regulated exocytosis.
Breeding is ongoing for the derivation and purification of Rab3b single knockout.
However, the Rab3bcd triple knockout enables the preliminary assessment of
cocaine response involving a similar set of gene products. There exists the
possibility that manifestation of abnormal cocaine response could be in part due
to elimination of Rab3c and Rab3d, but it should be noted that the COCIA Chr 4
QTL harbors neither of these genes.
Habituation
Assessment of inter- (Figure 4-6A) and intra-session (Figure 4-6B)
habituation on Day 1 and Day 2 revealed that Rab3bcd-/- mice fail to habituate.
To assess intra-session habituation, data were binned into five-minute intervals
C57BL/6J and Rab3bcd+/- mice showed typical habituation curves, i.e.
decreasing locomotor activity over time intervals. Rab3bcd-/- mice, however,
displayed typical habituations patterns for intra-session habituation only on Day 2
(Figure 4-6A). Statistically, intra-session habituation can be determined by
calculating activity change scores (activity during the initial five minutes / [activity
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Figure 4-6. Habituation deficits in the Rab3bcd-/-.
A) Assessment of intra-session habituation reveals that Rab3bcd-/- mice show
abnormal habituation curves. Unlike C57BL/6J and Rab3bcd+/-, Rab3bcd-/- mice
show no decrease in distance travelled over the 20 min test period. Assessment
of activity change scores revealed that C57BL/6J and Rab3bcd+/- had normal
habituation patterns, i.e. significantly different from the activity change score of
0.5 (no habituation) on Day 1 (C57BL/6J: t = -2.95, df = 31,p = 0.006; Rab3bcd+/-:
t = -2.71, df = 31, p = 0.011) and Day 2 (C57BL/6J: t = -8.24, df = 31,p < 0.0001;
Rab3bcd+/-: t = -4.10, df = 31, p = 0.003). Rab3bcd-/- mice showed significantly
different from the activity change score of 0.5 only on Day 2 (Rab3bcd-/-: Day 1: t
= -2.89, df =2 9, p = 0.775; Day 2: t = -2.31, df = 29, p = 0.027). B) Compared to
C57BL/6J and Rab3bcd+/-, Rab3bcd-/- had a marginal increase in total distance
travelled on Day 2 compared to Day 1. Additionally, C57BL/6J depicted
significant decreases in locomotor activity on Day 2 compared to Day 1 (p <
0.0001). While the Rab3bcd+/- exhibit decreased locomotor activity on Day 2
compared to Day 1, this decrease was not significant (p = 0.1175). These two
results suggest that Rab3bcd-/- have inherent habituation deficits. Error bars are
SE
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during the initial five minutes + activity during the final five minutes]) (119).
Activity change scores equal to or nearing 0, 0.5 and 1 are representative of
habituation, no habituation and increased activity compared to the initial time
period, respectively. Mean activity change scores for C57BL/6J, Rab3bcd+/- and
Rab3bcd-/- mice on Day 1 were 0.45 (SEM = 0.02), 0.46 (SEM = 0.01) and 0.50
(SEM = 0.01), respectively. On Day 2 mean activity change scores for C57BL/6J,
Rab3bcd+/- and Rab3bcd-/- mice were 0.41 (SEM = 0.01), 0.45 (SEM = 0.01) and
0.48 (SEM = 0.01), respectively. Comparison of mean activity change scores to
an activity change score of 0.5 (representing no habituation) facilitates
determination of the extent of intra-session habituations among the three
genotypes on days 1 and 2. On Day 1, mean activity change scores for
C57BL/6J and Rab3bcd+/- were statistically different and lower compared to 0.5
(C57BL/6J: t = -2.95, df = 31,p = 0.006; Rab3bcd+/-: t = -2.71, df = 31, p = 0.011).
Inter-session habituation revealed that while C57BL/6J and Rab3bcd+/- mice
show decreased locomotor activity on Day 2 compared to Day 1, Rab3bcd-/- mice
show a marginal increase in locomotor activity (Figure 4-6B). Specifically,
C57BL/6J had significant differences in locomotor activity on Day 1 (Mean =
5946.41, SEM = 196.08) compared to Day2 (Mean = 4979.40, SEM = 175.67) (t
= -4.63, df = 31, p < 0.0001). The decrease in locomotor activity for Rab3bcd+/mice on Day 1 (Mean = 5329.72, SEM = 171.41) compared to Day 2 (Mean =
4943.46, SEM = 203.39) was non-significant (t = -1.61, df = 31, p = 0.117).
Similarly, the marginal increase in locomotor activity on Day 1 (Mean = 5709.17,
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SEM = 201.50) compared to Day 2 (Mean = 5999.13, SEM = 321.62) for the
Rab3bcd-/- was also non-significant (t = 1.1, df = 29, p = 0.280). Furthermore,
over the duration of the behavioral testing protocol, among the SAL group of
mice, Rab3bcd-/- showed consistently greater locomotor activity post saline on
days 2, 3, 5, 7 and 9 compared to C57BL/6J and Rab3bcd+/- mice (Table 4-3,
Figure 4-7).
Acute response to cocaine
Analysis of acute response to cocaine (Day 3COCA – Day 2SAL) revealed a
significant effect of Treatment ! Genotype (F (2,2) = 6.04, p < 0.003) (Figure 48). Specific tests for significant effects of genotype for the COCA and SAL groups
were performed using planned contrasts statements. Planned comparisons
revealed a significant effect of genotype for the COCA groups of mice (F (2,90) =
10.75, p < 0.0001) and not the SAL group (F (2,90) = 0.08, p < 0.92). Within the
COCA group, Rab3bcd -/- mice had the greatest change in locomotor response
following cocaine compared to Rab3bcd +/- and C57BL/6J (Figure 4-8).
Response to repeated exposure to cocaine
A repeated measures analysis of variance approach was used to assess
locomotor response following repeated exposure to cocaine (repeated factor
being day). As assumptions of sphericity were not met, the correction factors of
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Figure 4-7. Consistent increase locomotor activity in saline-treated
Rab3bcd-/-.
Rab3bcd-/- showed consistently greater locomotor activity following saline
compared to C57BL/6J and Rab3bcd+/- mice on all days except Day 1. * indicate
significant differences (p < 0.05). Error bars are SEM.
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Figure 4-8. Rab3bcd-/- and acute cocaine response.
Acute response to cocaine measured here, as the difference in total distance
travelled on Day2 (post saline) from that on Day3 (post cocaine) for the Cocaine
group indicates that Rab3bcd-/- mice have a significant increase in change in
locomotor activity following cocaine compared to Rab3bcd+/- and C57BL/6J mice.
No significant differences exist across the three genotypes among the mice
belonging to the Saline group. Error bars are SEM.
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Table 4-3. Assessment of baseline locomotor differences in Rab3bcd-/-.
Table 4-3 continued.

!

!

!

Day

Genotype1

Genotype2

1

C57BL/6J
C57BL/6J
Rab3bcd-/-

Rab3bcd+/Rab3bcd-/Rab3bcd+/-

Difference
[Genotype1 Genotype2, cm]
616.69
333.07
283.62

2

Rab3bcd-/Rab3bcd-/C57BL/6J

Rab3bcd+/C57BL/6J
Rab3bcd+/-

3

Rab3bcd-/Rab3bcd-/Rab3bcd+/-

!

!

!

LCL

UCL

p

281.76
281.76
281.76

-54.42
-338.03
-387.49

1287.79
1004.18
954.72

0.08
0.47
0.57

1007.27
971.33
35.94

334.59
334.59
334.59

210.34
174.4
-760.99

1804.19
1768.25
832.87

0.01*
0.01*
0.99

C57BL/6J
Rab3bcd+/C57BL/6J

1313.46
1179.46
134

427.37
413.79
427.37

278.46
177.32
-901.01

2348.47
2181.61
1169.01

0.01*
0.02*
0.95

5

Rab3bcd-/Rab3bcd-/C57BL/6J

Rab3bcd+/C57BL/6J
Rab3bcd+/-

1453.04
1307.62
145.41

483.3
499.15
499.15

282.56
98.76
-1063.45

2623.52
2516.49
1354.28

0.01*
0.03*
0.95

7

Rab3bcd-/Rab3bcd-/Rab3bcd+/-

C57BL/6J
Rab3bcd+/C57BL/6J

2073.86
1407.8
666.06

485.82
470.4
485.82

897.28
268.58
-510.52

3250.44
2547.02
1842.64

0.001*
0.01*
0.36
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SE
Difference

Table 4-3 continued.

!

Day

Genotype1

Genotype2

9

Rab3bcd-/Rab3bcd-/Rab3bcd+/-

C57BL/6J
Rab3bcd+/C57BL/6J

!

!
Difference
[Genotype1 Genotype2, cm]
1778.71
1205.1
573.61

* Indicate significant differences (p < 0.05)

!

!

!

SE
Difference

LCL

UCL

p

474.66
459.58
474.66

629.17
92.06
-575.93

2928.25
2318.14
1723.15

0.001*
0.03*
0.45
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the Greenhouse-Geisser Epsilon (G-G) and the Huynh-Feldt Epsilon (H-F) were
used for the assessment of the day ! genotype effect. No significant effect of day
! genotype (F (6,132) = 0.72, G-G: p < 0.61, H-F: p < 0.62) was detected (Figure
4-9).
Sensitized response to cocaine
In addition to assessing the effects of repeated exposure to cocaine in this
panel on mice, we also assessed the development of cocaine sensitization.
Analysis of cocaine sensitization calculated as Day 9COCA – Day 3COCA
locomotion revealed no significant effect of Genotype (F (2,2) = 1.39; p < 0.25).
Effect of habituation on cocaine induced locomotor activation
Assessment of the effect of habituation on cocaine induced locomotor
activation led to the manifestation of a significant habituation x genotype
interaction (F (1,2) = 4.25, p < 0.03). On Day 1, C57BL/6J (Mean = 16815.36,
SEM = 1535.22) and Rab3bcd+/- (Mean = 16018.17, SEM = 1535.22) mice
showed increased cocaine induced locomotor activation compared to Rab3bcd-/(Mean = 11481.20, SEM = 1880.26) mice. Furthermore, following two days of
habituation C57BL/6J (Mean = 8594.24, SEM = 1535.22) and Rab3bcd+/- (Mean
= 10876.61, SEM = 1535.22) exhibited reduced amounts of cocaine induced
locomotor activation compared to Day 1. Unlike the C57BL/6J and Rab3bcd+/-,
Rab3bcd-/- mice showed a marginal non-significant increase in cocaine induced
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Figure 4-9. Rab3bcd-/- and lack of sensitized cocaine response.
On Days 1 and 2 all mice have approximately the same amount of distance
travelled following saline injections. Over the course of the experiment Rab3bcd/mice have higher baseline locomotor activity compared to Rab3bcd+/- and
C57BL/6J. Administration of cocaine (Days 3,5 7 and 9) results in an increase in
locomotor activity for all three genotypes compared to the saline treated group
with Rab3bcd-/- exhibiting the highest amount of locomotor activity across the
three genotypes. Repeated measures ANOVA resulted in no significant increase
in locomotor activity over days following administration of cocaine
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locomotor activation on Day 3 (Mean = 12888.41, SEM = 1681.75) as compared
to Day 1 (Mean = 11481.20, SEM = 1880.26). This result suggests that lack of
habituation exhibited by the Rab3bcd-/- may affect the magnitude of cocaine
induced locomotor activation observed.
Differences in Rab3b transcript lengths between C57BL/6J and DBA/2J
There are four transcripts of Rab3b according to the Vertebrate Genome
Annotation database (VEGA) genome browser (7, 226). Of these four, two are
CCDS or consensus coding sequences of different lengths, henceforth referred
to as Rab3b-L (OTTMUST00000018722) and Rab3b-S
(OTTMUST00000018724) transcripts. Rab3b-/KDVDQH[WHQGHG¶HQG
compared to Rab3b-S. As a possible means of differential regulation of Rab3b
between the BXD progenitors, namely B6 and D2, we sought to quantify
transcript abundance using two TaqMan probes, namely, Mm01258423 and
Mm00772238. Mm01258423 spans Exons 1-2 and hence would uniquely target
Rab3b-L. Mm00772238 span Exons 3±4 and targets both Rab3b-L and Rab3b6¨&t values were analyzed for differential expression across the two strains.
qRT-PCR results suggest that there is no differential expression between the two
strains for either of the probes (Table 4-4, Rab3b-L: p < 0.24; Rab3b-S: p <
0.31).
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Table 4-4. !Ct values for probes targeting Rab3b-S and Rab3b-L transcripts.
Transcript ID
OTTMUST00000018724
OTTMUST00000018722

TaqMan Probe
ID
Mm00772238
Mm01258423

Exons
spanned
Exons 3–4
Exons 1–2

Identifier
Rab3b-S
Rab3b-L

!Ct – Mean ± SE
C57BL/6J
6.29 ± 0.08
6.79 ± 0.08

DBA/2J
6.2 ± 0.04
6.67 ± 0.05
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CART transcript abundance in Rab3bcd -/- and C57BL/6J
A previously published QTL mapping study involving CART transcript
abundance (20) overlapped our COCIA Chr4 QTL. CART or cocaine- and
amphetamine-regulated transcript peptide is involved in reward and
feedingrelated behaviors. Studies in rats have shown that CART mRNA
expression is upregulated after acute cocaine self-administration in brain regions
of the mesocorticolimbic dopamine system (59). To assess the effects of
Rab3bcd KO on cartpt expression, we analyzed CART expression using !Ct
values to detect genotype (Rab3bcd -/- and C57BL/6J) ! treatment (naïve, SAL
and COCA) effects (Table 4-5). The genotype x treatment effect was suggestive
(F (1,2) = 2.58; p < 0.08). No significant differences were observed across
genotypes for the naïve group, suggesting that baseline levels of Cartpt
expression are not altered in Rab3bcd mutants. Planned contrasts were used to
detect differences in CART expression following saline or cocaine treatment.
Following saline and cocaine treatment Cartpt is differentially expressed across
the two genotypes (SAL: F (1,42) = 10.03, p < 0.003; COCA: F (1,42) = 11.10, p
< 0.002). Within genotype contrasts failed to detect any significant differences
across the two treatments (Rab3bcd-/-: F (1,42) = 1.76, p < 0.19; C57BL/6J: F
(1,42) = 1.84, p < 0.18). These results suggest that it is unlikely that disruption of
Rab3bcd alone induces dysregulation of Cartpt. However, in combination with
external factors, in this case repeated handling and injection stress, an increase
in Cartpt expression was detected (Table 4-6). There was a significant genotype
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Table 4-5. Cartpt !Ct values for C57BL/6J and Rab3bcd-/- among naïve,
saline and cocaine treated mice.
!!
!Ct – Mean ± SE
Genotype
!
Treatment
C57BL/6J
Rab3bcd-/Naïve
10.24 ± 0.19
10.12 ± 0.23
Saline
10.55 ± 0.11
9.75 ± 0.15
Cocaine
10.22 ± 0.16
9.42 ± 0.18
Gapdh was used in the calculations of !Ct.
Table 4-6. Cartpt !Ct values for C57BL/6J and Rab3bcd-/- among naïve and
challenged (saline and cocaine treated) mice.
!!
!Ct – Mean ± SE
Genotype
!
Challenge
C57BL/6J
Rab3bcd-/Naïve
10.24 ± 0.19
10.12 ± 0.23
Challenge (saline or cocaine)
10.36 ± 0.11
9.58 ± 0.11
Gapdh was used in the calculations of !Ct.
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! challenge (naïve or injection) effect when the cocaine and saline injected mice
were collapsed and grouped as “challenge” (F (1,1) = 4.69; p < 0.03). Planned
contrasts revealed a significant difference in Cartpt expression between
Rab3bcd-/- naïve and injected mice (F (1,44) = 6.18; p < 0.02). No significant
difference in Cartpt expression was detected between C57BL/6J, naïve and
challenge mice (F (1,44) = 0.33; p < 0.57).

Discussion
The highly heritable component of alcoholism and drug addiction has led
to numerous studies attempting to understand and characterize the genetic basis
of addiction. One method that has been widely used for the unbiased detection of
genomic regions harboring polymorphic candidate genes for complex traits is
QTL mapping. Widespread utilization of this approach has resulted in the
detection of large numbers of QTL harboring numerous candidate genes with
only a handful of candidate genes within these QTL being successfully
nominated and validated as the QTG. Most, if not all QTG have been identified
using a combination of approaches such as fine mapping, sequence and
expression level comparison of genes between progenitor strains or between
congenics and background strains (138). While genetic methods have
successfully identified QTGs, they have been extremely time- and resourceintensive, often-taking years and large numbers of mice (especially recombinant
progeny required for fine-mapping a QTL interval). Complementary bioinformatic
tools have been proposed as a means of accelerating QTG identification but to
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date very few genes have been nominated as QTG (57, 84, 151). A strategy with
tremendous potential in facilitating QTG discovery that has emerged over the last
few years is integrative functional genomics. This strategy, as the name
suggests, involves integration of candidate genes with empirically derived
genome-scale information available via published studies that span multiple
platforms, species, and curated data repositories, such as Mammalian
Phenotype Ontology (MP,(194)), Gene Ontology (GO, (3)) and Kyoto
Encyclopedia of Genes and Genomes (KEGG, (102)). This strategy has been
successfully applied towards the analysis of bipolar disorder (117, 151). Existing
integrative approaches suffer from a lack of cross-species integration, scalability
and computationally efficient algorithms, in order to achieve true genome-wide
integrative analysis. Cross-species integration is vital to facilitate translation of
research findings from induced animal models to humans. To facilitate a
theoretically comprehensive integrative analysis, i.e. no limit on the number of
gene sets in the analysis, it is important that integrative approaches be scalable.
By being computationally efficient, reasonable analysis run times can be
achieved, making genome scale integrative analysis feasible.
Presented here is the integrative functional genomic analysis of the
candidate genes for a previously mapped cocaine-induced activation QTL in BXD
RI strain panel (164). By incorporating multiple independent lines of evidence, it
is possible to efficiently and seamlessly query a QTL interval, in an unbiased
manner, and nominate QTGs. In the current analysis, empirical information was
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derived from 21 published studies, totaling 122 genomic data sets. Using these
genomic data sets Rab3b was identified as the most highly ranked (maximum
gene to gene set connectivity) positional candidate for the COCIA Chr4 QTL.
RAB proteins are proteins belonging to the family of Ras-like GTPases.
These proteins are primarily involved in trafficking of secretory and endocytic
vesicles of eukaryotic cells (133, 154). Sixty known RAB proteins exist, of these
RAB¶VDUHWKHPRVWDEXQGDQWDQGH[SUHVVHGDWYDULDEOHOHYHOVLQWKHEUDLQ (85,
197, 203). The RAB3 protein family consists of four homologous isoforms,
namely, RAB3A, 3B, 3C and 3D$PRQJWKH5$%¶VRAB3A, 3B and 3D colocalize on presynaptic vesicles, while RAB3D localizes on secretory vesicles on
exocrine glands (72, 152, 183). RAB¶VDUHLQYROYHGin regulated exocytosis and
are involved in docking, priming and fusion stages of the synaptic vesicle cycle.
Specifically, in vitro studies have revealed that RAB3 proteins inhibit Ca2+triggered exocytosis in PC12 cells (183). Additional lines of evidence support the
involvement of RAB3 in inhibition of neurotransmitter release. Overexpression of
GTPase-deficient mutants of RAB3 inhibits release of neurotransmitters and
hormones (92, 93, 97, 171). Overexpression of the catalytic domain of RAB3
GEP, which promotes the exchange of GDP for GTP on RAB3, reduces
exocytosis (157). Decreasing the expression of Rab3a via antisense
oligonucleotides microinjection, resulted in an increase in response to repetitive
stimulations (97). In vitro and in vivo studies involving overexpression of Rab3b
in dopamine neurons of the rat SN increases dopamine content, uptake, number
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and size of synaptic vesicles, and levels of presynaptic proteins consistent with
the results obtained in studies involving RAB3B (40). Within the synapse a
number of putative effector proteins of RAB3 exist. These include RIMs (RIM1
and RIM2 ), Rabphillin, NOC2, SNAP-25, synapsin, synaptogamin and CaM.
Among these, it has been shown that disruption of RAB3A-CaM interaction (and
not the other effector proteins) result in the lack of inhibition in exocytosis by
RAB3 (46). Furthermore, overexpression of Rab3b also leads to an increase in
CaM (190). Similar to disrupting the RAB3A-CaM interaction, one can
hypothesize that disruption of the RAB3B-CaM interaction could also lead to
RAB3 inhibition of exocytosis, primarily due to the redundant functionality and
high degree of homology among the Rab3 proteins.
While Rab3b¶VIXQFWLRQDOinvolvement in inhibiting neurotransmitter
release makes it a highly attractive candidate gene for drug addiction, is it a
QTG? Using the characteristics of a QTG suggested by the Complex Trait
Consortium (CTC) (5) and Glazier and colleagues (78), we show that Rab3b
satisfies multiple criteria that makes it a highly likely and valid QTG. These are:
a) Rab3b is polymorphic between the B6 and D2, the progenitor strains for the
BXD RI genetic reference population. Two upstream and 46 intronic
polymorphisms located within the first and second introns of Rab3b exist(Table
4-2). Detailed analysis these polymorphisms using the recent Sanger
resequencing project (105) revealed important insights regarding the nature of
these polymorphisms. Of the two upstream polymorphisms, one (wt37-4151

108551617, B6: A>D2: T) underlies the potential transcription factor binding site
of nuclear factor 1(NF-1). This could potentially result in differential gene
regulation of Rab3b across the B6 and D2 strains. Among the intronic
polymorphisms, the D2 sequences of four SNPs closely resemble the consensus
sequences for splice acceptor (wt37-4-108568303, B6: G>D2: A), branch (wt374-108553715, B6: G> D2: A; wt37-4-108554864, B6: G> D2: A) and donor (wt374-108557288, B6: C> D2: T) sites (Table 4-2). These polymorphisms could
potentially create cryptic splice sites due to the presence of novel splice
acceptor, branch and donor sites again resulting in differential regulation of
Rab3b across B6 and D2 strains, b) Rab3b is expressed in brain regions relevant
to cocaine related responses. It is expressed in the striatum, nucleus accumbens
and the ventral tegmental area (www.brain-map.org). Each of these brain regions
contain dopaminergic neurons and plays a central role in cocaine-mediated
behaviors, c) Rab3b is differentially expressed following chronic nicotinic
exposure across five brain regions in two inbred strains of mice, namely,
C57BL/6J and C3H/HeJ (218). Specifically, Rab3b was down regulated in the
nucleus accumbens of C57BL/6J mice, while being upregulated in the ventral
tegmental area of C3H/HeJ mice. Furthermore, a recent RNA-Seq study has
shown that Rab3b (p < 0.02, q-value < 0.07) is differentially expressed in the
striatum of C57BL/6J and DBA/2J strains of mice (21). The differential
expression of Rab3b across the two strains could be attributable to the presence
of functional SNPS, i.e. cryptic splice sites and can be experimentally validated,
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and d) The COCIA Chr4 QTL harboring Rab3b, has also been detected in three
previous mapping studies for cart transcript abundance (20), methamphetamine
related climbing response (82) and cocaine related behavior (repeated
movements at 5 mg/kg) (100). It should be noted that we were not able to
reproduce the results from the above-mentioned three original publications using
new BXD genotypes and interval mapping. The non-reproducibility is in the
location of QTLs upon remapping the original publications. Even though there is
disparity in the location of the remapped QTLs compared to previously published
QTLs, it must be noted that this disparity does not affect the results of the IFG
analysis. Rab3b is still the most highly connected gene regardless of the
inclusion of the previously published QTLs.
To validate Rab3b as a QTG, an in vivo gene targeting approach was
used. Rab3b KO mice are only available as a triple KO, which also involves
Rab3c and Rab3d. Among the Rab3bcd-/- mice, two of the three RAB3 proteins
that co-localize on presynaptic vesicles, namely Rab3b and Rab3c, are absent.
Rab3d does not localize within synaptic vesicles (72, 152, 183) and may not be
involved in regulated exocytosis. This could result in possible alterations in the
inhibition of exocytosis by Rab3s. Given this, we would expect the Rab3bcd-/mice to have increased neurotransmitter release (here dopamine), which
behaviorally would result in increased locomotor activity following saline and
cocaine treatment. As shown in Figure 4-7, this was in fact observed; Rab3bcd -/mice consistently had increased locomotor activity post saline (suggesting
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habituation deficits) compared to their Rab3bcd-/- and C57BL/6J mice throughout
the length of the study. Furthermore, the cocaine response observed is an acute
response (Figure 4-8) rather than a sensitized response (Figure 4-9).
Interestingly, we also detected significant differences in Cartpt expression across
naïve and treated Rab3bcd-/- mice. This suggests a role of Rab3bcd in Cartpt
variation following external stressors, in this case repeated injection and handling
stress. This is of additional value as one of the previously published QTLs
overlapping the COCIA Chr4 QTL was for Cartpt expression in the BXD RI strain
panel and mapped to a region on Chr 4 that contains Rab3b. The similar levels of
Cartpt after saline and cocaine exposure might be attributed to the harvesting of
brain regions after 24 ± 48 hr from the last cocaine injection.
Future work will involve backcrossing and purification of Rab3b-/- mice to
N5 and higher, at which stage they can be considered as incipient congenic
strains followed by assessment of acute cocaine response in the Rab3b single
nulls. While functional validation of the Rab3b-/- mice will serve as proof of
Rab3b¶VLQYROYHPHQWLQFRFDLQHUHVSRQVHLWVWLOOZLOOQRWXQHTXLYRFDOO\SURYHWKDW
it is the QTG. Conclusive proof that Rab3b is the QTG can be obtained via
additional fine-mapping of the QTL using RISTs (50). As this approach starts with
recombinants among the RI strain panel within the QTL interval, it can readily be
applied to the COCIA Chr4 QTL that was mapped in the BXD RI strain panel.
The COCIA Chr4 QTL interval contains twelve recombinants, namely, BXD 13,
15, 16, 28, 32, 43, 55, 67, 86, 87 90 and 100. Of these twelve, BXD 55 and BXD
154

86 are double recombinants. BXD 33 could also possibly be a double
recombinant. BXD 15, 16, 28, 67 and 87 strains are best suited for the derivation
of RISTs as they contain almost equal progenitor strain contribution in the QTL
interval. There are two RIST populations, namely, RIST-F2 and RIST-BC,
available for fine-mapping a QTL. Since the original QTL was detected in the
BXD RI mapping population, which only allows for assessment of additive
effects, the RIST-F2 approach will be most suited for fine mapping. Another
approach that can be used to verify Rab3b as a QTG is to perform a QTL ±
knockout interaction test or quantitative complementation test (52, 196). In order
to do so, four strains are required. Two co-isogenic strains, one containing the
QXOODOOHOHZKLOHWKHRWKHUEHLQJWKHZLOGW\SH7KHVHVWUDLQVDUHFDOOHG³&URVV´LQ
this approach. The other twRVWUDLQVDUH³KLJK´DQG³ORZ´SKHQRW\SLFVWUDLQV
7KHVHVWUDLQVDUHUHIHUUHGWRDV³/LQH´7KHQH[WVWHSLQYROYHVFURVVLQJWKHQXOO
strain with the high and low strains, to obtain high/null and low/null F1 hybrids.
Similarly, the wild-type (137) is crossed with the high and low strains to obtaining
high/wt and low/wt F1 hybrids. A significant Line x Cross interaction in an
ANOVA analysis is interpreted as evidence that the knockout is in fact the QTL.
Rgs2 was validated as the gene underlying the QTL using this approach (230).
However, the possibility that the significant interaction is due to the gene of
interest interacting with loci on other chromosomes cannot be ruled out. An
approach such as reciprocal hemizygosity, first applied for the dissection of
quantitative traits in yeast (126), can help resolve such issues.
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While the eventual proof of a candidate gene as the QTG lies in genetic
approaches, in silico approaches can help point future studies in the right
direction through the identification and nomination of putative QTG. As shown
here, using an integrative functional genomics approach within the framework of
GeneWeaver (www.geneweaver.org), Rab3b was identified as a putative QTG
for acute cocaine response. GeneWeaver facilitates the detection of putative
QTGs by its extensive and well-curated data repository of functional genomic
studies that span multiple species and experimental platforms. In addition to this
H[WHQVLYHGDWDUHSRVLWRU\*HQH:HDYHU¶VFRPSXWDWLRQDOO\UREXVWdatabase and
efficient graph theoretical algorithmic enable integrative analysis to be performed
at a truly genomic scale. These features make GeneWeaver an extremely useful
and applicable resource for the acceleration of QTG identification and nomination
by well-defined hypothesis driven integrative analyses.
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CHAPTER V: CONCLUSION
The results presented here address the key issue for efficient nomination of
Quantitative Trait Genes (QTG). Nomination and validation of a QTG is the end
goal of all Quantitative Trait Locus (QTL) mapping studies. Despite the
widespread utilization of QTL mapping, very few QTG have been nominated and
validated. This is partly attributable to the power and resolution with which a QTL
is mapped that depends heavily upon the genetic architecture of the mapping
population or experimental crosses utilized. Frequently, the resolution
(confidence interval; CI) of a mapped QTL is large and harbors numerous
positional candidate genes, which makes the task of QTG nomination tedious.
Improvements in statistical methodologies and experimental crosses have greatly
improved the prospect of QTG nomination.
To address the issue of efficient QTG nomination, the methodology and
results assess the current and future state for QTL to QTG discovery by:
•

Assessing the power and resolution of QTL mapping in two recently
developed experimental crosses, the BXD RI (Chapter II) and the
collaborative cross (CC, Chapter III)

•

Presenting integrative functional genomics as an alternative in silico
approach for the successful nomination of QTGs (Chapter IV).
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QTL mapping in the expanded BXD Recombinant Inbred and the emerging
collaborative cross mouse strains
The BXD recombinant inbred (RI) strain panel has been a widely used
mapping population for the study of complex traits. Prior to their recent
expansion, the original panel of BXD RI strains (n = 26) was able to reliably
detect QTLs accounting for 32% of trait variance (power = 0.90, alpha = 0.05)
(18). QTL accounting for such large trait variance are representative of QTL
underlying Mendelian rather than complex traits. Hence, genes underlying such
QTL would be Mendelian rather than quantitative trait genes. Following the
expansion, the number of RI strains in the BXD panel increased to approximately
90 strains, facilitating the detection of QTL accounting for as little as 11% of trait
variance (power = 0.90, alpha = 0.05). Additionally, the increased number of
strains makes feasible the detection of epistatic interactions. In Chapter II, the
recently expanded BXD RI strains were utilized for genetic analysis of a multitude
of complex traits. In total, 257 behavioral traits were assayed across an average
of 60 BXD RI strains. The majority of the traits were amenable to QTL mapping
(broad sense heritability or h2 > 0.30) with better mapping resolution
performance. Furthermore, QTLs accounting for approximately 16% of trait
variance can be detected with 90% power (alpha = 0.05) using 60 BXD RI
strains. Mapping resolution, determined using the 95% CI, revealed that the
mean 95% CI of significant QTL (LOD > 3.2 (73)) was 12.5 cM, a considerable
improvement from 20-30 cM that was achieved using the initial BXD RI strain
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panel. Part of this improvement is attributable to dense marker maps, but it is
largely due to the increased numbers of recombination events in the expanded
BXD RI strains (162). Despite these improvements, the BXD RI strain panel
suffers from the unavoidable constraint of limited genetic variation. On average,
two progenitor RILs capture approximately 15% of available genetic variation
(genetic variation captured in the BXD RILs is about 16%), primarily due to their
shared ancestry and large haplotype blocks (162, 232, 233). The limited
SHUFHQWDJHRIFDSWXUHGJHQHWLFYDULDELOLW\OHDGVWR³EOLQGVSRWV´LQ47/PDSSLQJ
Blind spots are regions of limited or no variation within RILs, which mask the
presence and impede the detection of true QTLs (175). These limitations
necessitate the generation of advanced experimental crosses, such as the CC.
The CC is derived from eight inbred strains rather than two. The eight inbred
strains chosen for the derivation of the CC are C57BL/6J, 129S1/SvImJ,
NOD/LtJ, A/J, NZO/HiLtJ, CAST/EiJ, WSB/EiJ and PWK/PhJ (34, 42, 211).
Three of the eight founder strains, namely, CAST/EiJ, PWK/PhJ and WSB/EiJ
are wild-derived strains representing, M. m. castaneus, M. m. musculus and M.
m. domesticus mouse sub-species, respectively. The eight combined inbred
strains capture 89% of the available genetic variation (175). The increased
genetic variation results in smaller regions of identity by descent (IBD) that
consequently reduces the presence of blind spots. In addition to increased
genetic variation, the CC is expected to have higher numbers of recombination
events and larger numbers of independent genetically diverse RI strains, each a
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fine-grained mosaic of the eight founder strains. The increased amount of genetic
variation and higher number of recombinations are expected to greatly improve
QTL mapping resolution in the CC, once completed. In Chapter III, an
assessment of QTL mapping in the early breeding generations of the CC was
performed. QTL mapping in this population achieved an average confidence
interval (1.5-LOD support interval around the significant QTL peaks) of 3.98 Mb
(approximately 2 cM) with an average of 50 positional candidate genes in these
intervals (8, 165). This is a considerable reduction in QTL mapping resolution
compared to the BXD RI strain panel. However, QTL mapping in the CC still
does not achieve single gene resolution, necessitating additional fine mapping to
further reduce the QTL interval.
In silico reduction of QTL intervals
Thus far almost all the QTGs nominated and validated have made use
of genetic approaches. While successful, these approaches are considerably
resource and time intensive, and do not necessarily expedite the process of QTG
nomination and validation. To expedite QTG discovery, complementary
bioinformatic tools have been developed. Unfortunately, current bioinformatic
tools require considerable end-user involvement due to the disparate nature of
empirically derived genomic data sets. This severely limits the ability with which
they can be used to perform a truly cross-species and cross-platform oriented
integrative genomic analysis. An approach that has emerged over the last few
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years and has tremendous potential in addressing and resolving these issues is
integrative functional genomics.
The appeal of integrative functional genomics lies in its ability to
facilitate convergent analyses across multiple genomic experiments, platforms
and species (11). This approach can help expedite QTG discovery, as candidate
genes within a QTL interval can be integrated with other relevant empirically
derived genomic data sets across multiple species to nominate highly relevant
QTG. In Chapter IV, the approach of integrative functional genomics is
implemented using GeneWeaver (www.geneweaver.org) that facilitates
computationally efficient integrative functional genomic analyses by providing
comprehensive data sources and analytical toolsets (11). Using GeneWeaver,
Rab3b is nominated as a putative QTG for a cocaine-induced locomotor
activation QTL on Chr 4 mapped in the expanded BXD RI strain panel (164).
Rab3b meets multiple criteria that justify its classification as a QTG, including
relevant polymorphism (here, intronic cryptic splice site polymorphisms),
differential expression in the striatum across C57BL/6J and DBA/2J inbred
strains (21) and basal expression in mesocorticolimbic regions of the brain.
Additionally, functional evaluation of the Rab3 complex in cocaine response was
performed using mixed background Rab3bcd triple knockout (KO) mice (B6;129
Rab3bcd-/-). This analysis revealed the role of Rab3b in acute cocaine response.
Specifically, Rab3bcd-/- mice have increased cocaine-induced activation
compared to Rab3bcd+/- and C57BL/6J mice in a test for acute cocaine response.
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Conclusive evidence of Rab3b as the QTG will be obtained by: a) derivation and
functional evaluation of the Rab3b single KO mice, b) additional fine-mapping of
the cocaine-induced locomotor activation QTL on Chr 4 using recombinant inbred
segregation tests (RISTs) and c) experimental validation of the potential splice
branch site polymorphisms.
The nomination of Rab3b as the putative QTG for cocaine-induced
locomotor activation speaks to the utility and efficiency of integrative functional
genomics and GeneWeaver. The analysis that led to its identification consisted of
122 empirically derived genomic data sets spanning 21 publications. The efficient
algorithm and database features within GeneWeaver resulted in rapid generation
of a prioritized or ranked list of positional candidates within the cocaine-induced
locomotor activation QTL, with Rab3b ranked first. Furthermore, no single study
or line of evidence pointed towards Rab3b as the likely QTG. It was the
convergence of suggestive results from these multiple independent studies that
led to the nomination of Rab3b. This is an important point to note, since often
times (and naturally) published results only contain significant findings with
suggestive findings being either discarded or overlooked. In a field such as QTL
mapping wherein suggestive evidence is acceptable, it is important to utilize all
available information (significant or suggestive) for finding QTG underlying
suggestive QTL. However, the results of such integrative analysis should be
interpreted with extreme caution to ensure the validity of such findings. This
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responsibility lies entirely in the hands of the researcher and must be undertaken
prior to embarking upon any kind of biological validation of in silico findings.
The future of QTG nomination and validation
As advanced mouse genetic resources continue to become available,
finding genes that underlie complex traits will undoubtedly occur at a faster pace
with increased success. For example, the generation of the CC RI panel is
nearing completion. As of 2011, approximately 100 CC strains were to be derived
(211). The CC, as preliminary studies have revealed, will certainly improve QTL
mapping resolution. Furthermore, mapping populations derived from the CC,
such as the Diversity Outbred (DO), will also serve as a high-resolution mapping
resource. In fact, QTL mapping studies in the DO, like the CC, have shown
considerable improvements in QTL mapping resolution (125). Improved QTL
mapping resolution results in fewer positional candidate genes, making the task
of QTG nomination feasible. Applying the approach of integrative functional
genomics to these positional candidate genes will aid in the rapid and efficient
nomination highly relevant QTG. These putative QTG can then be readily
validated using targeted transgenic mouse technologies. This step will be greatly
expedited, in larger part due to the efforts of the Knockout Mouse Project (124)
and the International Mouse Knockout Consortium (45), that are in the process of
generating knockouts for all protein coding genes. These resources, in concert
with high-throughput sequencing technologies such as RNA-Seq, will further aid
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in the nomination of highly relevant QTG, facilitating an improved understanding
of the genetic basis of complex traits.
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APPENDIX
Table A1. List of gene sets used in the integrative functional genomic
analysis using GeneWeaver (11).
Table A1 continued.
Gene set
Gene set Name
ID
Genetic influences on
impulsivity, risk taking,
GS1132
stress responsivity and
vulnerability to drug abuse
and addiction.
Distinctive profiles of gene
expression in the human
GS1229
nucleus accumbens
associated with cocaine
and heroin abuse.
Distinctive profiles of gene
expression in the human
GS1231
nucleus accumbens
associated with cocaine
and heroin abuse.
Distinctive profiles of gene
expression in the human
GS1232
nucleus accumbens
associated with cocaine
and heroin abuse.
Gene Expression in
Human Hippocampus
from Cocaine Abusers
GS1256
Identifies Genes which
Regulate Extracellular
Matrix Remodeling.
Candidate genes,
pathways and
mechanisms for bipolar
(manic-depressive) and
GS3649
related disorders: an
expanded convergent
functional genomics
approach.
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Pubmed
ID

Additional
information

16251987

NA

16710320

Differentially
expressed among
both cocaine and
heroin abusers

16710320

Upregulated in both
cocaine and heroin
abusers

16710320

Upregulated in
cocaine abusers but
downregulated in
heroin abusers

18000554

NA

15314610

NA

Table A1 continued.
Gene set
Gene set Name
ID
Nicotine causes agedependent changes in
GS14885
gene expression in the
adolescent female rat
brain.

GS14888

GS14890

GS14891

GS14892

GS14893

GS14905

Strain- and region-specific
gene expression profiles
in mouse brain in
response to chronic
nicotine treatment.
Strain- and region-specific
gene expression profiles
in mouse brain in
response to chronic
nicotine treatment.
Strain- and region-specific
gene expression profiles
in mouse brain in
response to chronic
nicotine treatment.
Strain- and region-specific
gene expression profiles
in mouse brain in
response to chronic
nicotine treatment.
Strain- and region-specific
gene expression profiles
in mouse brain in
response to chronic
nicotine treatment.
Molecular genetics of
nicotine dependence and
abstinence: whole
genome association using
520,000 SNPs.

181

Pubmed
ID

Additional
information

17234382

NA

Differentially
expressed genes
modulated by nicotine
17504244 in five combined brain
regions (Amyg, HP,
NA, PFC and VTA) for
C3H/HeJ mice
Downregulated genes
in five combined brain
17504244
regions, Amyg, HP,
NA, PFC and VTA, in
C57BL/6J mice
Upregulated genes in
five combined brain
17504244
regions, Amyg, HP,
NA, PFC and VTA, in
C57BL/6J mice
17504244

Downregulated genes
in five brain regions,
NA, PFC, and VTA, in
C3H/HeJ mice

17504244

Upregulated genes in
three brain regions,
NA, PFC, and VTA, in
C3H/HeJ mice

17407593

Genes implicated in
nicotine dependence

Table A1 continued.
Gene set
Gene set Name
ID
Molecular genetics of
nicotine dependence and
GS14906
abstinence: whole
genome association using
520,000 SNPs.
Genome-wide association
for nicotine dependence
GS14907
and smoking cessation
success in NIH research
volunteers.
Genome-wide association
for nicotine dependence
GS14908
and smoking cessation
success in NIH research
volunteers.
Gene profiling the
response to repeated
GS14909 cocaine self-administration
in dorsal striatum: a focus
on circadian genes.
Region-specific
transcriptional response to
GS15464
chronic nicotine in rat
brain.
Nicotine modulates the
expression of a diverse
GS18839
set of genes in the
neuronal SH-SY5Y cell
line.
Nicotine modulates the
expression of a diverse
GS18841
set of genes in the
neuronal SH-SY5Y cell
line.
Novel genes identified in a
high-density genome wide
GS26287
association study for
nicotine dependence.

182

Pubmed
ID

Additional
information

17407593

Genes implicated in
smoking cessation

19009022

19009022

Nicotine Dependence
Genes found in
Genome-wide
Association Studies
(GWAS)
Nicotine Abstinence
Genes found in
Genome-wide
Association Studies
(GWAS)

18452895

NA

11478936

NA

12588870

12588870

17158188

Downregulated
Nicotine-dependent
genes in human
neuroblastoma (SHSY5Y) cells
Upregulated Nicotinedependent genes in
human
neuroblastoma (SHSY5Y) cells
NA

Table A1 continued.
Gene set
Gene set Name
ID
Cholinergic nicotinic
receptor genes implicated
in a nicotine dependence
GS26304
association study targeting
348 candidate genes with
3713 SNPs.
Cholinergic nicotinic
receptor genes implicated
in a nicotine dependence
GS26305
association study targeting
348 candidate genes with
3713 SNPs.
Gene Expression in
Human Hippocampus
from Cocaine Abusers
GS26324
Identifies Genes which
Regulate Extracellular
Matrix Remodeling
A genomewide
association study of
GS46978
nicotine and alcohol
dependence in Australian
and Dutch populations.
A genomewide
association study of
GS46980
nicotine and alcohol
dependence in Australian
and Dutch populations.
A genomewide
association study of
GS46981
nicotine and alcohol
dependence in Australian
and Dutch populations.
A genomewide
association study of
GS46983
nicotine and alcohol
dependence in Australian
and Dutch populations.

183

Pubmed
ID

Additional
information

17135278

Genes with SNPs
associated with
nicotine dependence

17135278

Nicotine dependence
Candidate Genes
combined from
GWAS and SNP
association methods

18000554

NA

18000554

Nicotine Dependence
in Australian DNAPools

18000554

Comorbid Alcohol
and Nicotine
Dependence in
Australian DNA-Pools

18000554

Meta-Analysis of
Nicotine Dependence
in Australian and
Dutch Samples

18000554

Nicotine Dependence
in Dutch Sample

Table A1 continued.
Gene set
Gene set Name
ID
The dissection of
transcriptional modules
GS75633 regulated by various drugs
of abuse in the mouse
striatum.
The dissection of
transcriptional modules
GS75635 regulated by various drugs
of abuse in the mouse
striatum.
The dissection of
transcriptional modules
GS75636 regulated by various drugs
of abuse in the mouse
striatum.
The dissection of
transcriptional modules
GS75637 regulated by various drugs
of abuse in the mouse
striatum.
Methamphetamine
induces dopamine D1
receptor-dependent
GS86511
endoplasmic reticulum
stress-related molecular
events in the rat striatum.
Distinctive profiles of gene
expression in the human
GS86571
nucleus accumbens
associated with cocaine
and heroin abuse.
Essential role of the
histone
GS86697
methyltransferaseG9a in
cocaine-induced plasticity.
Distinctive profiles of gene
expression in the human
GS86937
nucleus accumbens
associated with cocaine
and heroin abuse.
184

Pubmed
ID

Additional
information

20459597

Genes regulated by
methamphetamine in
mouse striatum, 1h

20459597

Genes regulated by
methamphetamine in
mouse striatum, 2h

20459597

Genes regulated by
methamphetamine in
mouse striatum, 4h

20459597

Genes regulated by
methamphetamine in
mouse striatum, 8h

19564919

Table 1: METH
administration causes
changes in ER stressrelated genes

16710320

NA

20056891

NA

16710320

NA

Table A1 continued.
Gene set
Gene set Name
ID

Pubmed
ID

GS87050

Repeated cocaine
administration induces
gene expression changes
through the dopamine D1
receptors.

15770241

GS87302

Gene expression profile of
the nucleus accumbens of
human cocaine abusers:
evidence for dysregulation
of myelin.

15009677

GS87306

Repeated cocaine
administration induces
gene expression changes
through the dopamine D1
receptors.

15770241

GS87365

Transcriptional changes
common to human
cocaine, cannabis and
phencyclidine abuse.

17205118

GS87516

Methamphetamine
induces dopamine D1
receptor-dependent
endoplasmic reticulum
stress-related molecular
events in the rat striatum.
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19564919

Additional
information
395 genes are
differentially down- (-)
or up-(+ ) regulated in
the CPu in D1
receptor mutant mice
compared to wild-type
mice after repeated
saline injections
NA
109 genes are
differentially down- (-)
or up-(+ ) regulated in
the CPu in D1
receptor mutant mice
compared to wild-type
mice after repeated
cocaine
administration
Table S2: Full list of
significantly regulated
transcripts in
postmortem aPFC
from cocaine,
phencyclidine and / or
cannabis abusers.
(Whole Table) [DRG]
Table S3: SCH23390sensitive METHresponsive genes in
the rat striatum (173
genes)

Table A1 continued.
Gene set
Pubmed
Gene set Name
ID
ID
Methamphetamine
induces dopamine D1
receptor-dependent
GS87527
19564919
endoplasmic reticulum
stress-related molecular
events in the rat striatum.
GO:0050780 dopamine
GS93572
NA
receptor binding
GO:0050780 dopamine
GS93573
NA
receptor binding
GO:0060160 negative
regulation of dopamine
GS94395
NA
receptor signaling
pathway
GO:0007191 activation of
adenylate cyclase activity
GS94413
NA
by dopamine receptor
signaling pathway
GO:0007195 inhibition of
adenylate cyclase activity
GS94417
NA
by dopamine receptor
signaling pathway
GO:0001963 synaptic
GS94576
transmission,
NA
dopaminergic
GO:0031752 D5
GS95079
NA
dopamine receptor binding
GO:0031750 D3
GS95081
NA
dopamine receptor binding
GO:0031751 D4
GS95082
NA
dopamine receptor binding
GO:0042417 dopamine
GS95241
NA
metabolic process
GO:0005330
GS95389
dopamine:sodium
NA
symporter activity
GO:0060161 positive
regulation of dopamine
GS95559
NA
receptor signaling
pathway
186

Additional
information
Table S4: SCH23390resistant METHresponsive genes in
the rat striatum (372
genes)
NA
NA
NA

NA

NA

NA
NA
NA
NA
NA
NA

NA

Table A1 continued.
Gene set
Gene set Name
ID
GO:0019811 cocaine
GS95590
binding
GO:0035240 dopamine
GS95732
binding
GO:0007269
GS95842
neurotransmitter secretion
GO:0042220 response to
GS96672
cocaine
GO:0042053 regulation of
GS96863
dopamine metabolic
process
GO:0042416 dopamine
GS97110
biosynthetic process
GO:0033602 negative
GS97790
regulation of dopamine
secretion
GO:0004500 dopamine
GS97887
beta-monooxygenase
activity
GO:0001593 dopamine
GS97959
D4 receptor activity
GO:0004952 dopamine
GS97960
receptor activity
GO:0001591 dopamine
GS97961
receptor activity, coupled
viaGi/Go
GO:0001590 dopamine
GS97962
D1 receptor activity
GO:0001670 dopamine
GS98438
D2 receptor activity
GO:0032227 negative
regulation of synaptic
GS99511
transmission,
dopaminergic
GO:0032226 positive
regulation of synaptic
GS99512
transmission,
dopaminergic
GO:0032225 regulation of
GS99513
synaptic transmission,
dopaminergic
187

Pubmed
ID

Additional
information

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

Table A1 continued.
Gene set
Gene set Name
ID
GO:0051583 dopamine
GS99535
uptake
GO:0051585 negative
GS99536
regulation of dopamine
uptake
GO:0051584 regulation of
GS99537
dopamine uptake
GO:0051586 positive
GS99538
regulation of dopamine
uptake
GO:0060159 regulation of
GS99966
dopamine receptor
signaling pathway
GO:0006585 dopamine
GS100542 biosynthetic process from
tyrosine
GO:0007212 dopamine
GS100663
receptor signaling
pathway
GO:0060158 activation of
phospholipase C activity
GS101218
by dopamine receptor
signaling pathway
GO:0005329 dopamine
GS101469
transmembrane
transporter activity
GO:0031749 D2
GS101610
dopamine receptor binding
GO:0031748 D1
GS101611
dopamine receptor binding
GO:0015872 dopamine
GS101683
transport
GO:0045963 negative
GS102100
regulation of dopamine
metabolic process
GO:0042420 dopamine
GS102436
catabolic process
GO:0045964 positive
GS103206
regulation of dopamine
metabolic process
188

Pubmed
ID

Additional
information

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

Table A1 continued.
Gene set
Gene set Name
ID
GO:0048148 behavioral
GS103507
response to cocaine
GO:0001588 dopamine
GS103863 receptor activity, coupled
viaGs
GO:0014059 regulation of
GS103955
dopamine secretion
GO:0001589 dopamine
GS103980
D5 receptor activity
GO:0033603 positive
GS104211
regulation of dopamine
secretion
GO:0033076 isoquinoline
GS104228
alkaloid metabolic process
GO:0071542
GS105153
dopaminergic neuron
differentiation
GO:0001592 dopamine
GS105758
D3 receptor activity
MP:0002556 abnormal
GS107749
cocaine consumption
MP:0004077 abnormal
GS108180
striatum morphology
MP:0009754 enhanced
GS108435
behavioral response to
cocaine
MP:0009758 impaired
GS108445
behavioral response to
cocaine
MP:0001905 abnormal
GS109244
dopamine level
MP:0009943 abnormal
olfactory bulb
GS109499
periglomerular cell
morphology
MP:0001906 increased
GS110717
dopamine level
MP:0005643 decreased
GS111278
dopamine level
MP:0001988 cocaine
GS111849
preference
189

Pubmed
ID

Additional
information

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

Table A1 continued.
Gene set
Pubmed
Gene set Name
ID
ID
MP:0010149 abnormal
GS113111
synaptic dopamine
NA
release
MP:0003243 abnormal
GS113769
dopaminergic neuron
NA
morphology
MP:0003244 loss of
GS113770
NA
dopaminergic neurons
Discordant Nicotine Twins
GS114711
NA
Significant S-score Genes
Concordant Nicotine
GS114712 Twins Significant S-score
NA
Genes
Genome-wide association
for nicotine dependence
GS121068
and smoking cessation
19009022
success in NIH research
volunteers.
Cocaine interacting genes
GS122445
NA
(MeSH:D003042) in CTD
Methamphetamine
GS122980
interacting genes
NA
(MeSH:D008694) in CTD
Dopamine Antagonists
GS123349
interacting genes
NA
(MeSH:D018492) in CTD
arachidonyl dopamine
GS124877
interacting genes
NA
(MeSH:C474941) in CTD
dopamine quinone
GS126894
interacting genes
NA
(MeSH:C104705) in CTD
Dopamine interacting
GS126983 genes (MeSH:D004298) in
NA
CTD
ABA Average Intensity for
GS128000 Striatum dorsal region Chr
NA
4
ABA Average Intensity for
GS128002
Striatum ventral region
NA
Chr 4
190

Additional
information
NA
NA
NA
NA
NA

NA

NA
NA
NA
NA
NA
NA
NA
NA

Table A1 continued.
Gene set
Gene set Name
ID
ABA Average Intensity for
GS128083 Striatum dorsal region Chr
15
ABA Average Intensity for
GS123084
Striatum ventral region
Chr 15
G128007
BXD SNP Count Chr4
GS128085
BXD SNP Count Chr 15
RhoA, encoding a
GS128080 RhoGTPase, is associated
with smoking initiation.
Positional candidate
genes for Cocaine
Sensitization - TOTAL
GS128185
locomotion ( cm in 1 hr)
[Cocaine] in Females for
Suggestive BXD QTL on
Chr4 from 102 to 112 Mb
Gene expression
correlations for Nucleus
accumbens to cociane
GS128186
induced locomotor
activation following the
first (10 mg/kg) exposure
to cocaine
Gene expression
correlations for Striatum to
cocaine induced
GS128187
locomotor activation
following the first (10
mg/kg) exposure to
cocaine
Gene expression
correlations for Nucleus
accumbens to cocaine
GS128188
induced locomotor
activation following the
second (10 mg/kg)
exposure to cocaine

191

Pubmed
ID

Additional
information

NA

NA

NA

NA

NA
NA

NA
NA

17284169

NA

19958391

NA

19958391

NA

19958391

NA

19958391

NA

Table A1 continued.
Gene set
Gene set Name
ID
Gene expression
correlations for Striatum to
cocaine induced
GS128189
locomotor activation
following the second (10
mg/kg) exposure to
cocaine
Chromosomal loci that
influence oral nicotine
GS128205 consumption in C57BL/6J
x C3H/HeJ F2 intercross
mice.
Positional candidate
genes for Cocaine
Sensitization - TOTAL
GS33776
locomotion ( cm in 1 hr)
[Cocaine] in Females for
Suggestive BXD QTL on
Chr15 from 30 to 55 Mb

192

Pubmed
ID

Additional
information

19958391

NA

17010155

NA

19958391

NA
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